Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

Share Name	Share Symbol	Market	Type
Archer Daniels Midland Company	NYSE:ADM	NYSE	Common Stock

	Price Change	% Change	Share Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-0.33	-0.62%	53.19	53.63	52.87	53.05	2,943,552	00:04:24

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D. C. 20549

FORM 10-Q/A

AMENDMENT NO. 1

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission file number 1-44

ARCHER-DANIELS-MIDLAND COMPANY

(Exact name of registrant as specified in its charter)


Delaware		41-0129150
(State or other jurisdiction of incorporation or organization)		(I. R. S. Employer Identification No.)

77 West Wacker Drive, Suite 4600
Chicago,	Illinois	60601
(Address of principal executive offices)		(Zip Code)

(312) 634-8100

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, no par value	ADM	NYSE
1.000% Notes due 2025		NYSE

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐.

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer

☒

Accelerated Filer

☐

Emerging Growth Company

☐

Non-accelerated Filer

☐

Smaller Reporting Company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒.

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Common Stock, no par value – 494,437,789 shares

(April 29, 2024)

SAFE HARBOR STATEMENT

This Quarterly Report on Form 10-Q/A contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical fact included in this Quarterly Report on Form 10-Q/A, are forward-looking statements. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as “anticipate,” “estimate,” “expect,” “project,” “plan,” “intend,” “believe,” “may,” “outlook,” “will,” “should,” “can have,” “likely,” and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. For example, all statements the Company makes relating to its future results and operations, growth opportunities, pending litigation and investigations, and timing of the remediation of the Company’s material weakness in the Company’s internal control over financial reporting are forward-looking statements. All forward-looking statements are subject to significant risks, uncertainties and changes in circumstances that could cause actual results and outcomes to differ materially from the forward-looking statements. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties, including, without limitation, those that are described in Item 1A, "Risk Factors" included in our Annual Report on Form 10-K/A for the year ended December 31, 2023, as may be updated in this or subsequent Quarterly Reports on Form 10-Q. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements. Except to the extent required by law, Archer-Daniels- Midland Company does not undertake, and expressly disclaims, any duty or obligation to update publicly any forward-looking statement whether as a result of new information, future events, changes in assumptions or otherwise.

Explanatory Note

Archer-Daniels-Midland Company (the “Company”) is filing this Amendment No. 1 on Form 10-Q/A (this “Amendment”) to its Quarterly Report on Form 10‑Q for the quarter ended March 31, 2024, which was originally filed with the United States Securities and Exchange Commission (“SEC”) on April 30, 2024 (the “Form 10‑Q”).

In filing this Amendment, the Company is restating its previously issued unaudited consolidated financial statements as of March 31, 2024 and 2023 and for the quarters ended March 31, 2024 and 2023 (collectively, the “Affected Periods”) for the correction of certain segment-specific historical financial information as further described below.

In addition, the Company filed an amendment to its Annual Report on Form 10-K for the year ended December 31, 2023 and intends to file an amendment to its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, originally filed with the SEC on March 12, 2024 and July 30, 2024, respectively (such reports, together with this Amendment, the “Amended Reports”). All material restatement information will be included in the Amended Reports, and the Company does not intend to separately amend other filings that were previously filed with the SEC.

Accordingly, investors and other readers should rely only on the financial information and other disclosures regarding the periods described above in this Amendment and in any other future filings with the SEC (as applicable) and should not rely on any previously issued or filed reports, press releases, corporate presentations or similar communications relating to the Affected Periods.

Background of Correction

Following ongoing dialogue with the staff of the SEC, the Company concluded that it would amend the 2023 Form 10-K and Form 10-Qs for the first and second quarters of 2024 (collectively, the “Q1 and Q2 2024 Form 10-Qs”) to restate the segment information disclosure included in those filings. These restatements do not impact ADM’s Consolidated Statements of Earnings, Consolidated Statements of Comprehensive Income (Loss), Consolidated Balance Sheets, Consolidated Statements of Cash Flows or Consolidated Statements of Shareholders’ Equity as of and for the periods presented in the Amended Reports.

As previously disclosed in Note 13. Segment Information, to the Company’s unaudited Consolidated Financial Statements included in the Form 10-Q, the Company identified and corrected certain intersegment sales amounts that either (i) were not in accordance with prior disclosures about presenting such sales at amounts approximating market or (ii) included intrasegment sales (resulting from sales within the segment) and should have included exclusively intersegment sales (resulting from sales from one segment to another). In connection with the error corrections, the Company identified a material weakness in its internal control over financial reporting related to its accounting practices and procedures for intersegment sales. The Company put in place a plan to remediate this material weakness, as disclosed in the 2023 Form 10-K and Q1 and Q2 2024 Form 10-Qs.

In the course of testing new controls implemented as part of the Company’s material weakness remediation plan in the third quarter of 2024, the Company identified additional misclassified intersegment transactions. These newly identified errors concern additional intersegment sales for each of its Ag Services and Oilseeds, Carbohydrate Solutions and Nutrition segments that included certain intrasegment sales and should have included exclusively intersegment sales. The Company also identified some intersegment transactions between Ag Services and Oilseeds and Carbohydrate Solutions that were not accounted for consistently in accordance with revenue recognition and segment reporting standards and should not have been reported as intersegment sales. The Company also is correcting certain segment disclosure presentation errors in the Amended Reports.

This Amendment reflects corrections for the newly identified errors related to intersegment sales (described below), the previously-corrected errors related to intersegment sales and segment operating profit, and other segment disclosure corrections (See Note 1 to the Consolidated Financial Statements in this Amendment for further information).

Restatement of Consolidated Financial Statements

This Amendment includes unaudited restated Consolidated Financial Statements for the Affected Periods. See Note 13 to the Consolidated Financial Statements in this Amendment for the restated unaudited segment information as of March 31, 2024 and 2023 for the quarters ended March 31, 2024 and 2023.

Items Amended in This Filing

This Amendment amends and restates the following items of the Form 10-Q:

•Part I - Item 1. Financial Statements

•Part I - Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

•Part I - Item 4. Controls and Procedures

•Part II - Item 1A. Risk Factors

•Part II - Item 6. Exhibits

The exhibit list included in Item 6, “Exhibits” herein has been amended to contain currently dated certifications from the Company’s Chief Executive Officer (as Principal Executive Officer) and Chief Financial Officer (as Principal Financial Officer), as required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002 and filed as Exhibits 31.1/31.2 and 32.1/32.2, respectively.

In accordance with applicable SEC rules, this Form 10-Q/A also includes an updated signature page.

Please note that the only changes to the Form 10-Q are those related to the matters described herein and only in the Items listed above. Otherwise, this Amendment speaks as of the original filing date of the Form 10-Q, and does not modify, amend or update any other item or disclosures in the Form 10-Q. As such, this Amendment does not reflect events occurring after the filing of the Form 10-Q or modify or update those disclosures affected by subsequent events.

Such subsequent information or events include, among others, the information and events described in our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2024, which we are restating currently with this Amendment, and the information and events described in our Current Reports on Form 8-K filed subsequent to the date of the Form 10-Q. For a description of such subsequent information and events, please read our reports filed pursuant to the Exchange Act subsequent to the date of the Form 10-Q, which update and supersede certain information contained in the Form 10-Q and this Amendment.

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

Archer-Daniels-Midland Company

Consolidated Statements of Earnings

(Unaudited)


	Three Months Ended March 31,
	2024		2023
	(In millions, except per share amounts)

Revenues	$	21,847	$	24,072
Cost of products sold	20,188		21,992
Gross Profit	1,659		2,080

Selling, general, and administrative expenses	951		881
Asset impairment, exit, and restructuring costs	18		7
Equity in earnings of unconsolidated affiliates	(212)		(174)
Interest and investment income	(123)		(134)
Interest expense	166		147
Other (income) expense – net	(26)		(44)
Earnings Before Income Taxes	885		1,397

Income tax expense	166		225
Net Earnings Including Noncontrolling Interests	719		1,172

Less: Net earnings (losses) attributable to noncontrolling interests	(10)		2

Net Earnings Attributable to Controlling Interests	$	729	$	1,170

Average number of shares outstanding – basic	513		550

Average number of shares outstanding – diluted	514		551

Basic earnings per common share	$	1.42	$	2.13

Diluted earnings per common share	$	1.42	$	2.12

Dividends per common share	$	0.50	$	0.45

See notes to consolidated financial statements.

Archer-Daniels-Midland Company

Consolidated Statements of Comprehensive Income (Loss)

(Unaudited)


	Three Months Ended March 31,
	2024		2023
	(In millions)

Net earnings including noncontrolling interests	$	719	$	1,172
Other comprehensive income (loss):
Foreign currency translation adjustment	4		153
Tax effect	(20)		14
Net of tax amount	(16)		167

Pension and other postretirement benefit liabilities adjustment	(4)		(26)
Tax effect	1		(13)
Net of tax amount	(3)		(39)

Deferred gain (loss) on hedging activities	(69)		(104)
Tax effect	10		16
Net of tax amount	(59)		(88)

Unrealized gain (loss) on investments	(7)		4
Tax effect	(1)		(1)
Net of tax amount	(8)		3
Other comprehensive income (loss)	(86)		43
Comprehensive income (loss)	633		1,215

Less: Comprehensive income (loss) attributable to noncontrolling interests	(13)		(1)

Comprehensive income (loss) attributable to controlling interests	$	646	$	1,216

See notes to consolidated financial statements.

Archer-Daniels-Midland Company

Consolidated Balance Sheets


(In millions)	March 31, 2024		December 31, 2023
	(Unaudited)
Assets
Current Assets
Cash and cash equivalents	$	830	$	1,368

Segregated cash and investments	7,381		7,228
Trade receivables - net	4,178		4,232
Inventories	11,634		11,957

Other current assets	4,983		4,982
Total Current Assets	29,006		29,767

Investments and Other Assets
Investments in affiliates	5,566		5,500

Goodwill and other intangible assets	7,051		6,341
Right of use assets	1,285		1,211
Other assets	1,327		1,304
Total Investments and Other Assets	15,229		14,356

Property, Plant, and Equipment
Land and land improvements	573		573
Buildings	5,940		5,876
Machinery and equipment	20,298		20,223
Construction in progress	1,421		1,360
	28,232		28,032
Accumulated depreciation	(17,636)		(17,524)
Net Property, Plant, and Equipment	10,596		10,508

Total Assets	$	54,831	$	54,631

Liabilities, Temporary Equity, and Shareholders’ Equity
Current Liabilities
Short-term debt	$	1,734	$	105
Trade payables	5,599		6,313
Payables to brokerage customers	8,176		7,867
Accrued expenses and other payables	3,922		4,076
Current lease liabilities	298		300
Current maturities of long-term debt	1		1

Total Current Liabilities	19,730		18,662

Long-Term Liabilities
Long-term debt	8,245		8,259
Deferred income taxes	1,291		1,309
Non-current lease liabilities	1,010		931
Other	1,016		1,005
Total Long-Term Liabilities	11,562		11,504

Temporary Equity - Redeemable noncontrolling interest	307		320

Shareholders’ Equity
Common stock	2,720		3,154
Reinvested earnings	23,069		23,465
Accumulated other comprehensive income (loss)	(2,570)		(2,487)
Noncontrolling interests	13		13
Total Shareholders’ Equity	23,232		24,145
Total Liabilities, Temporary Equity, and Shareholders’ Equity	$	54,831	$	54,631

See notes to consolidated financial statements.

Archer-Daniels-Midland Company

Consolidated Statements of Cash Flows

(Unaudited)


(In millions)	Three Months Ended March 31,
	2024		2023


Operating Activities
Net earnings including noncontrolling interests	$	719	$	1,172
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities
Depreciation and amortization	280		259
Asset impairment charges	3		3
Deferred income taxes	(64)		47
Equity in earnings of affiliates, net of dividends	(136)		(113)
Stock compensation expense	66		65


Deferred cash flow hedges	(69)		(104)
(Gain) losses on sales/revaluation of assets	14		(11)
Other – net	69		(8)
Changes in operating assets and liabilities, net of acquisitions and dispositions
Segregated investments	(159)		(935)
Trade receivables	61		488
Inventories	295		52

Other current assets	163		328
Trade payables	(713)		(1,556)
Payables to brokerage customers	319		(460)
Accrued expenses and other payables	(148)		(837)
Total Operating Activities	700		(1,610)

Investing Activities
Capital expenditures	(328)		(327)
Net assets of businesses acquired	(915)		—
Proceeds from sales of assets	6		13


Investments in affiliates	(4)		(4)




Other – net	11		(10)
Total Investing Activities	(1,230)		(328)

Financing Activities

Long-term debt payments	—		(2)
Net borrowings (payments) under lines of credit agreements	1,619		1,306

Share repurchases	(1,327)		(351)
Cash dividends	(257)		(248)

Other – net	(37)		(107)
Total Financing Activities	(2)		598

Effect of exchange rate on cash, cash equivalents, restricted cash, and restricted cash equivalents	(13)		(6)
Increase (decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents	(545)		(1,346)
Cash, cash equivalents, restricted cash, and restricted cash equivalents - beginning of period	5,390		7,033

Cash, cash equivalents, restricted cash, and restricted cash equivalents - end of period	$	4,845	$	5,687

Reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents to the consolidated balance sheets

Cash and cash equivalents	$	830	$	899
Restricted cash and restricted cash equivalents included in segregated cash and investments	4,015		4,788
Total cash, cash equivalents, restricted cash, and restricted cash equivalents	$	4,845	$	5,687

See notes to consolidated financial statements.

Archer-Daniels-Midland-Company

Consolidated Statements of Shareholders’ Equity

(Unaudited)


	Common Stock			Reinvested Earnings		Accumulated Other Comprehensive Income (Loss)		Noncontrolling Interests		Total Shareholders’ Equity
(In millions, except per share amounts)	Shares	Amount












Balance, December 31, 2023	513	$	3,154	$	23,465	$	(2,487)	$	13	$	24,145
Comprehensive income
Net earnings				729				(10)
Other comprehensive income (loss)						(83)		(3)
Total comprehensive income										633
Cash dividends paid - $0.50 per share				(257)						(257)
Share repurchases	(13)			(868)						(868)
Share repurchases prepayment		(462)								(462)
Stock compensation expense	3	66								66
Stock option exercises net of taxes	(1)	(41)								(41)

Other	—	3		—		—		13		16
Balance, March 31, 2024	502	$	2,720	$	23,069	$	(2,570)	$	13	$	23,232















Balance, December 31, 2022	547	$	3,147	$	23,646	$	(2,509)	$	33	$	24,317


Comprehensive income
Net earnings				1,170				2
Other comprehensive income (loss)						46		(3)
Total comprehensive income										1,215
Cash dividends paid - $0.45 per share				(248)						(248)
Share repurchases	(4)			(351)						(351)
Stock compensation expense	3	65								65
Stock option exercises net of taxes	(1)	(108)								(108)
Other	—	2		—		—		4		6
Balance, March 31, 2023	546	$	3,106	$	24,217	$	(2,463)	$	36	$	24,896

See notes to consolidated financial statements.

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements

(Unaudited)

Note 1. Basis of Presentation and Restatement of Previously Filed Consolidated Financial Statements

The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, these statements do not include all of the information and footnotes required by GAAP for audited financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024. For further information, refer to the consolidated financial statements and notes thereto included in the Annual Report on Form 10-K/A for the year ended December 31, 2023 for Archer-Daniels-Midland Company (the Company or ADM).

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany accounts and transactions have been eliminated. The Company consolidates all entities, including variable interest entities (VIEs), in which it has a controlling financial interest. For VIEs, the Company assesses whether it is the primary beneficiary as defined under the applicable accounting standard. Investments in affiliates, including VIEs through which the Company exercises significant influence but does not control the investee and is not the primary beneficiary of the investee’s activities, are carried at cost plus equity in undistributed earnings since acquisition and are adjusted, where appropriate, for basis differences between the investment balance and the underlying net assets of the investee and impairments determined to be other than temporary in nature. The Company’s portion of the results of certain affiliates and results of certain VIEs are included using the most recent available financial statements. In each case, the financial statements are within 93 days of the Company’s year end and are consistent from period to period.

Restatement of Previously Filed Financial Statements

Following ongoing dialogue with the staff of the United States Securities and Exchange Commission, the Company concluded that it would amend its fiscal year 2023 Form 10-K (the “FY2023 Form 10-K”) and Forms 10-Q for the first and second quarters of 2024 (collectively, the “Q1 and Q2 2024 Form 10-Qs”) to restate the segment information disclosure included in those filings. These restatements do not impact ADM’s Consolidated Statements of Earnings, Consolidated Statements of Comprehensive Income (Loss), Consolidated Balance Sheets, Consolidated Statements of Cash Flows or Consolidated Statements of Shareholders’ Equity as of and for the periods presented in the Amended Reports.

As previously disclosed in Note 13. Segment Information, to ADM’s consolidated financial statements included in the Form 10-Q for the quarter ended March 31, 2024, ADM identified and corrected certain intersegment sales amounts that either (i) were not in accordance with prior disclosures about presenting such sales at amounts approximating market or (ii) included intrasegment sales (resulting from sales within the segment) and should have included exclusively intersegment sales (resulting from sales from one segment to another). In connection with the error corrections, ADM identified a material weakness in its internal control over financial reporting related to its accounting practices and procedures for intersegment sales. The Company put in place a plan to remediate this material weakness, as disclosed in the FY2023 Form 10-K and Q1 and Q2 2024 Form 10-Qs.

In the course of testing new controls implemented as part of the Company’s material weakness remediation plan in the third quarter of 2024, ADM identified additional intrasegment sales previously misclassified and reported as intersegment sales. These newly identified errors concern intersegment sales for each of its Ag Services and Oilseeds, Carbohydrate Solutions and Nutrition segments that included certain additional intrasegment sales and should have included exclusively intersegment sales. The Company also identified some intersegment sales between Ag Services and Oilseeds and Carbohydrate Solutions that were not accounted for consistently in accordance with revenue recognition and segment reporting standards and should not have been reported as intersegment sales.

The Company also is correcting certain segment disclosure presentation errors. In this Amendment, the Company is revising its reconciliation and calculation of total segment operating profit. The revised reconciliation in Note 13. Segment Information presents a subtotal for total segment operating profit that is equal to the sum of the segment operating profit reported for each of the Ag Services and Oilseeds, Carbohydrate Solutions and Nutrition segments. Amounts for other business and specified items,

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 1. Basis of Presentation and Restatement of Previously Filed Consolidated Financial Statements (Continued)

which previously were reflected in the calculation of total segment operating profit, are now reflected as reconciling items, similar to Corporate, between total segment operating profit and earnings before income taxes.

The Company has restated its Consolidated Financial Statements for the quarters ended March 31, 2024 and 2023 in Note 13, Segment Information (Unaudited).

Segregated Cash and Investments

The Company segregates certain cash, cash equivalents, and investment balances in accordance with regulatory requirements, commodity exchange requirements, and insurance arrangements. These balances represent deposits received from customers of the Company’s registered futures commission merchant and commodity brokerage services, cash margins and securities pledged to commodity exchange clearinghouses, and cash pledged as security under certain insurance arrangements. Segregated cash and investments also include restricted cash collateral for the various insurance programs of the Company’s captive insurance business. To the degree these segregated balances are comprised of cash and cash equivalents, they are considered restricted cash and cash equivalents on the consolidated statements of cash flows.

Receivables

The Company records receivables at net realizable value in trade receivables, other current assets, and other assets. These amounts include allowances for estimated uncollectible accounts to reflect any loss anticipated on the accounts receivable balances including any accrued interest thereon. The Company estimates uncollectible accounts by pooling receivables according to type, region, credit risk rating, and age. Each pool is assigned an expected loss co-efficient to arrive at a general reserve based on historical write-offs adjusted, as needed, for regional, economic, and other forward-looking factors. The Company minimizes credit risk due to the large and diversified nature of its worldwide customer base. ADM manages its exposure to counter-party credit risk through credit analysis and approvals, credit limits, and monitoring procedures. Long-term receivables recorded in other assets were not material to the Company’s overall receivables portfolio.

Changes to the allowance for estimated uncollectible accounts are as follows:


	March 31, 2024		March 31, 2023
	(In millions)
Beginning, January 1	$	215	$	199
Current year provisions	5		4
Recoveries	8		1
Write-offs against allowance	(13)		(24)
Foreign exchange translation adjustment	1		1
Other	—		1
Ending, March 31	$	216	$	182

Write-offs against allowance in the three months ended March 31, 2024 were primarily related to long-term receivables. Write-offs against allowance in the three months ended March 31, 2023 were primarily related to allowance on receivables that were subsequently sold.

Inventories

Certain merchandisable agricultural commodity inventories, which include inventories acquired under deferred pricing contracts, are stated at market value. In addition, the Company values certain inventories using the first-in, first-out (FIFO) method at the lower of cost or net realizable value.

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 1. Basis of Presentation and Restatement of Previously Filed Consolidated Financial Statements (Continued)

The following table sets forth the Company’s inventories as of March 31, 2024 and December 31, 2023.


	March 31, 2024		December 31, 2023
	(In millions)
Raw materials and supplies	$	1,880	$	1,944
Finished goods	3,047		3,026
Market inventories	6,707		6,987
Total inventories	$	11,634	$	11,957

Included in raw materials and supplies are work in process inventories which were not material as of March 31, 2024 and December 31, 2023.

Cost Method Investments

Cost method investments of $421 million and $438 million as of March 31, 2024 and December 31, 2023, respectively, were included in Other Assets in the Company’s consolidated balance sheets. Revaluation loss of $18 million in the three months ended March 31, 2024 was related to an investment in alternative protein and precision fermentation, partially offset by an upward adjustment of $2 million. There were no revaluation gains or losses in the three months ended March 31, 2023. Revaluation gains and losses are recorded in interest and investment income in the Company’s consolidated statements of earnings. As of March 31, 2024, the cumulative amounts of upward and downward adjustments were $115 million and $94 million, respectively.

Note 2. New Accounting Standards

Through December 31, 2024, the Company has the option to adopt the amended guidance of Accounting Standards Codification (ASC) 848, Reference Rate Reform, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The expedients and exceptions provided by the amended guidance do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2024, except for hedging relationships existing as of December 31, 2024, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. Through March 31, 2024, ADM has completed the transition of its financing, funding, and hedging portfolios from LIBOR to alternative reference rates. The transition did not have an impact on the Company’s consolidated financial statements.

Effective December 31, 2024, the Company will be required to adopt the amended guidance of ASC 280, Segment Reporting, which improves disclosures about a public entity’s reportable segments and addresses requests from investors and other allocators of capital for more detailed information about a reportable segment’s expenses. The amended guidance improves reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses and permits entities to disclose more than one measure of a reportable segment’s profitability used by the Chief Operating Decision Maker. The adoption of the amended guidance will result in expanded disclosures in the Company’s segment and geographic information footnote but will not have an impact on the consolidated financial statements.

Effective December 31, 2025, the Company will be required to adopt the amended guidance of ASC 740, Income Taxes, which enhances the transparency and decision usefulness of income tax disclosures. The amendments address investor requests for more transparency about income tax information. The adoption of the amended guidance will result in expanded disclosures in the Company’s income taxes footnote but will not have an impact on the consolidated financial statements.

Note 3. Revenues

Revenue Recognition

The Company principally generates revenue from merchandising and transporting agricultural commodities, and manufacturing products for use in food, beverages, feed, energy, and industrial applications, and ingredients and solutions for human and

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 3. Revenues (Continued)

animal nutrition. Revenue is measured based on the consideration specified in the contract with a customer. The Company follows a policy of recognizing revenue at a single point in time when it satisfies its performance obligation by transferring control over a product or service to a customer. The majority of the Company’s contracts with customers have one performance obligation and a contract duration of one year or less. The Company applies the practical expedient in paragraph 10-50-14 of ASC 606, Revenue from Contracts with Customers, (Topic 606) and does not disclose information about remaining performance obligations that have original expected durations of one year or less. For transportation service contracts, the Company recognizes revenue over time as the mode of transportation moves towards its destination in accordance with the transfer of control guidance of Topic 606. The Company recognized revenue from transportation service contracts of $193 million and $178 million for the three months ended March 31, 2024 and 2023, respectively. For physically settled derivative sales contracts that are outside the scope of Topic 606, the Company recognizes revenue when control of the inventory is transferred within the meaning of Topic 606 as required by ASC 610-20, Gains and Losses from the Derecognition of Nonfinancial Assets (Topic 610-20).

Shipping and Handling Costs

Shipping and handling costs related to contracts with customers for the sale of goods are accounted for as a fulfillment activity and are included in cost of products sold. Accordingly, amounts billed to customers for such costs are included as a component of revenues.

Taxes Collected from Customers and Remitted to Governmental Authorities

The Company does not include taxes assessed by governmental authorities that are (i) imposed on and concurrent with a specific revenue-producing transaction and (ii) collected from customers, in the measurement of transaction prices or as a component of revenues and cost of products sold.

Contract Liabilities

Contract liabilities relate to advance payments from customers for goods and services the Company has yet to provide. Contract liabilities of $508 million and $626 million as of March 31, 2024 and December 31, 2023, respectively, were recorded in accrued expenses and other payables in the consolidated balance sheets. Revenues recognized in the three months ended March 31, 2024 from the December 31, 2023 contract liabilities were $235 million.

Disaggregation of Revenues

The following tables present revenue disaggregated by timing of recognition and major product lines for the three months ended March 31, 2024 and 2023.

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 3. Revenues (Continued)


	Three Months Ended March 31, 2024
	Topic 606 Revenue						Topic 815(1)		Total
(In millions)	Point in Time		Over Time		Total		Revenue		Revenues









Ag Services and Oilseeds
Ag Services	$	1,022	$	193	$	1,215	$	9,982	$	11,197
Crushing	117		—		117		3,210		3,327
Refined Products and Other	548		—		548		2,147		2,695
Total Ag Services and Oilseeds	1,687		193		1,880		15,339		17,219
Carbohydrate Solutions
Starches and Sweeteners	1,593		—		1,593		563		2,156
Vantage Corn Processors	527		—		527		—		527
Total Carbohydrate Solutions	2,120		—		2,120		563		2,683
Nutrition
Human Nutrition	964		—		964		—		964
Animal Nutrition	872		—		872		—		872
Total Nutrition	1,836		—		1,836		—		1,836

Total Segment Revenues	5,643		193		5,836		15,902		21,738
Other Business	109		—		109		—		109
Total Revenues	$	5,752	$	193	$	5,945	$	15,902	$	21,847


	Three Months Ended March 31, 2023
	Topic 606 Revenue						Topic 815(1)		Total
(In millions)	Point in Time		Over Time		Total		Revenue		Revenues









Ag Services and Oilseeds
Ag Services	$	1,017	$	178	$	1,195	$	10,500	$	11,695
Crushing	191		—		191		3,492		3,683
Refined Products and Other	626		—		626		2,575		3,201
Total Ag Services and Oilseeds	1,834		178		2,012		16,567		18,579
Carbohydrate Solutions
Starches and Sweeteners	2,084		—		2,084		653		2,737
Vantage Corn Processors	800		—		800		—		800
Total Carbohydrate Solutions	2,884		—		2,884		653		3,537
Nutrition
Human Nutrition	936		—		936		—		936
Animal Nutrition	917		—		917		—		917
Total Nutrition	1,853		—		1,853		—		1,853

Total Segment Revenues	6,571		178		6,749		17,220		23,969
Other Business	103		—		103		—		103
Total Revenues	$	6,674	$	178	$	6,852	$	17,220	$	24,072

(1) Topic 815 revenue relates to the physical delivery or the settlement of the Company’s sales contracts that are accounted for as derivatives and are outside the scope of Topic 606.

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 3. Revenues (Continued)

Ag Services and Oilseeds

The Ag Services and Oilseeds segment generates revenue from the sale of commodities, from service fees for the transportation of goods, from the sale of products manufactured in its global processing facilities, and from its structured trade finance activities. Revenue is measured based on the consideration specified in the contract. Revenue is recognized when a performance obligation is satisfied by transferring control over a product or providing service to a customer. For transportation service contracts, the Company recognizes revenue over time as the mode of transportation moves towards its destination in accordance with the transfer of control guidance of Topic 606. The amount of revenue recognized follows the contractually specified price, which may include freight or other contractually specified cost components. For physically settled derivative sales contracts that are outside the scope of Topic 606, the Company recognizes revenue when control of the inventory is transferred within the meaning of Topic 606 as required by Topic 610-20.

Carbohydrate Solutions

The Carbohydrate Solutions segment generates revenue from the sale of products manufactured at the Company’s global corn and wheat milling facilities around the world. Revenue is recognized when control over products is transferred to the customer. Products are shipped to customers from the Company’s various facilities and from its network of storage terminals. The amount of revenue recognized is based on the consideration specified in the contract, which could include freight and other costs depending on the specific shipping terms of each contract. For physically settled derivative sales contracts that are outside the scope of Topic 606, the Company recognizes revenue when control of the inventory is transferred within the meaning of Topic 606 as required by Topic 610-20.

Nutrition

The Nutrition segment sells ingredients and solutions including plant-based proteins, natural flavors, flavor systems, natural colors, emulsifiers, soluble fiber, polyols, hydrocolloids, probiotics, prebiotics, enzymes, botanical extracts, edible beans, formula feeds, animal health and nutrition products, pet food and treats, and other specialty food and feed ingredients. Revenue is recognized when control over products is transferred to the customer. The amount of revenue recognized follows the contracted price or the mutually agreed price of the product. Freight and shipping are recognized as a component of revenue at the same time control transfers to the customer.

Other Business

Other Business includes the Company’s futures commission business whose primary sources of revenue are commissions and brokerage income generated from executing orders and clearing futures contracts and options on futures contracts on behalf of its customers. Commissions and brokerage revenue are recognized on the date the transaction is executed. Other Business also includes the Company’s captive insurance business, which generates third party revenue through its proportionate share of premiums from third-party reinsurance pools. Reinsurance premiums are recognized on a straight-line basis over the period underlying the policy.

Note 4. Acquisitions

During the three months ended March 31, 2024, the Company acquired Revela Foods (“Revela”), a Wisconsin-based developer and manufacturer of innovative dairy flavor ingredients and solutions, FDL, a UK-based leading developer and producer of premium flavor and functional ingredient systems, and PT Trouw Nutrition Indonesia (“PT”), a subsidiary of Nutreco and leading provider of functional and nutritional solutions for livestock farming in Indonesia, for an aggregate cash consideration of $924 million.

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 4. Acquisitions (Continued)

The aggregate cash consideration of these acquisitions, net of $9 million in cash acquired, was allocated as follows, subject to final measurement period adjustments:


(In millions)	Revela		FDL		PT		Total
Working capital	$	50	$	—	$	5	$	55
Property, plant, and equipment	38		33		5		76
Goodwill	403		145		5		553
Other intangible assets	166		97		—		263
Other long-term assets	28		1		—		29
Long-term liabilities	(35)		(26)		—		(61)
Aggregate cash consideration	$	650	$	250	$	15	$	915

Goodwill recorded in connection with the acquisitions is primarily attributable to the synergies expected to arise after the Company’s acquisition of the businesses. Of the $553 million allocated to goodwill, none is expected to be deductible for tax purposes.

These acquisitions add capabilities to the Human and Animal Nutrition businesses. The Company’s consolidated statement of earnings for the quarter ended March 31, 2024 includes the post-acquisition results of the acquired businesses which were immaterial.

The following table sets forth the fair values and the useful lives of the other intangible assets acquired.


	Useful Lives			Revela		FDL		Total
	(In years)			(In millions)



Intangible assets with finite lives:
Trademarks/brands	3			$	—	$	4	$	4
Customer lists	10	to	18	124		73		197
Recipes and others	10	to	21	42		20		62
Total other intangible assets acquired				$	166	$	97	$	263

Note 5. Fair Value Measurements

The following tables set forth, by level, the Company’s assets and liabilities that were accounted for at fair value on a recurring basis as of March 31, 2024 and December 31, 2023.

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 5. Fair Value Measurements (Continued)


	Fair Value Measurements at March 31, 2024
	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
	(In millions)

Assets:
Inventories carried at market	$	—	$	3,759	$	2,948	$	6,707
Unrealized derivative gains:
Commodity contracts	—		598		764		1,362
Foreign currency contracts	—		187		—		187


Cash equivalents	206		—		—		206

Segregated investments	1,663		—		—		1,663

Total Assets	$	1,869	$	4,544	$	3,712	$	10,125

Liabilities:
Unrealized derivative losses:
Commodity contracts	$	—	$	448	$	435	$	883
Foreign currency contracts	—		94		—		94


Inventory-related payables	—		1,928		62		1,990

Total Liabilities	$	—	$	2,470	$	497	$	2,967


	Fair Value Measurements at December 31, 2023
	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
	(In millions)

Assets:
Inventories carried at market	$	—	$	4,274	$	2,713	$	6,987
Unrealized derivative gains:
Commodity contracts	—		628		731		1,359
Foreign currency contracts	—		187		—		187

Cash equivalents	209		—		—		209

Segregated investments	1,362		—		—		1,362

Total Assets	$	1,571	$	5,089	$	3,444	$	10,104

Liabilities:
Unrealized derivative losses:
Commodity contracts	$	—	$	500	$	457	$	957
Foreign currency contracts	—		144		—		144


Inventory-related payables	—		1,219		101		1,320
Total Liabilities	$	—	$	1,863	$	558	$	2,421

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 5. Fair Value Measurements (Continued)

Estimated fair values for inventories and inventory-related payables carried at market are based on exchange-quoted prices, adjusted for differences in local markets and quality, referred to as basis. Market valuations for the Company’s inventories are adjusted for location and quality (basis) because the exchange-quoted prices represent contracts with standardized terms for commodity, quantity, future delivery period, delivery location, and commodity quality or grade. The basis adjustments are generally determined using the inputs from competitor and broker quotations or market transactions and are considered observable. Basis adjustments are impacted by specific local supply and demand characteristics at each facility and the overall market. Factors such as substitute products, weather, fuel costs, contract terms, and futures prices also impact the movement of these basis adjustments. In some cases, the basis adjustments are unobservable because they are supported by little to no market activity. When unobservable inputs have a significant impact (more than 10%) on the measurement of fair value, the inventory is classified in Level 3. Changes in the fair value of inventories and inventory-related payables are recognized in the consolidated statements of earnings as a component of cost of products sold.

Derivative contracts include exchange-traded commodity futures and options contracts, forward commodity purchase and sale contracts, and over-the-counter (OTC) instruments related primarily to agricultural commodities, energy, interest rates, and foreign currencies. Exchange-traded futures and options contracts are valued based on unadjusted quoted prices in active markets and are classified in Level 1. Substantially all of the Company’s exchange-traded futures and options contracts are cash-settled on a daily basis and, therefore, are not included in these tables. Fair value for forward commodity purchase and sale contracts is estimated based on exchange-quoted prices adjusted for differences in local markets. Market valuations for the Company’s forward commodity purchase and sale contracts are adjusted for location (basis) because the exchange-quoted prices represent contracts that have standardized terms for commodity, quantity, future delivery period, delivery location, and commodity quality or grade. The basis adjustments are generally determined using inputs from competitor and broker quotations or market transactions and are considered observable. Basis adjustments are impacted by specific local supply and demand characteristics at each facility and the overall market. Factors such as substitute products, weather, fuel costs, contract terms, and futures prices also impact the movement of these basis adjustments. In some cases, the basis adjustments are unobservable because they are supported by little to no market activity. When observable inputs are available for substantially the full term of the contract, it is classified in Level 2. When unobservable inputs have a significant impact (more than 10%) on the measurement of fair value, the contract is classified in Level 3. Except for certain derivatives designated as cash flow hedges, changes in the fair value of commodity-related derivatives are recognized in the consolidated statements of earnings as a component of cost of products sold. Changes in the fair value of foreign currency-related derivatives are recognized in the consolidated statements of earnings as a component of revenues, cost of products sold, and other (income) expense - net, depending upon the purpose of the contract. The changes in the fair value of derivatives designated as effective cash flow hedges are recognized in the consolidated balance sheets as a component of accumulated other comprehensive income (AOCI) until the hedged items are recorded in earnings or it is probable the hedged transaction will no longer occur.

The Company’s cash equivalents are comprised of money market funds valued using quoted market prices and are classified as Level 1.

The Company’s segregated investments are comprised of U.S. Treasury securities. U.S. Treasury securities are valued using quoted market prices and are classified in Level 1.

The debt conversion option was the equity linked embedded derivative related to the exchangeable bonds. The fair value of the embedded derivative was included in long-term debt, with changes in fair value recognized as interest, and was valued with the assistance of a third-party pricing service (a level 3 measurement).

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 5. Fair Value Measurements (Continued)

The following table presents a rollforward of assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2024.


	Level 3 Fair Value Asset Measurements at
	March 31, 2024
	Inventories Carried at Market		Commodity Derivative Contracts Gains		Total Assets
	(In millions)
Balance, December 31, 2023	$	2,713	$	731	$	3,444
Total increase (decrease) in net realized/unrealized gains included in cost of products sold*	(97)		375		278
Purchases	3,789		—		3,789
Sales	(3,883)		—		(3,883)
Settlements	—		(352)		(352)
Transfers into Level 3	516		28		544
Transfers out of Level 3	(90)		(18)		(108)
Ending balance, March 31, 2024	$	2,948	$	764	$	3,712

* Includes increase in unrealized gains of $564 million relating to Level 3 assets still held at March 31, 2024.

The following table presents a rollforward of liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2024.


	Level 3 Fair Value Liability Measurements at
	March 31, 2024
	Inventory- related Payables		Commodity Derivative Contracts Losses		Total Liabilities
	(In millions)

Balance, December 31, 2023	$	101	$	457	$	558
Total increase (decrease) in net realized/unrealized losses included in cost of products sold*	(3)		329		326
Purchases	1		—		1
Sales	(38)		—		(38)
Settlements	—		(290)		(290)
Transfers into Level 3	1		13		14
Transfers out of Level 3	—		(74)		(74)
Ending balance, March 31, 2024	$	62	$	435	$	497

* Includes increase in unrealized losses of $338 million relating to Level 3 liabilities still held at March 31, 2024.

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 5. Fair Value Measurements (Continued)

The following table presents a rollforward of assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2023.


	Level 3 Fair Value Asset Measurements at
	March 31, 2023
	Inventories Carried at Market		Commodity Derivative Contracts Gains		Total Assets
	(In millions)

Balance, December 31, 2022	$	2,760	$	541	$	3,301
Total increase (decrease) in net realized/unrealized gains included in cost of products sold*	2		477		479
Purchases	8,665		—		8,665
Sales	(8,254)		—		(8,254)
Settlements	—		(382)		(382)
Transfers into Level 3	605		50		655
Transfers out of Level 3	(275)		(37)		(312)
Ending balance, March 31, 2023	$	3,503	$	649	$	4,152

* Includes increase in unrealized gains of $632 million relating to Level 3 assets still held at March 31, 2023.

The following table presents a rollforward of liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2023.


	Level 3 Fair Value Liability Measurements at
	March 31, 2023
	Inventory- related Payables		Commodity Derivative Contracts Losses		Debt Conversion Option		Total Liabilities
	(In millions)

Balance, December 31, 2022	$	89	$	603	$	6	$	698
Total increase (decrease) in net realized/unrealized losses included in cost of products sold and interest expense*	(2)		243		(5)		236
Purchases	2		—		—		2

Settlements	(31)		(424)		—		(455)
Transfers into Level 3	—		39		—		39
Transfers out of Level 3	(1)		(6)		—		(7)
Ending balance, March 31, 2023	$	57	$	455	$	1	$	513

* Includes increase in unrealized losses of $248 million relating to Level 3 liabilities still held at March 31, 2023.

Transfers into Level 3 of assets and liabilities previously classified in Level 2 were due to the relative value of unobservable inputs to the total fair value measurement of certain products and derivative contracts rising above the 10% threshold. Transfers out of Level 3 were primarily due to the relative value of unobservable inputs to the total fair value measurement of certain products and derivative contracts falling below the 10% threshold and thus permitting reclassification to Level 2.

In some cases, the price components that result in differences between exchange-traded prices and local prices for inventories

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 5. Fair Value Measurements (Continued)

and commodity purchase and sale contracts are observable based upon available quotations for these pricing components, and in some cases, the differences are unobservable. These price components primarily include transportation costs and other adjustments required due to location, quality, or other contract terms. In the table below, these other adjustments are referred to as basis. The changes in unobservable price components are determined by specific local supply and demand characteristics at each facility and the overall market. Factors such as substitute products, weather, fuel costs, contract terms, and futures prices also impact the movement of these unobservable price components.

The following table sets forth the weighted average percentage of the unobservable price components included in the Company’s Level 3 valuations as of March 31, 2024 and December 31, 2023. The Company’s Level 3 measurements may include basis only, transportation cost only, or both price components. As an example, for Level 3 inventories with basis, the unobservable component as of March 31, 2024 is a weighted average 28.2% of the total price for assets and 25.9% of the total price for liabilities.


	Weighted Average % of Total Price
	March 31, 2024				December 31, 2023
Component Type	Assets		Liabilities		Assets		Liabilities
Inventories and Related Payables
Basis	28.2	%	25.9	%	25.0	%	33.2	%
Transportation cost	18.6	%	—	%	11.5	%	—	%

Commodity Derivative Contracts
Basis	40.1	%	28.2	%	24.2	%	24.9	%
Transportation cost	8.3	%	1.5	%	9.3	%	3.2	%

In certain of the Company’s principal markets, the Company relies on price quotes from third parties to value its inventories and physical commodity purchase and sale contracts. These price quotes are generally not further adjusted by the Company in determining the applicable market price. In some cases, availability of third-party quotes is limited to only one or two independent sources. In these situations, absent other corroborating evidence, the Company considers these price quotes as 100% unobservable and, therefore, the fair value of these items is reported in Level 3.

Note 6. Derivative Instruments and Hedging Activities

Derivatives Not Designated as Hedging Instruments

The majority of the Company’s derivative instruments have not been designated as hedging instruments. The Company uses exchange-traded futures and exchange-traded and OTC options contracts to manage its net position of merchandisable agricultural product inventories and forward cash purchase and sales contracts to reduce price risk caused by market fluctuations in agricultural commodities and foreign currencies. The Company also uses exchange-traded futures and exchange-traded and OTC options contracts as components of merchandising strategies designed to enhance margins. The results of these strategies can be significantly impacted by factors such as the correlation between the value of exchange-traded commodities futures contracts and the value of the underlying commodities, counterparty contract defaults, and volatility of freight markets. Derivatives, including exchange-traded contracts and forward commodity purchase or sale contracts, and inventories of certain merchandisable agricultural products, which include amounts acquired under deferred pricing contracts, are stated at fair value. Inventory is not a derivative and therefore fair values of and changes in fair values of inventories are not included in the tables below.

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 6. Derivative Instruments and Hedging Activities (Continued)

The following table sets forth the fair value of derivatives not designated as hedging instruments as of March 31, 2024 and December 31, 2023.


	March 31, 2024				December 31, 2023
	Assets		Liabilities		Assets		Liabilities
	(In millions)

Foreign Currency Contracts	$	145	$	94	$	187	$	122

Commodity Contracts	1,351		883		1,343		957

Total	$	1,496	$	977	$	1,530	$	1,079

The following tables set forth the pre-tax gains (losses) on derivatives not designated as hedging instruments that have been included in the consolidated statements of earnings for the three months ended March 31, 2024 and 2023.


					Other (income) expense - net
			Cost of				Interest
(In millions)	Revenues		products sold				expense
Three Months Ended March 31, 2024
Consolidated Statement of Earnings	$	21,847	$	20,188	$	(26)	$	166

Pre-tax gains (losses) on:





Foreign Currency Contracts	$	1	$	(63)	$	54	$	—
Commodity Contracts	—		197		—		—

Total gain (loss) recognized in earnings	$	1	$	134	$	54	$	—	$	189

Three Months Ended March 31, 2023
Consolidated Statement of Earnings	$	24,072	$	21,992	$	(44)	$	147

Pre-tax gains (losses) on:
Foreign Currency Contracts	$	(11)	$	95	$	(16)	$	—
Commodity Contracts	—		440		—		—
Debt Conversion Option	—		—		—		5
Total gain (loss) recognized in earnings	$	(11)	$	535	$	(16)	$	5	$	513

Changes in the market value of inventories of certain merchandisable agricultural commodities, inventory-related payables, forward cash purchase and sales contracts, exchange-traded futures and exchange-traded and OTC options contracts are recognized in earnings immediately as a component of cost of products sold.

Changes in the fair value of foreign currency-related derivatives are recognized in the consolidated statements of earnings as a component of revenues, cost of products sold, and other (income) expense - net depending on the purpose of the contract.

Derivatives Designated as Cash Flow and Net Investment Hedging Strategies

The Company had certain derivatives designated as cash flow and net investment hedges as of March 31, 2024 and December 31, 2023.

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 6. Derivative Instruments and Hedging Activities (Continued)

For derivative instruments that are designated and qualify as highly-effective cash flow hedges (i.e., hedging the exposure to variability in expected future cash flow that is attributable to a particular risk), the gain or loss on the derivative instrument is reported as a component of AOCI and as an operating activity in the statement of cash flows, and is reclassified into earnings in the same line item affected by the hedged transaction in the same period or periods during which the hedged transaction affects earnings. Hedge components excluded from the assessment of effectiveness and gains and losses related to discontinued hedges are recognized in the consolidated statement of earnings during the current period.

Commodity Contracts

For each of the hedge programs described below, the derivatives are designated as cash flow hedges. The changes in the market value of such derivative contracts have historically been, and are expected to continue to be, highly effective at offsetting changes in price movements of the hedged item. Once the hedged item is recognized in earnings, the gains and losses arising from the hedge are reclassified from AOCI to either revenues or cost of products sold, as applicable.

The Company uses futures or options contracts to hedge the purchase price of anticipated volumes of corn to be purchased and processed in a future month. The objective of this hedging program is to reduce the variability of cash flows associated with the Company’s forecasted purchases of corn. The Company’s corn processing plants normally grind approximately 59 million bushels of corn per month. During the past 12 months, the Company hedged between 12% and 34% of its monthly grind. At March 31, 2024, the Company had designated hedges representing between 0% and 29% of its anticipated monthly grind of corn for the next 12 months.

The Company uses futures and options contracts to hedge the purchase price of the anticipated volumes of soybeans to be purchased and processed in a future month for certain of its U.S. soybean crush facilities, subject to certain program limits. The Company also uses futures or options contracts to hedge the sales prices of anticipated soybean meal and soybean oil sales proportionate to the soybean crushing process at these facilities, subject to certain program limits. During the past 12 months, the Company hedged between 77% and 100% of the anticipated monthly soybean crush for soybean purchases and soybean meal and oil sales at the designated facilities. At March 31, 2024, the Company had designated hedges representing between 3% and 100% of the anticipated monthly soybean crush for soybean purchases and soybean meal and oil sales at the designated facilities over the next 12 months.

The Company uses futures and OTC swaps to hedge the purchase price of anticipated volumes of natural gas consumption in a future month for certain of its facilities in North America and Europe, subject to certain program limits. During the past 12 months, the Company hedged between 39% and 80% of the anticipated monthly natural gas consumption at the designated facilities. At March 31, 2024, the Company had designated hedges representing between 34% and 70% of the anticipated monthly natural gas consumption over the next 12 months.

As of March 31, 2024 and December 31, 2023, the Company had after-tax losses of $9 million and after-tax gains of $42 million in AOCI, respectively, related to gains and losses from these programs. The Company expects to recognize $9 million of the March 31, 2024 after-tax losses in its consolidated statement of earnings during the next 12 months.

Foreign Currency Contracts

The Company uses cross-currency swaps and foreign exchange forwards designated as net investment hedges to protect the Company’s investment in a foreign subsidiary against changes in foreign currency exchange rates. The Company executed USD-fixed to Euro-fixed cross-currency swaps with an aggregate notional amount of $0.8 billion as of March 31, 2024 and December 31, 2023, and foreign exchange forwards with an aggregate notional amount of $2.1 billion as of March 31, 2024 and December 31, 2023.

As of March 31, 2024 and December 31, 2023, the Company had after-tax gains of $46 million and after-tax losses of $5 million in AOCI, respectively, related to foreign exchange gains and losses from net investment hedge transactions. The amount is deferred in AOCI until the underlying investment is divested.

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 6. Derivative Instruments and Hedging Activities (Continued)

The following table sets forth the fair value of derivatives designated as hedging instruments as of March 31, 2024 and December 31, 2023.


	March 31, 2024				December 31, 2023
	Assets		Liabilities		Assets		Liabilities
	(In millions)
Commodity Contracts	$	11	$	—	$	16	$	—
Foreign Currency Contracts	42		—		—		22

Total	$	53	$	—	$	16	$	22

The following table sets forth the pre-tax gains (losses) on derivatives designated as hedging instruments that have been included in the consolidated statements of earnings for the three months ended March 31, 2024 and 2023.


	Cost of products sold
(In millions)
Three Months Ended March 31, 2024
Consolidated Statement of Earnings	$	20,188

Effective amounts recognized in earnings
Pre-tax gains (losses) on:

Commodity Contracts	$	19

Total gain (loss) recognized in earnings	$	19	$	19

Three Months Ended March 31, 2023
Consolidated Statement of Earnings	$	21,992

Effective amounts recognized in earnings
Pre-tax gains (losses) on:

Commodity Contracts	$	(104)




Total gain (loss) recognized in earnings	$	(104)	$	(104)

Other Net Investment Hedging Strategies

The Company has designated €0.7 billion of its outstanding long-term debt and commercial paper borrowings at March 31, 2024 and December 31, 2023 as hedges of its net investment in a foreign subsidiary. As of March 31, 2024 and December 31, 2023, the Company had after-tax gains of $224 million and $212 million in AOCI, respectively, related to foreign exchange gains and losses from the net investment hedge transactions. The amount is deferred in AOCI until the underlying investment is divested.

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 7. Other Current Assets

The following table sets forth the items in other current assets:


	March 31,		December 31,
	2024		2023
	(In millions)

Unrealized gains on derivative contracts	$	1,549	$	1,546

Margin deposits and grain accounts	585		560
Customer omnibus receivable	1,131		1,052
Financing receivables - net (1)	178		237
Insurance premiums receivable	48		61
Prepaid expenses	412		445
Biodiesel tax credit	77		119
Tax receivables	479		491
Non-trade receivables	376		304
Other current assets	148		167
	$	4,983	$	4,982

(1) The Company provides financing to certain suppliers, primarily Brazilian farmers, to finance a portion of the suppliers’ production costs. The amounts are reported net of allowances of $6 million at March 31, 2024 and December 31, 2023. Interest earned on financing receivables of $5 million and $6 million for the three months ended March 31, 2024 and 2023, respectively, is included in interest and investment income in the consolidated statements of earnings.

Note 8. Accrued Expenses and Other Payables

The following table sets forth the items in accrued expenses and other payables:


	March 31,		December 31,
	2024		2023
	(In millions)

Unrealized losses on derivative contracts	$	977	$	1,101
Accrued compensation	327		439
Income tax payable	312		284
Other taxes payable	196		172


Insurance claims payable	84		73
Contract liability	508		626


Other accruals and payables	1,518		1,381
	$	3,922	$	4,076

Note 9. Debt and Financing Arrangements

At March 31, 2024, the fair value of the Company’s long-term debt was below the carrying value by $0.3 billion, as estimated using quoted market prices (a Level 2 measurement under applicable accounting standards).

At March 31, 2024, the Company had lines of credit, including the accounts receivable securitization programs described below, totaling $12.8 billion, of which $8.8 billion was unused. Of the Company’s total lines of credit, $5.0 billion supported

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 9. Debt and Financing Arrangements (Continued)

the combined U.S. and European commercial paper borrowing programs, against which there was $0.9 billion of commercial paper outstanding at March 31, 2024.

The Company has accounts receivable securitization programs (the “Programs”). The Programs provide the Company with up to $3.0 billion in funding resulting from the sale of accounts receivable with $0.7 billion unused capacity as of March 31, 2024.

Note 10. Income Taxes

The Company’s effective tax rate was 18.8% for the three months ended March 31, 2024 compared to 16.1% for the three months ended March 31, 2023. The increase in the rate was primarily due to the change in the geographic mix of forecasted pretax earnings and the impact of discrete tax items.

The Organization for Economic Cooperation and Development’s Pillar Two initiative introduced a 15% global minimum tax applied on a country-by-country basis that has been enacted in certain jurisdictions in which the Company operates, with effective dates starting in fiscal year 2024. The Company is in scope of the enacted legislation and has performed an assessment of the potential exposure based on its most recent tax filings, country-by-country reporting, and the financial results of the constituent entities. Based on the assessment, the effective tax rates in most of the jurisdictions in which the Company operates are above the 15% global minimum tax threshold. However, there are a limited number of jurisdictions where the effective tax rate is close to 15%. ADM does not expect a material liability to global minimum tax in those jurisdictions.

The Company is subject to income taxation and routine examinations in many jurisdictions around the world and frequently faces challenges regarding the amount of taxes due. These challenges include positions taken by the Company related to the timing, nature, and amount of deductions and the allocation of income among various tax jurisdictions. In its routine evaluations of the exposure associated with various tax filing positions, the Company recognizes a liability, when necessary, for estimated potential tax owed by the Company in accordance with applicable accounting standards. Resolution of the related tax positions, through negotiations with relevant tax authorities or through litigation, may take years to complete. Therefore, it is difficult to predict the timing for resolution of tax positions and the Company cannot predict or provide assurance as to the ultimate outcome of these ongoing or future examinations. However, the Company does not anticipate the total amount of unrecognized tax benefits will increase or decrease significantly in the next twelve months. Given the long periods of time involved in resolving tax positions, the Company does not expect the recognition of unrecognized tax benefits will have a material impact on the Company’s effective income tax rate in any given period.

In 2014, the Company’s wholly-owned subsidiary in the Netherlands, ADM Europe B.V., received a tax assessment from the Netherlands tax authority challenging the transfer pricing aspects of a 2009 business reorganization, which involved two of its subsidiary companies in the Netherlands. As of March 31, 2024, this assessment was $88 million in tax and $34 million in interest (adjusted for variation in currency exchange rates). On April 23, 2020, the court issued an unfavorable ruling and in October 2020, assigned a third party expert to establish a valuation. During the second quarter of 2021, the third party expert issued a final valuation. On September 30, 2022, the court issued a ruling consistent with the valuation report, and the Dutch tax authorities have filed an appeal. During the quarter ended March 31, 2023, ADM filed a cross-appeal and is currently awaiting the court’s ruling. As of March 31, 2024, the Company has accrued its best estimate of what it believes will be the likely outcome of the litigation.

Note 11. Shareholders’ Equity

Accelerated Share Repurchase

On March 12, 2024, the Company entered into an accelerated share repurchase (“ASR”) transaction agreement (“ASR Agreement”) with Merrill Lynch International, an affiliate of BofA Securities, Inc., to repurchase $1.0 billion (the “Prepayment Amount”) of ADM common stock (“Common Stock”). The ASR transaction is part of ADM’s existing share repurchase program to repurchase up to 200 million shares through December 31, 2024.

Under the terms of the ASR Agreement, on March 13, 2024, the Company paid the Prepayment Amount and received no upfront shares of Common Stock. The total number of shares of Common Stock to be repurchased under the ASR Agreement will be based on volume weighted-average prices of the Common Stock during the term of the ASR transaction less a discount and subject to certain adjustments pursuant to the terms of the ASR Agreement. ADM will receive share deliveries at the end

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 11. Shareholders’ Equity (Continued)

of each month commencing in March 2024, and upon final settlement of the ASR transaction, which is expected to occur no later than the end of the second quarter of 2024.

On March 28, 2024, the Company received an interim delivery of 8,880,986 shares at an average share price of $60.596 or $538 million. The Prepayment Amount initially recorded in additional paid in capital was partially reclassified to reinvested earnings for the $538 million amount repurchased.

As of March 31, 2024, the Company had 38.5 million remaining shares under its share repurchase program.

Accumulated Other Comprehensive Income

The following tables set forth the changes in AOCI by component for the three months ended March 31, 2024 and the reclassifications out of AOCI for the three months ended March 31, 2024 and 2023:


	Three months ended March 31, 2024
	Foreign Currency Translation Adjustment		Deferred Gain (Loss) on Hedging Activities		Pension Liability Adjustment		Unrealized Gain (Loss) on Investments		Total
	(In millions)
Balance at December 31, 2023	$	(2,539)	$	158	$	(108)	$	2	$	(2,487)
Other comprehensive income (loss) before reclassifications	(77)		(50)		(2)		(7)		(136)
Gain (loss) on net investment hedges	84		—		—		—		84
Amounts reclassified from AOCI	—		(19)		(2)		—		(21)
Tax effect	(20)		10		1		(1)		(10)
Net of tax amount	(13)		(59)		(3)		(8)		(83)
Balance at March 31, 2024	$	(2,552)	$	99	$	(111)	$	(6)	$	(2,570)


	Amount reclassified from AOCI
	Three months ended March 31,				Affected line item in the consolidated statements of earnings
Details about AOCI components	2024		2023
	(In millions)





Deferred loss (gain) on hedging activities

	(19)		104			Cost of products sold


	(19)		104			Total before tax
	4		(18)			Tax
	$	(15)	$	86		Net of tax

Pension liability adjustment
Amortization of defined benefit pension items:
Prior service loss (credit)	$	(5)	$	(11)		Other (income) expense-net
Actuarial losses	3		(20)			Other (income) expense-net
	(2)		(31)			Total before tax
	1		(12)			Tax
	$	(1)	$	(43)		Net of tax

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 11. Shareholders’ Equity (Continued)

The Company’s accounting policy is to release the income tax effects from AOCI when the individual units of account are sold, terminated, or extinguished.

Note 12. Other (Income) Expense – Net

The following table sets forth the items in other (income) expense:


	Three Months Ended
	March 31,
	2024		2023
	(In millions)
Gains on sale of assets	$	(2)	$	(11)



Other – net	(24)		(33)
Other (Income) Expense – Net	$	(26)	$	(44)

Gains on sale of assets in the three months ended March 31, 2024 and 2023 consisted of gains on sales of certain assets and disposals of individually insignificant assets in the ordinary course of business.

Other – net in the three months ended March 31, 2024 included the non-service components of net pension benefit income of $5 million, net foreign exchange gains, and net other income. Other – net in the three months ended March 31, 2023 included the non-service components of net pension benefit income of $4 million, net foreign exchange gains, and net other income.

Note 13. Segment Information - Restated

Intersegment sales have been recorded using principles consistent with ASC 606, Revenue from Contracts with Customers. Operating profit for each segment is based on net sales less identifiable operating expenses. Also included in operating profit for each segment is equity in earnings of affiliates based on the equity method of accounting. Specified items and certain corporate items are not allocated to the Company’s individual business segments because operating performance of each business segment is evaluated by management exclusive of these items. Corporate results principally include unallocated corporate expenses, interest cost net of interest income, and revaluation gains and losses on cost method investments and the share of the results of equity investments in early-stage start-up companies.

Restatement of Certain Segment-Specific Historical Financial Information

As described in Note 1 to the Consolidated Financial Statements, the Company has restated its Consolidated Financial Statements as of March 31, 2024 and 2023 and for the quarters ended March 31, 2024 and 2023. As a result, the previously reported financial information as of March 31, 2024 and 2023 and for the quarters ended March 31, 2024 and 2023 in this Note 13. Segment Information, has been updated to reflect the restatements.

The following tables set forth the impact of the restatements on intersegment sales and segment operating profit for each of the Company’s three reportable segments for the three months ended March 31, 2024 and 2023.

Intersegment pricing adjustments include restatements related to intersegment sales that were not in accordance with prior disclosures about presenting such sales at amounts approximating market. Intersegment classification adjustments include restatements related to intrasegment sales (resulting from sales within the segment) previously misclassified and reported as intersegment sales (resulting from sales from one segment to another). Intersegment pricing adjustments and Intersegment classification adjustments are included within the Intersegment sales amounts and segment operating profit amounts previously reported by the Company in the Form 10-Q filed with the SEC on April 30, 2024.

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 13. Segment Information - Restated (Continued)

In the course of testing new controls implemented as part of the Company’s material weakness remediation plan in the third quarter of 2024, ADM identified additional intrasegment sales previously misclassified and reported as intersegment sales. The Company also identified some intersegment sales that were not accounted for consistently in accordance with revenue recognition and segment reporting standards and should not have been reported as intersegment sales. These amounts are presented in the table below as Additional intersegment classification adjustments. The Company also is correcting certain segment disclosure presentation errors in this Form 10-Q/A. See Note 1 for further information.

Impact of the Restatement on the Ag Services and Oilseeds Segment


	Three Months Ended
	March 31,
(In millions)	2024 (Restated)		2023 (Restated)




Intersegment revenues, as originally reported	$	609	$	1,335
Intersegment pricing adjustments	—		1
Intersegment classification adjustments	—		(595)
Intersegment revenues, as previously reported	609		741
Additional intersegment classification adjustments	(183)		(211)
Intersegment revenues, as restated	$	426	$	530

Segment operating profit, as originally reported	$	864	$	1,210
Intersegment pricing adjustments	—		1
Segment operating profit, as restated	$	864	$	1,211

Impact of the Restatement on the Carbohydrate Solutions Segment


	Three Months Ended
	March 31,
(In millions)	2024 (Restated)		2023 (Restated)




Intersegment revenues, as originally reported	$	279	$	729
Intersegment pricing adjustments	—		6
Intersegment classification adjustments	—		(230)
Intersegment revenues, as previously reported	279		505
Additional intersegment classification adjustments	(71)		(235)
Intersegment revenues, as restated	$	208	$	270

Segment operating profit, as originally reported	$	248	$	273
Intersegment pricing adjustments	—		6
Segment operating profit, as restated	$	248	$	279

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 13. Segment Information - Restated (Continued)

Impact of the Restatement on the Nutrition Segment


	Three Months Ended
	March 31,
(In millions)	2024 (Restated)		2023 (Restated)
Intersegment revenues, as originally reported	$	6	$	91
Intersegment pricing adjustments	—		—
Intersegment classification adjustments	—		(55)
Intersegment revenues, as previously reported	6		36
Additional intersegment classification adjustments	7		(24)
Intersegment revenues, as restated	$	13	$	12

Segment operating profit, as originally reported	$	84	$	145
Intersegment pricing adjustments	—		(7)
Segment operating profit, as restated	$	84	$	138

For more information about the Company’s business segments, refer to Note 17 of “Notes to Consolidated Financial Statements” included in Item 8, “Financial Statements and Supplementary Data” included in the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2023.

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 13. Segment Information - Restated (Continued)


Segment Information for the Three Months ended March 31, 2024 and 2023
	Three Months Ended
	March 31,
(In millions)	2024		2023
























Revenues from external customers










Ag Services and Oilseeds
Ag Services	$	11,197	$	11,695
Crushing	3,327		3,683
Refined Products and Other	2,695		3,201
Total Ag Services and Oilseeds	17,219		18,579
Carbohydrate Solutions
Starches and Sweeteners	2,156		2,737
Vantage Corn Processors	527		800
Total Carbohydrate Solutions	2,683		3,537
Nutrition
Human Nutrition	964		936
Animal Nutrition	872		917
Total Nutrition	1,836		1,853
Total segment revenues from external customers	21,738		23,969

Other Business	109		103


Total revenues from external customers	$	21,847	$	24,072

Intersegment revenues, as restated


Ag Services and Oilseeds	$	426	$	530
Carbohydrate Solutions	208		270
Nutrition	13		12

Total intersegment revenues, as restated	$	647	$	812






Segment operating profit, as restated


Ag Services and Oilseeds	$	864	$	1,211
Carbohydrate Solutions	248		279
Nutrition	84		138




Total segment operating profit, as restated	1,196		1,628
Other Business earnings (loss)	121		97
Corporate	(426)		(322)

Specified items:
Gains on sale of assets(1)	—		1
Impairment and restructuring charges(2)	(6)		(7)
Earnings before income taxes	$	885	$	1,397

(1) Prior quarter gains were related to the sale of certain assets.

(2) Current and prior quarter charges were related to the impairment of certain long-lived assets and restructuring.

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 14. Asset Impairment, Exit, and Restructuring Costs

Asset impairment, exit, and restructuring costs in the three months ended March 31, 2024 consisted of impairments related to certain long-lived assets of $3 million and restructuring charges of $3 million, presented as specified items, and restructuring charges in Corporate of $12 million.

Asset impairment, exit, and restructuring costs in the three months ended March 31, 2023 consisted of $3 million of impairments related to certain long-lived assets and $4 million of restructuring charges, presented as specified items.

Note 15. Sale of Accounts Receivable

The Company has an accounts receivable securitization program (the “First Program”) with certain commercial paper conduit purchasers and committed purchasers (collectively, the “First Purchasers”). Under the First Program, certain U.S.-originated trade accounts receivable are sold to a wholly-owned bankruptcy-remote entity, ADM Receivables, LLC (“ADM Receivables”). ADM Receivables transfers certain of the purchased accounts receivable to each of the First Purchasers together with a security interest in all of its right, title, and interest in the remaining purchased accounts receivable. In exchange, ADM Receivables receives a cash payment of up to $1.9 billion for the accounts receivable transferred. The First Program terminates on May 17, 2024, unless extended.

The Company also has an accounts receivable securitization program (the “Second Program”) with certain commercial paper conduit purchasers and committed purchasers (collectively, the “Second Purchasers”). Under the Second Program, certain non-U.S.-originated trade accounts receivable are sold to a wholly-owned bankruptcy-remote entity, ADM Ireland Receivables Company (ADM Ireland Receivables). ADM Ireland Receivables transfers certain of the purchased accounts receivable to each of the Second Purchasers together with a security interest in all of its right, title, and interest in the remaining purchased accounts receivable. In exchange, ADM Ireland Receivables receives a cash payment of up to $1.1 billion (€1.0 billion) for the accounts receivables transferred. The Second Program terminates on April 18, 2025, unless extended.

Under the First and Second Programs (collectively, the “Programs”), ADM Receivables and ADM Ireland Receivables use the cash proceeds from the transfer of receivables to the First Purchasers and Second Purchasers (collectively, the “Purchasers”) and other consideration, as applicable, to finance the purchase of receivables from the Company and the ADM subsidiaries originating the receivables. The Company accounts for these transfers as sales. The Company acts as a servicer for the transferred receivables. At March 31, 2024 and December 31, 2023, the Company did not record a servicing asset or liability related to its retained responsibility, based on its assessment of the servicing fee, market values for similar transactions, and its cost of servicing the receivables sold.

As of March 31, 2024 and December 31, 2023, the fair value of trade receivables transferred to the Purchasers under the Programs and derecognized from the Company’s consolidated balance sheets was $2.3 billion and $1.6 billion, respectively. Total receivables sold were $12.3 billion and $15.1 billion for the three months ended March 31, 2024 and 2023, respectively. Cash collections from customers on receivables sold were $11.8 billion and $14.8 billion for the three months ended March 31, 2024 and 2023, respectively. As of March 31, 2024 and December 31, 2023, receivables pledged as collateral to the Purchasers was $0.7 billion and $1.1 billion, respectively.

Transfers of receivables under the Programs resulted in an expense for the loss on sale of $27 million and $23 million for the three months ended March 31, 2024 and 2023, respectively, which is classified as selling, general, and administrative expenses in the consolidated statements of earnings.

All cash flows under the Programs are classified as operating activities because the cash received from the Purchasers upon both the sale and collection of the receivables is not subject to significant interest rate risk given the short-term nature of the Company’s trade receivables.

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 16. Supplier Finance Programs

ADM has Supplier Payable Programs (“SPP”) with financial institutions which act as its paying agents for payables due to certain of its suppliers. The Company has neither an economic interest in a supplier’s participation in the SPP nor a direct financial relationship with the financial institutions, and has concluded that its obligations to the suppliers, including amounts due and scheduled payment terms, are not impacted by their participation in the SPP. Accordingly, amounts associated with the SPP continue to be classified in trade payables in the Company’s consolidated balance sheet and in operating activities in its consolidated statement of cash flows. The supplier invoices that have been confirmed as valid under the program require payment in full generally within 90 days of the invoice date. As of March 31, 2024 and December 31, 2023, the Company’s outstanding payment obligations that suppliers had elected to sell to the financial institutions were $275 million and $274 million, respectively.

Changes to the outstanding payment obligations are as follows:


	March 31, 2024
	(In millions)
Beginning, January 1, 2024	$	274
Obligations confirmed	257
Obligations paid	(256)
Ending, March 31, 2024	$	275

Note 17. Legal Proceedings

The Company is routinely involved in a number of actual or threatened legal actions, including those involving alleged personal injuries, employment law, product liability, intellectual property, environmental issues, alleged tax liability (see Note 10 for information on income tax matters), and class actions. The Company also routinely receives inquiries from regulators and other government authorities relating to various aspects of its business, and at any given time, the Company has matters at various stages of resolution. The outcomes of these matters are not within Company’s complete control and may not be known for prolonged periods of time. In some actions, claimants seek damages, as well as other relief including injunctive relief, that could require significant expenditures or result in lost revenues. In accordance with applicable accounting standards, the Company records a liability in its consolidated financial statements for material loss contingencies when a loss is known or considered probable and the amount can be reasonably estimated. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a material loss contingency is reasonably possible but not known or probable, and can be reasonably estimated, the estimated loss or range of loss is disclosed in the notes to the consolidated financial statements. When determining the estimated loss or range of loss, significant judgment is required to estimate the amount and timing of a loss to be recorded. Estimates of probable losses resulting from litigation and governmental proceedings involving the Company are inherently difficult to predict, particularly when the matters are in early procedural stages, with incomplete facts or legal discovery; involve unsubstantiated or indeterminate claims for damages; potentially involve penalties, fines, disgorgement, or punitive damages; or could result in a change in business practice.

Commodities Class Actions

On September 4, 2019, AOT Holding AG (“AOT”) filed a putative class action under the U.S. Commodities Exchange Act in federal district court in Urbana, Illinois, alleging that the Company sought to manipulate the benchmark price used to price and settle ethanol derivatives traded on futures exchanges. On March 16, 2021, AOT filed an amended complaint adding a second named plaintiff Maize Capital Group, LLC (“Maize”). AOT and Maize allege that members of the putative class collectively suffered damages calculated to be between approximately $500 million to over $2.0 billion as a result of the Company’s alleged actions. On July 14, 2020, Green Plains Inc. and its related entities (“GP”) filed a putative class action lawsuit, alleging substantially the same operative facts, in federal court in Nebraska, seeking to represent sellers of ethanol. On July 23, 2020, Midwest Renewable Energy, LLC (“MRE”) filed a putative class action in federal court in Illinois alleging substantially the same operative facts and asserting claims under the Sherman Act. On November 11, 2020, United Wisconsin Grain Producers

Archer-Daniels-Midland Company

Notes to Consolidated Financial Statements (Continued)

(Unaudited)

Note 17. Legal Proceedings (Continued)

LLC (“UWGP”) and five other ethanol producers filed a lawsuit in federal court in Illinois alleging substantially the same facts and asserting claims under the Sherman Act and Illinois, Iowa, and Wisconsin law. The court granted ADM’s motion to dismiss the MRE and UWGP complaints without prejudice on August 9, 2021 and September 28, 2021, respectively. On August 16, 2021, the court granted ADM’s motion to dismiss the GP complaint, dismissing one claim with prejudice and declining jurisdiction over the remaining state law claim. MRE filed an amended complaint on August 30, 2021, which ADM moved to dismiss on September 27, 2021. The court denied ADM’s motion to dismiss on September 26, 2023. UWGP filed an amended complaint on October 19, 2021, which the court dismissed on July 12, 2022. UWGP has appealed the dismissal to the United States Court of Appeals for the Seventh Circuit. On October 26, 2021, GP filed a new complaint in Nebraska federal district court, alleging substantially the same facts and asserting a claim for tortious interference with contractual relations. On March 18, 2022, the Nebraska federal district court granted ADM’s motion to transfer the GP case back to the Central District of Illinois for further proceedings. ADM moved to dismiss the complaint on May 20, 2022 and on December 30, 2022, the court dismissed GP’s complaint with prejudice. GP appealed the dismissal. On January 12, 2024, the appellate court vacated the dismissal and remanded the case to the district court for further proceedings. On March 8, 2024, GP filed an amended complaint. The Company denies liability, and is vigorously defending itself in these actions. As these actions are in pretrial proceedings, the Company is unable at this time to predict the final outcome with any reasonable degree of certainty, but believes the outcome will not have a material adverse effect on its financial condition, results of operations, or cash flows.

Intersegment Sales Investigations

On June 30, 2023, the Company received a voluntary document request from the SEC relating to intersegment sales between the Company’s Nutrition reporting segment and the Company’s Ag Services and Oilseeds and Carbohydrate Solutions reporting segments, and subsequently received an additional document request from the SEC. The Company is cooperating with the SEC. Following the Company’s January 21, 2024 announcement of the Investigation, the Company received document requests from the Department of Justice (“DOJ”) focused primarily on the same subject matter, and the DOJ directed grand jury subpoenas to certain current and former Company employees. The Company is cooperating with the DOJ. The Company is unable to predict the final outcome of these investigations with any reasonable degree of certainty.

Securities Litigation

On January 24, 2024, following the Company’s January 21, 2024 announcement of the investigation relating to intersegment sales, a purported stockholder of the Company filed a putative class action in the U.S. District Court for the Northern District of Illinois against the Company and its Chief Executive Officer, as well as Vikram Luthar and Ray Young. The plaintiff alleges false and misleading statements in the Company’s disclosures and seeks unspecified compensatory and punitive damages. On March 29, 2024 and April 12, 2024, purported stockholders of the Company filed derivative lawsuits in the U.S. District Court for the Northern District of Illinois against the Chief Executive Officer, Vikram Luthar, Ray Young, and certain individual ADM Directors, alleging false and misleading statements in the Company’s proxy statements, breach of fiduciary duty, and corporate waste, among other claims, and seeking unspecified damages. On April 23, 2024, a purported stockholder of the Company filed a derivative lawsuit in the U.S. District Court for the District of Delaware against the Chief Executive Officer, Vikram Luthar, Ray Young, and certain individual ADM Directors, asserting claims for breach of fiduciary duty and contribution and indemnification under the Securities Exchange Act and seeking unspecified damages. The Company is unable to predict the final outcome of these proceedings with any reasonable degree of certainty.

Note 18. Subsequent Event

On April 15, 2024, the Company received a final delivery of 7,325,733 shares at an average share price of $63.065 or $462 million as final settlement of the ASR transaction (see Note 11 for more information).

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A) should be read in conjunction with the accompanying unaudited consolidated financial statements.

Restatement of Previously Issued Consolidated Financial Statements

As described in the Explanatory Note above and in Part I, Item 1, Note 1 to the Consolidated Financial Statements, the Company has restated its Consolidated Financial Statements as of March 31, 2024 and 2023 and for the quarters ended March 31, 2024 and 2023 contained in this Amendment. As a result, the previously reported financial information as of March 31, 2024 and 2023 and for the quarters ended March 31, 2024 and 2023, in this Item 2. MD&A has been updated to reflect the relevant restatements. See Item 1, Note 1. Basis of Presentation and Restatement of Previously Filed Consolidated Financial Statements, and Note 13. Segment Information, in the Consolidated Financial Statements for additional information related to the restatements, including descriptions of the adjustments and the impacts on the Consolidated Financial Statements. The Company also is correcting certain segment disclosure presentation errors.

Company Overview

ADM is an essential global agricultural supply chain manager and processor; a premier human and animal nutrition provider; a trailblazer in groundbreaking solutions to support healthier living; an industry-leading innovator in replacing petroleum-based products; and a leader in sustainability. The Company is one of the world’s leading producers of ingredients for sustainable nutrition. The Company uses its significant global asset base to originate and transport agricultural commodities, connecting to markets in over 190 countries. The Company also processes corn, oilseeds, and wheat into products for food, animal feed, industrial, and energy uses. The Company also engages in the manufacturing, sale, and distribution of a wide array of ingredients and solutions including plant-based proteins, natural flavors, flavor systems, natural colors, emulsifiers, soluble fiber, polyols, hydrocolloids, probiotics, prebiotics, enzymes, botanical extracts, and other specialty food and feed ingredients. The Company uses its global asset network, business acumen, and its relationships with suppliers and customers to efficiently connect the harvest to the home thereby generating returns for its shareholders, principally from margins earned on these activities.

The Company’s operations are organized, managed, and classified into three reportable business segments: Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition. Each of these segments is organized based upon the nature of products and services offered. The Company’s remaining operations are not reportable business segments, as defined by the applicable accounting standard, and are classified as Other Business. Financial information with respect to the Company’s reportable business segments is set forth in Note 13 of “Notes to Consolidated Financial Statements” included in Item 1 herein, “Financial Statements”.

ADM’s recent significant portfolio actions and announcements include:

•the acquisitions in January 2024 of Revela Foods, a Wisconsin-based developer and manufacturer of innovative dairy flavor ingredients and solutions and FDL, a UK-based leading developer and producer of premium flavor and functional ingredient systems.

Sustainability is a key driver in ADM’s expanding portfolio of environmentally responsible, plant-derived products. Consumers today increasingly expect their food and drink to come from sustainable ingredients, produced by companies that share their values, and ADM is continually finding new ways to meet those needs through its portfolio actions.

The Company’s strategic transformation is focused on three strategic pillars: Productivity, Innovation, and Culture.

The Productivity pillar includes (1) partnering across various global teams including procurement, supply chain, operations, and commercial to optimize costs and improve production volumes across the enterprise; (2) continued roll out of the 1ADM business transformation program and implementation of improved standardized business processes; and (3) increased use of technology, data analytics, and automation at production facilities, in offices, and with customers to improve efficiencies and customer service.

The Innovation pillar includes expansions and investments in (1) improving the customer experience by leveraging producer relationships and enhancing the use of state-of-the-art digital technology; (2) sustainability-driven innovation, which

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

encompasses the full range of products, solutions, capabilities, and commitments to serve customers’ needs; and (3) growth initiatives, including organic growth with additional capacity to meet growing market demand and strategic objectives.

The Culture pillar focuses on building capabilities and enabling collaboration, teamwork, and agility from process standardization and digitalization and ADM’s diversity, equity, and inclusion initiatives, which bring new perspectives and expertise to the Company’s decision-making.

ADM plans to support the three pillars with investments in technology, which include expanding digital capabilities and investing further in research and development.

Environmental and Social Responsibility

The Company’s policy to protect forests, biodiversity, and communities includes provisions that promote conservation of water resources and biodiversity in agricultural landscapes, promote solutions to reduce climate change and greenhouse gas emissions, and support agriculture as a means to advance sustainable development by reducing poverty and increasing food security. Additionally, the policy confirms ADM’s commitment to protect human rights defenders, whistleblowers, complainants, and community spokespersons; ADM’s aspiration to cooperate with all parties necessary to enable access to fair and just remediation; and the Company’s non-compliance protocol for suppliers. In 2022, the Company achieved full traceability of its direct and indirect sourcing throughout its soy supply chains in Brazil, Paraguay, and Argentina. ADM is committed to eliminating deforestation from all of the Company’s supply chains by 2025. In 2023, after a strategic investigation of the impact of conversion of native habitats in its key supply chains, the Company announced its commitment to eliminate conversion of native habitats in high risk areas in South America for direct suppliers of all commodities by 2025 and indirect suppliers by 2027, with a 2025 cutoff date (a date after which conversion of primary native vegetation renders a given area or production unit non-compliant) for both direct and indirect suppliers.

The Company’s environmental goals, collectively called “Strive 35” – an ambitious plan to, by 2035, reduce absolute Scope 1 and 2 greenhouse gas (GHG) emissions by 25 percent from a 2019 baseline, reduce Scope 3 emissions by 25% from a 2021 baseline, reduce energy intensity by 15 percent from a 2019 baseline, reduce water intensity by 10 percent from a 2019 baseline, and achieve a 90 percent landfill diversion rate. In 2023, ADM refined two of its Strive 35 commitments to more meaningfully drive progress: ADM aims to reduce its absolute water withdrawal by 10%, from a 2019 baseline, by 2035, and ADM aims to increase its use of low-carbon energy sources to 25% of total energy used by 2035.

Operating Performance Indicators

The Company is exposed to certain risks inherent to an agricultural-based commodity business. These risks are further described in Part I Item 1A, “Risk Factors” included in the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2023.

The Company’s Ag Services and Oilseeds and Carbohydrate Solutions operations are principally agricultural commodity-based businesses where changes in selling prices move in relationship to changes in prices of the commodity-based agricultural raw materials. As a result, changes in agricultural commodity prices have relatively equal impacts on both revenues and cost of products sold. Therefore, changes in revenues of these businesses do not necessarily correspond to changes in margins or gross profit. Thus, gross margins per volume or metric ton are more meaningful than gross margins as percentage of revenues.

The Nutrition businesses also utilize agricultural commodities (or products derived from agricultural commodities) as raw materials. However, in these operations, agricultural commodity market price changes do not necessarily correlate to changes in cost of products sold. Therefore, changes in revenues of these businesses may correspond to changes in margins or gross profit. Thus, gross margins rates are more meaningful as a performance indicator in these businesses.

The Company has consolidated subsidiaries in more than 70 countries. For the majority of the Company’s subsidiaries located outside the United States, the local currency is the functional currency except for certain significant subsidiaries in Switzerland where Euro is the functional currency, and Brazil and Argentina where U.S. dollar is the functional currency. Revenues and expenses denominated in foreign currencies are translated into U.S. dollars at the weighted average exchange rates for the applicable periods. For the majority of the Company’s business activities in Brazil and Argentina, the functional currency is the U.S. dollar; however, certain transactions, including taxes, occur in local currency and require remeasurement to the functional currency. Changes in revenues are expected to be correlated to changes in expenses reported by the Company caused by

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

fluctuations in the exchange rates of foreign currencies, primarily the Euro, British pound, Canadian dollar, and Brazilian real, as compared to the U.S. dollar. Effective April 1, 2022, the Company changed the functional currency of its Turkish entities to the U.S. dollar which did not and is not expected to have a material impact on the Company’s consolidated financial statements.

The Company measures its performance using key financial metrics including net earnings, adjusted earnings per share (EPS), gross margins, segment operating profit, total segment operating profit, earnings before interest, taxes, depreciation, and amortization (EBITDA), adjusted EBITDA, return on invested capital, economic value added, and operating cash flows before working capital. Some of these metrics are not defined by accounting principles generally accepted in the United States and should be considered in addition to, and not in lieu of, GAAP financial measures. For more information, see “Non-GAAP Financial Measures” on page 41. The Company’s financial results can vary significantly due to changes in factors such as fluctuations in energy prices, weather conditions, crop plantings, government programs and policies, trade policies, changes in global demand, general global economic conditions, changes in standards of living, global production of similar and competitive crops, and geopolitical developments. Due to the unpredictable nature of these and other factors, the Company undertakes no responsibility for updating any forward-looking information contained within “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

Market Factors Influencing Operations or Results in the Three Months Ended March 31, 2024

The Company is subject to a variety of market factors which affect the Company's operating results. In Ag Services and Oilseeds, following two years of very favorable market conditions, several headwinds in the agriculture cycle led to more normalized results throughout the entire value chain. Ag Services experienced slow South American farmer selling, low demand for North American exports, along with low margins in all regions with the move to a carry market. Crushing saw strong run rates, the anticipation of a more normal global supply environment, and new capacity suppressing meal values. In Refined Products and Other, oil values in North America were under pressure due to low carbon intensity feedstocks competing in the renewable diesel market. In Carbohydrate Solutions, demand for starches and sweeteners remained solid with margins remaining steady across the entire portfolio. Industry ethanol stocks remained elevated. Solid export demand for ethanol helped minimize the imbalance between supply and demand. In Nutrition, demand was softer in a few food and beverage product categories. Human Nutrition was impacted by inflation which drove lower demand and impacted volumes in alternative proteins. Demand has started to recover in the food, beverage, and dietary supplement segment. In Animal Nutrition, a soft amino acids market driven by price weakness in North America was partially compensated by a slightly improved market in Europe, Middle East, and Africa (EMEA). The global feed and feed additives market remained challenged on the demand side, with weakness in the Chinese beef and pork business and continued subdued global shrimp prices.

Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023

Earnings before income taxes decreased $512 million from $1.4 billion to $885 million. Total segment operating profit (a non-GAAP measure) decreased $432 million from $1.6 billion to $1.2 billion due primarily to lower results in Refined Products and Other, Ag Services, Crushing, Human Nutrition, and Starches and Sweeteners, partially offset by higher results in Wilmar, Vantage Corn Processors, and Animal Nutrition. Total segment operating profit (a non-GAAP measure) excluded asset impairment and restructuring charges totaling $6 million. Excluded from the total segment operating profit (a non-GAAP measure) in the prior-year quarter was a net charge of $6 million consisting of charges totaling $7 million related to asset impairment and restructuring, partially offset by a gain on the sale of certain assets of $1 million. Corporate results in the current quarter were a net charge of $426 million and included restructuring charges of $12 million. Corporate results in the prior-year quarter were a net charge of $322 million and included a mark-to-market gain of $5 million on the conversion option of the exchangeable bonds issued in August 2020.

Income tax expense decreased $59 million to $166 million. The effective tax rate for the quarter ended March 31, 2024 was 18.8% compared to 16.1% for the quarter ended March 31, 2023. The increase in the rate was primarily due to changes in the geographic mix of forecasted pretax earnings and the impact of discrete tax items.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Analysis of Statements of Earnings

Processed volumes by product for the quarter are as follows (in metric tons):


	Three Months Ended
	March 31,
(In thousands)	2024	2023	Change
Oilseeds	9,387	8,627	760
Corn	4,407	4,394	13
Total	13,794	13,021	773

The Company generally operates its production facilities, on an overall basis, at or near capacity, adjusting facilities individually, as needed, to react to the current margin environment and seasonal local supply and demand conditions. The overall increase in oilseeds processed volumes was primarily related to improved crush rates in the current quarter compared to lower crush rates in the prior-year quarter resulting from weather related issues and reduced capacity due to the Russian-Ukraine war.

Revenues by segment for the quarter are as follows:


	Three Months Ended
	March 31,
	2024		2023		Change
	(In millions)












Ag Services and Oilseeds
Ag Services	$	11,197	$	11,695	$	(498)
Crushing	3,327		3,683		(356)
Refined Products and Other	2,695		3,201		(506)
Total Ag Services and Oilseeds	17,219		18,579		(1,360)

Carbohydrate Solutions
Starches and Sweeteners	2,156		2,737		(581)
Vantage Corn Processors	527		800		(273)
Total Carbohydrate Solutions	2,683		3,537		(854)

Nutrition
Human Nutrition	964		936		28
Animal Nutrition	872		917		(45)
Total Nutrition	1,836		1,853		(17)
Total Segment Revenues	21,738		23,969		(2,231)

Other Business	109		103		6


Total Revenues	$	21,847	$	24,072	$	(2,225)

Revenues and cost of products sold in a commodity merchandising and processing business are significantly correlated to the underlying commodity prices and volumes. During periods of significant changes in commodity prices, the underlying performance of the Company is better evaluated by looking at margins because both revenues and cost of products sold, particularly in Ag Services and Oilseeds, generally have a relatively equal impact from market price changes, which generally result in an insignificant impact to gross profit.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Revenues decreased $2.2 billion to $21.8 billion due to lower sales prices ($5.0 billion), partially offset by higher sales volumes ($2.8 billion). Lower sales prices of oils, corn, soybeans, and meal and lower sales volumes of alcohol, rapeseed, and farming materials, were partially offset by higher sales volumes of corn, soybeans, wheat, and meal. Ag Services and Oilseeds revenues decreased 7% to $17.2 billion due to lower sales prices ($4.3 billion), partially offset by higher sales volumes ($3.0 billion). Carbohydrate Solutions revenues decreased 24% to $2.7 billion due to lower sales prices ($0.7 billion) and lower sales volumes ($0.2 billion). Nutrition revenues of $1.8 billion was comparable to the prior-year quarter.

Cost of products sold decreased $1.8 billion to $20.2 billion due principally to lower average commodity costs. Manufacturing expenses decreased $86 million to $1.8 billion due principally to lower energy costs, partially offset by higher salaries and benefit costs and commercial service fees.

Foreign currency translation increased revenues by $64 million and cost of products sold by $64 million.

Gross profit decreased $0.4 billion or 20% to $1.7 billion. Lower results in Ag Services and Oilseeds ($363 million), Starches and Sweeteners ($58 million), and Human Nutrition ($48 million) were partially offset by higher results in Vantage Corn Processors ($18 million), Animal Nutrition ($17 million), and Other ($17 million). These factors are explained in the segment operating profit discussion on page 4 0.

Selling, general, and administrative expenses increased $70 million to $951 million due primarily to higher legal and professional fees, increased amortization of intangibles, and higher salaries and benefit costs.

Asset impairment, exit, and restructuring costs increased $11 million to $18 million. Charges in the current quarter consisted of $3 million of impairments related to certain long-lived assets and $3 million of restructuring, presented as specified items, and restructuring of $12 million in Corporate. Charges in the prior-year quarter consisted of $3 million of impairments related to certain long-lived assets and $4 million of restructuring, presented as specified items.

Equity in earnings of unconsolidated affiliates increased $38 million to $212 million due primarily to higher earnings from the Company’s investment in Wilmar.

Interest and investment income decreased $11 million to $123 million due primarily to a valuation loss related to an investment in alternative protein and precision fermentation, partially offset by higher interest income driven by higher interest rates.

Interest expense increased $19 million to $166 million due primarily to increased short-term rates on customer deposit balances in ADM Investor Services. Interest expense in the prior-year quarter also included a mark-to-market gain adjustment of $5 million related to the conversion option of the exchangeable bonds issued in August 2020.

Other income-net decreased $18 million to $26 million. Income in the current quarter included gains on disposals of individually insignificant assets in the ordinary course of business, the non-service components of net pension benefit income, net foreign exchange gains, and net other income. Income in the prior-year quarter included gains on disposals of individually insignificant assets in the ordinary course of business, the non-service components of net pension benefit income, net foreign exchange gains, and net other income.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Total segment operating profit (a non-GAAP measure) is reconciled to earnings before income taxes, the most directly comparable GAAP measure, for the quarters ended March 31, 2024 and 2023 as follows:


	Three Months Ended
	March 31,
	2024		2023		Change
	(In millions)
Earnings before income taxes	$	885	$	1,397	$	(512)
Other Business (earnings) loss	(121)		$	(97)	(24)
Corporate	426		322		104

Specified Items:
Gains on sale of assets	—		(1)		1
Impairment and restructuring charges	6		7		(1)
Total Segment Operating Profit	$	1,196	$	1,628	$	(432)













Segment Operating Profit
Ag Services and Oilseeds
Ag Services	$	232	$	348	$	(116)
Crushing	313		427		(114)
Refined Products and Other	170		327		(157)
Wilmar	149		109		40
Total Ag Services and Oilseeds	$	864	$	1,211	$	(347)

Carbohydrate Solutions
Starches and Sweeteners	$	261	$	313	$	(52)
Vantage Corn Processors	(13)		(34)		21
Total Carbohydrate Solutions	$	248	$	279	$	(31)

Nutrition
Human Nutrition	$	76	$	138	$	(62)
Animal Nutrition	8		—		8
Total Nutrition	$	84	$	138	$	(54)

Ag Services and Oilseeds segment operating profit decreased 29%. Ag Services results were lower than the first quarter of 2023 due to the stabilization of trade flows leading to lower global trade and risk management results. Crushing results were lower than the prior-year quarter as increased imports of used cooking oil and the anticipation of large South American supplies negatively impacted North American soy crush margins. Significant positive mark-to-market timing impacts that contributed to the prior-year quarter results also drove lower results in the current quarter. Refined Products and Other results were lower than the prior-year quarter as the increased imports of used cooking oil negatively impacted refining margins in North America. Negative mark-to-market timing impacts affected current quarter results versus positive impacts in the prior-year quarter. Equity earnings from Wilmar were higher versus the first quarter of 2023.

Carbohydrate Solutions segment operating profit decreased 11%. Starches and Sweeteners results were lower year-over-year as strong starches and sweeteners margins were offset by lower domestic ethanol margins due to strong industry production and elevated stocks, as well as moderating margins in the EMEA region. Vantage Corn Processors results improved year-over-year as strong demand for sustainably certified exports of ethanol supported volumes and margins.

Nutrition segment operating profit decreased 39%. Human Nutrition results were lower than the first quarter of 2023 as impacts related to unplanned downtime at Decatur East and a normalizing texturants market negatively impacted margins.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Animal Nutrition results were higher compared to the same quarter last year as cost optimization efforts and lower input costs bolstered margins.

Other Business operating profit increased $24 million. Captive insurance results were higher due to higher program premiums and lower claims. ADM Investor Services results improved on higher net interest income.

Corporate results for the quarter are as follows:


	Three Months Ended
	March 31,
	2024		2023		Change
	(In millions)

Interest expense-net	$	(110)	$	(103)	$	(7)
Unallocated corporate costs	(304)		(248)		(56)



Gain on debt conversion option	—		5		(5)
Restructuring charges	(12)		—		(12)
Other income	—		24		(24)
Total Corporate	$	(426)	$	(322)	$	(104)

Corporate results were a net charge of $426 million in the current quarter compared to a net charge of $322 million in the prior-year quarter. Interest expense-net increased $7 million due primarily to lower capitalized interest. Unallocated corporate costs increased $56 million due primarily to increases in legal and professional fees, global technology spend, incentive compensation accruals, and financing costs. Gain on debt conversion option in the prior-year quarter was related to the mark-to-market adjustment of the conversion option of the exchangeable bonds issued in August 2020. Other income in the current quarter includes foreign exchange gains of $15 million and the non-service components of net pension benefit income of $5 million offset by an investment revaluation loss of $18 million. Other income in the prior-year quarter included the non-service components of net pension benefit income of $4 million and foreign exchange gains of $22 million.

Non-GAAP Financial Measures

The Company uses adjusted net earnings, adjusted earnings per share (EPS), adjusted EBITDA, and total segment operating profit, non-GAAP financial measures as defined by the SEC, to evaluate the Company’s financial performance. These performance measures are not defined by accounting principles generally accepted in the United States and should be considered in addition to, and not in lieu of, GAAP financial measures.

Adjusted net earnings is defined as net earnings adjusted for the effects on net earnings of specified items. Adjusted EPS is defined as diluted EPS adjusted for the effects on reported diluted EPS of specified items. EBITDA is defined as earnings

before interest on borrowings, taxes, and depreciation and amortization. Adjusted EBITDA is defined as earnings before interest, taxes, depreciation, and amortization, adjusted for specified items. The Company calculates adjusted EBITDA by removing the impact of specified items and adding back the amounts of income tax expense, interest expense on borrowings, and depreciation and amortization to net earnings. Total segment operating profit is defined as ADM’s consolidated earnings before income taxes, adjusted for Other business, Corporate, and specified items.

Management believes that adjusted net earnings, adjusted EPS, adjusted EBITDA, and total segment operating profit are useful measures of the Company’s performance because they provide investors additional information about the Company’s operations allowing better evaluation of underlying business performance and better period-to-period comparability. Adjusted net earnings, adjusted EPS, adjusted EBITDA, and total segment operating profit are not intended to replace or be an alternative to net earnings, diluted EPS, net earnings, and earnings before income taxes, respectively, the most directly comparable amounts reported under GAAP. The table on page 4 0 provides a reconciliation of total segment operating profit to earnings before income taxes for the three months ended March 31, 2024 and 2023.

In this Amendment, the Company is revising its reconciliation and calculation of total segment operating profit. The revised reconciliation in Note 13. Segment Information presents a subtotal for total segment operating profit that is equal to the sum of the segment operating profit reported for each of the Ag Services and Oilseeds, Carbohydrate Solutions and Nutrition segments.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Amounts for other business and specified items, which previously were reflected in the calculation of total segment operating profit, are now reflected as reconciling items, similar to Corporate, between total segment operating profit and earnings before income taxes.

The table below provides a reconciliation of net earnings to adjusted net earnings and diluted EPS to adjusted EPS for the three months ended March 31, 2024 and 2023.


	Three months ended March 31,
	2024				2023
	In millions		Per share		In millions		Per share
Average number of shares outstanding - diluted	514				551

Net earnings and reported EPS (fully diluted)	$	729	$	1.42	$	1,170	$	2.12
Adjustments:

Gains on sale of assets - net of tax of $0 million (1)	—		—		(1)		—
Gain on debt conversion option - net of tax of $0 million (1)	—		—		(5)		(0.01)
Impairment and restructuring charges - net of tax of $0 million in 2024 and $2 million in 2023 (1)	18		0.03		5		0.01

Certain discrete tax adjustments	3		0.01		(18)		(0.03)
Total adjustments	21		0.04		(19)		(0.03)
Adjusted net earnings and adjusted EPS	$	750	$	1.46	$	1,151	$	2.09

(1) Tax effected using the U.S. and other applicable tax rates.

The tables below provide a reconciliation of net earnings to adjusted EBITDA for the three months ended March 31, 2024 and 2023.


	Three months ended
	March 31,
(In millions)	2024		2023		Change
Net earnings	$	729	$	1,170	$	(441)
Net earnings (losses) attributable to noncontrolling interests	(10)		2		(12)
Income tax expense	166		225		(59)
Interest expense	115		100		15
Depreciation and amortization	280		259		21
EBITDA	1,280		1,756		(476)
(Gain) loss on sales of assets and businesses	—		(1)		1



Impairment and restructuring charges	18		7		11
Adjusted EBITDA	$	1,298	$	1,762	$	(464)

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Liquidity and Capital Resources

A Company objective is to have sufficient liquidity, balance sheet strength, and financial flexibility to fund the operating and capital requirements of a capital-intensive agricultural commodity-based business. The Company depends on access to credit markets, which can be impacted by its credit rating and factors outside of ADM’s control, to fund its working capital needs and capital expenditures. The primary source of funds to finance ADM’s operations, capital expenditures, and advancement of its growth strategy is cash generated by operations and lines of credit, including a commercial paper borrowing facility and accounts receivable securitization programs. In addition, the Company believes it has access to funds from public and private equity and debt capital markets in both U.S. and international markets.

Cash provided by operating activities was $0.7 billion for the three months ended March 31, 2024 compared to a use of $1.6 billion for the same period last year. Working capital changes decreased cash by $0.2 billion for the three months ended March 31, 2024 compared to a decrease of $2.9 billion for the same period last year. Segregated investments increased $0.2 billion due to increased trading activity in the Company’s futures commission and brokerage business. Trade receivables decreased $0.1 billion due to lower revenues. Inventories decreased $0.3 billion due to lower inventory prices and volumes. Trade payables decreased $0.7 billion primarily due to lower payables related to grain purchases. Brokerage payables increased approximately $0.3 billion due to increased trading activity in the Company’s futures commission and brokerage business.

Cash used in investing activities was $1.2 billion for the three months ended March 31, 2024 compared to $0.3 billion for the same period last year. Capital expenditures for the three months ended March 31, 2024 of $0.3 billion was comparable to the same period last year. Net assets of businesses acquired in the three months ended March 31, 2024 were $0.9 billion compared to none in the same period last year.

Cash used in financing activities was $2 million for the three months ended March 31, 2024 compared to cash provided of $0.6 billion for the same period last year. Long-term debt payments were immaterial for the three months ended March 31, 2024 compared to $2 million for the same period last year. Net borrowings on short-term credit agreements for the three months ended March 31, 2024 were $1.6 billion compared to $1.3 billion for the same period last year. Share repurchases for the three months ended March 31, 2024 were $1.3 billion compared to $0.4 billion for the same period last year. Dividends were $0.3 billion for the three months ended March 31, 2024 compared to $0.2 billion for the same period last year.

At March 31, 2024, the Company had $0.8 billion of cash and cash equivalents and a current ratio, defined as current assets divided by current liabilities, of 1.5 to 1. Included in working capital was $6.7 billion of readily marketable commodity inventories. At March 31, 2024, the Company’s capital resources included shareholders’ equity of $23.2 billion and lines of credit, including the accounts receivable securitization programs described below, totaling $12.8 billion, of which $8.8 billion was unused. The Company’s ratio of long-term debt to total capital (the sum of long-term debt of $8.2 billion and shareholders’ equity of $23.2 billion in 2024 and the sum of long-term debt of $8.3 billion and shareholders’ equity of $24.1 billion in 2023) was 26% and 25% at March 31, 2024 and December 31, 2023, respectively. The Company uses this ratio as a measure of the Company’s long-term indebtedness and an indicator of financial flexibility. The Company’s ratio of net debt (the sum of short-term debt of $1.7 billion, current maturities of long-term debt of $1 million, and long-term debt of $8.2 billion less the sum of cash and cash equivalents of $0.8 billion and short-term marketable securities of none in 2024 and the sum of short-term debt of $0.1 billion, current maturities of long-term debt of $1 million, and long-term debt of $8.3 billion less the sum of cash and cash equivalents of $1.4 billion and short-term marketable securities of none in 2023) to capital (the sum of net debt of $9.2 billion and shareholders’ equity of $23.2 billion in 2024 and the sum of net debt of $7.0 billion and shareholders' equity of $24.1 billion in 2023) was 28% and 22% at March 31, 2024 and December 31, 2023, respectively. Of the Company’s total lines of credit, $5.0 billion supported the combined U.S. and European commercial paper borrowing programs, against which there was $0.9 billion of commercial paper outstanding at March 31, 2024.

As of March 31, 2024, the Company had $0.8 billion of cash and cash equivalents, $0.7 billion of which was cash held by foreign subsidiaries whose undistributed earnings are considered indefinitely reinvested. Based on the Company’s historical ability to generate sufficient cash flows from its U.S. operations and unused and available U.S. credit capacity of $5.2 billion, the Company has asserted that these funds are indefinitely reinvested outside the U.S.

The Company has accounts receivable securitization programs (the “Programs”) with certain commercial paper conduit purchasers and committed purchasers. The Programs provide the Company with up to $3.0 billion in funding against accounts receivable transferred into the Programs and expands the Company’s access to liquidity through efficient use of its balance sheet assets (see Note 15 of “Notes to Consolidated Financial Statements” included in Item 1 herein, “Financial Statements” for

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

more information and disclosures on the Programs). As of March 31, 2024, the Company had $0.7 billion unused capacity of its facility under the Programs.

As of March 31, 2024, the Company has total available liquidity of $9.6 billion comprised of cash and cash equivalents and unused lines of credit with a well-diversified group of primarily investment-grade institutions.

For the three months ended March 31, 2024, the Company spent approximately $0.3 billion in capital expenditures, $0.3 billion in dividends, and $1.3 billion in share repurchases. The Company has a stock repurchase program. On March 12, 2024, the Company entered into an ASR Agreement with Merrill Lynch International, an affiliate of BofA Securities, Inc., to repurchase $1.0 billion of ADM common stock as part of ADM’s existing share repurchase program to repurchase up to 200 million shares through December 31, 2024. On March 28, 2024, the Company received an interim delivery of 8,880,986 shares at an average share price of $60.596 or $538 million. Under the program, the Company had 38.5 million shares remaining as of March 31, 2024 that may be repurchased until December 31, 2024. On April 15, 2024, the Company received a final delivery of 7,325,733 shares as final settlement of the ASR transaction (see Notes 11 and 18 of “Notes to Consolidated Financial Statements” included in Item 1 herein, “Financial Statements” for more information). As of the final settlement date, the Company had 31.2 million shares remaining that may be repurchased under the program until December 31, 2024.

In 2024, the Company expects total capital expenditures of approximately $1.3 billion and additional cash outlays of approximately $1.0 billion in dividends and up to $2.3 billion in share repurchases, subject to other strategic uses of capital and the evolution of operating cash flows and the working capital position throughout the year.

Contractual Obligations and Commercial Commitments

The Company’s purchase obligations as of March 31, 2024 and December 31, 2023 were $12.2 billion and $14.0 billion, respectively. The decrease is primarily related to lower energy commitments and obligations to purchase agricultural commodity inventories at lower prices. As of March 31, 2024, the Company expects to make payments related to purchase obligations of $11.6 billion within the next twelve months. There were no other material changes in the Company’s contractual obligations during the quarter ended March 31, 2024.

Off Balance Sheet Arrangements

There were no material changes in the Company’s off balance sheet arrangements during the quarter ended March 31, 2024.

Critical Accounting Policies and Estimates

There were no material changes in the Company’s critical accounting policies and estimates during the quarter ended March 31, 2024. For a description of the Company’s critical accounting policies, estimates, and assumptions used in the preparation of the Company’s financial statements, see Part II, Item 7 and Note 1 of “Notes to Consolidated Financial Statements” included in Part II, Item 8, of the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2023.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The market risk inherent in the Company’s market risk sensitive instruments and positions is the potential loss arising from adverse changes in: commodity market prices as they relate to the Company’s net commodity position, foreign currency exchange rates, and interest rates. Significant changes in market risk sensitive instruments and positions for the quarter ended March 31, 2024 are described below. There were no material changes during the period in the Company’s potential loss arising from changes in foreign currency exchange rates and interest rates.

For detailed information regarding the Company’s market risk sensitive instruments and positions, see Item 7A, “Quantitative and Qualitative Disclosures About Market Risk” included in the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2023.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK (Continued)

Commodities

The availability and prices of agricultural commodities are subject to wide fluctuations due to factors such as changes in weather conditions, crop disease, plantings, government programs and policies, competition, changes in global demand, changes in customer preferences and standards of living, and global production of similar and competitive crops.

The fair value of the Company’s commodity position is a summation of the fair values calculated for each commodity by valuing all of the commodity positions at quoted market prices for the period, where available, or utilizing a close proxy. The Company has established metrics to monitor the amount of market risk exposure, which consist of volumetric limits and value-at-risk (VaR) limits. VaR measures the potential loss, at a 95% confidence level, that could be incurred over a one-year period. Volumetric limits are monitored daily and VaR calculations and sensitivity analysis are monitored weekly.

In addition to measuring the hypothetical loss resulting from an adverse two standard deviation move in market prices (assuming no correlations) over a one-year period using VaR, sensitivity analysis is performed measuring the potential loss in fair value resulting from a hypothetical 10% adverse change in market prices. The highest, lowest, and average weekly position together with the market risk from a hypothetical 10% adverse price change is as follows:


	Three months ended				Year ended
	March 31, 2024				December 31, 2023
Long/(Short) (In millions)	Fair Value		Market Risk		Fair Value		Market Risk
Highest position	$	(265)	$	(27)	$	498	$	50
Lowest position	6		1		(6)		(1)
Average position	(56)		(6)		125		13

The change in fair value of the average position was due to the overall decrease in average quantities, partially offset by the increase in prices of certain commodities.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

At the time of the filing of this Amendment, an evaluation was performed under the supervision and with the participation of the Company’s management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)), as of March 31, 2024. Based on that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer, concluded the Company’s disclosure controls and procedures were not effective as of March 31, 2024, due to the material weakness described below.

Internal Control Over Financial Reporting

As disclosed in the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2023, during the fourth quarter of 2023, in connection with the Investigation, the Company identified a material weakness in its internal control over financial reporting related to the Company’s accounting practices and procedures for segment disclosures. The material weakness resulted from inadequate controls that allowed for certain intersegment sales to be reported at amounts that were not in accordance with ASC 606, Revenue from Contracts with Customers. Specifically, the Company did not have adequate controls in place around measurement of certain intersegment sales between the Company’s reporting segments. In addition, appropriate controls were not in place for the reporting of intersegment sales and for the application of disclosure requirements within ASC 280, Segment Reporting. The absence of adequate controls with respect to the reporting of intersegment sales impacted the completeness and accuracy of the Company’s segment disclosures and review controls over projected financial information utilized in goodwill and other long-lived asset impairment tests.

Remediation Plan

The Company is implementing enhancements to its internal controls to remediate the identified material weakness in its internal control over financial reporting related to the Company’s accounting practices and procedures for intersegment sales and to enhance the reliability of its financial statements with respect to the pricing and reporting of such sales. Specifically, the

ITEM 4. CONTROLS AND PROCEDURES (Continued)

Company is: (i) enhancing the Company’s accounting policies with respect to the measurement of intersegment sales; (ii) improving and documenting the Company’s pricing guidelines for intersegment sales; (iii) enhancing the design and documentation of the execution of pricing and measurement controls, including as to the completeness and accuracy of the reporting for intersegment sales disclosure purposes and projected financial information used in impairment analyses; and (iv) increasing training for relevant personnel on the measurement of and application of relevant accounting guidance to intersegment sales and segment disclosures.

While the Company believes that these efforts will improve its internal control over financial reporting, the Company will not be able to conclude whether the steps the Company is taking will remediate the material weakness in internal control over financial reporting until a sustained period of time has passed to allow management to test the design and operational effectiveness of the new and enhanced controls.

Changes in Internal Control Over Financial Reporting

The Company is implementing a new enterprise resource planning (ERP) system on a worldwide basis, which is expected to occur in phases over the next several years. The Company did not have any further deployments of the ERP system during the quarter ended March 31, 2024.

Except for the material weakness described above and the related remediation measures that are being implemented, there have been no changes in internal control over financial reporting during the quarter ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

During the quarter ended March 31, 2024, the Company completed the acquisitions of Revela, FDL, and PT. As a result of the acquisitions, the Company is in the process of reviewing the internal control structures of these businesses and, if necessary, will make appropriate changes as the Company incorporates its controls and procedures into the acquired businesses.

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

The Company is routinely involved in a number of actual or threatened legal actions, including those involving alleged personal injuries, employment law, product liability, intellectual property, environmental issues, alleged tax liability (see Note 10, Income Taxes of “Notes to Consolidated Financial Statements” included in Part I, Item 1 herein, “Financial Statements,” for information on income tax matters), and class actions. The Company also routinely receives inquiries from regulators and other government authorities relating to various aspects of our business, and at any given time, the Company has matters at various stages of resolution. The outcomes of these matters are not within our complete control and may not be known for prolonged periods of time. In some actions, claimants seek damages, as well as other relief including injunctive relief, that could require significant expenditures or result in lost revenues. In accordance with applicable accounting standards, the Company records a liability in its consolidated financial statements for material loss contingencies when a loss is known or considered probable and the amount can be reasonably estimated. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a material loss contingency is reasonably possible but not known or probable, and can be reasonably estimated, the estimated loss or range of loss is disclosed in the notes to the consolidated financial statements. When determining the estimated loss or range of loss, significant judgment is required to estimate the amount and timing of a loss to be recorded. Estimates of probable losses resulting from litigation and governmental proceedings involving the Company are inherently difficult to predict, particularly when the matters are in early procedural stages, with incomplete facts or legal discovery; involve unsubstantiated or indeterminate claims for damages; potentially involve penalties, fines, disgorgement, or punitive damages; or could result in a change in business practice. See Note 17, Legal Proceedings of “Notes to Consolidated Financial Statements” included in Part I, Item 1 herein, “Financial Statements,” for information on the Company’s legal proceedings which is incorporated herein by reference.

ITEM 1A. RISK FACTORS

In addition to the other information set forth in this report, you should carefully consider the risk factors discussed in “Item 1A. Risk Factors” in the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2023.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities


Period	Total Number of Shares Purchased(1)	Average Price Paid per Share		Total Number of Shares Purchased as Part of a Publicly Announced Program(2)	Number of Shares Remaining to be Purchased Under the Program(2)
January 1, 2024 to
January 31, 2024	4,654,264	$	70.260	4,653,786	47,379,648

February 1, 2024 to
February 29, 2024	412,208	52.976		—	47,379,648

March 1, 2024 to
March 31, 2024	9,325,919	60.387		8,880,986	38,498,662
Total	14,392,391	$	63.368	13,534,772	38,498,662

(1)Total shares purchased represent those shares purchased in the open market as part of the Company’s publicly announced share repurchase program described below, shares received as payment for the exercise price of stock option exercises, and shares received as payment for the withholding taxes on vested restricted stock awards. During the three-month period ended March 31, 2024, there were 857,619 shares received as payments for the withholding taxes on vested restricted stock awards.

(2)On November 5, 2014, the Company’s Board of Directors approved a stock repurchase program authorizing the Company to repurchase up to 100,000,000 shares of the Company’s common stock during the period commencing January 1, 2015 and ending December 31, 2019. On August 7, 2019, the Company’s Board of Directors approved the

ITEM 4. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS (Continued)

extension of the stock repurchase program through December 31, 2024 and the repurchase of up to an additional 100,000,000 shares under the extended program.

ITEM 5. OTHER INFORMATION

None of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted, modified or terminated any contract, instruction, or written plan for the purchase or sale of ADM’s securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the quarter ended March 31, 2024.

ITEM 6. EXHIBITS


(3)(i)						Composite Certificate of Incorporation, as amended (incorporated by reference to Exhibit 3(i) to the Company’s Quarterly Report on Form 10-Q filed on November 13, 2001).

(3)(ii)						Bylaws, as amended through November 2, 2022 (incorporated by reference to Exhibit 3(ii) to the Company’s Annual Report on Form 10-K filed on February 14, 2023).

(10.1)						Form of Performance Share Unit Award Agreement under the Company’s 2020 Incentive Compensation Plan. (incorporated by reference to Exhibit (10.1) to the Company's Quarterly Report on Form 10-Q filed on April 30, 2024)

(10.2)						Form of Restricted Stock Unit Award Agreement under the Company’s 2020 Incentive Compensation Plan.(incorporated by reference to Exhibit (10.2) to the Company's Quarterly Report on Form 10-Q filed on April 30, 2024)

(31.1)						Certification of Principal Executive Officer pursuant to Rule 13a–14(a) and Rule 15d–14(a) of the Securities Exchange Act of 1934, as amended.

(31.2)						Certification of Principal Financial Officer pursuant to Rule 13a–14(a) and Rule 15d–14(a) of the Securities Exchange Act of 1934, as amended.

(32.1)						Certification of Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

(32.2)						Certification of Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

(101)						Inline XBRL file set for the consolidated financial statements and accompanying notes in Part I, Item 1, “Financial Statements” and for the information under Part II, Item 5, “Other Information” of this Quarterly Report on Form 10-Q.

(104)						Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL file set.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


		ARCHER-DANIELS-MIDLAND COMPANY



Dated:	November 18, 2024	/s/ M. Patolawala
		M. Patolawala
		Chief Financial Officer
		(Principal Financial Officer and Duly Authorized Officer)

Exhibit 31.1

RULE 13a – 14(a)/15d-14(a) CERTIFICATION

I, J. R. Luciano, certify that:

1.I have reviewed this quarterly report on Form 10-Q/A of Archer-Daniels-Midland Company;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 18, 2024


			/s/ J. R. Luciano
			J. R. Luciano
			Chair of the Board of Directors, President and Chief Executive Officer

Exhibit 31.2

RULE 13a – 14(a)/15d-14(a) CERTIFICATION

I, M. Patolawala, certify that:

1.I have reviewed this quarterly report on Form 10-Q/A of Archer-Daniels-Midland Company;

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 18, 2024


			/s/ M. Patolawala
			M. Patolawala
			Chief Financial Officer

Exhibit 32.1

SECTION 1350 CERTIFICATION

In connection with the Quarterly Report of Archer-Daniels-Midland Company (the “Company”) on Form 10-Q/A for the quarter ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, J. R. Luciano, Chair of the Board of Directors, President and Chief Executive Officer of the Company, certify that:

(i)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(ii)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 18, 2024


			/s/ J. R. Luciano
			J. R. Luciano
			Chair of the Board of Directors, President and Chief Executive Officer

Exhibit 32.2

SECTION 1350 CERTIFICATION

In connection with the Quarterly Report of Archer-Daniels-Midland Company (the “Company”) on Form 10-Q/A for the quarter ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, M. Patolawala, Chief Financial Officer of the Company, certify that:

(i)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(ii)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 18, 2024


			/s/ M. Patolawala
			M. Patolawala
			Chief Financial Officer

Cover Page - shares	3 Months Ended
Cover Page - shares	Mar. 31, 2024	Apr. 29, 2024
Class of Stock [Line Items]
Entity Central Index Key	0000007084
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Amendment Flag	true
Document Type	10-Q/A
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	1-44
Entity Registrant Name	ARCHER-DANIELS-MIDLAND CO
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	41-0129150
Entity Address, Address Line One	77 West Wacker Drive, Suite 4600
Entity Address, City or Town	Chicago,
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60601
City Area Code	312
Local Phone Number	634-8100
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		494,437,789
Amendment Description	Explanatory NoteArcher-Daniels-Midland Company (the “Company”) is filing this Amendment No. 1 on Form 10-Q/A (this “Amendment”) to its Quarterly Report on Form 10‑Q for the quarter ended March 31, 2024, which was originally filed with the United States Securities and Exchange Commission (“SEC”) on April 30, 2024 (the “Form 10‑Q”). In filing this Amendment, the Company is restating its previously issued unaudited consolidated financial statements as of March 31, 2024 and 2023 and for the quarters ended March 31, 2024 and 2023 (collectively, the “Affected Periods”) for the correction of certain segment-specific historical financial information as further described below.In addition, the Company filed an amendment to its Annual Report on Form 10-K for the year ended December 31, 2023 and intends to file an amendment to its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, originally filed with the SEC on March 12, 2024 and July 30, 2024, respectively (such reports, together with this Amendment, the “Amended Reports”). All material restatement information will be included in the Amended Reports, and the Company does not intend to separately amend other filings that were previously filed with the SEC.Accordingly, investors and other readers should rely only on the financial information and other disclosures regarding the periods described above in this Amendment and in any other future filings with the SEC (as applicable) and should not rely on any previously issued or filed reports, press releases, corporate presentations or similar communications relating to the Affected Periods.Background of CorrectionFollowing ongoing dialogue with the staff of the SEC, the Company concluded that it would amend the 2023 Form 10-K and Form 10-Qs for the first and second quarters of 2024 (collectively, the “Q1 and Q2 2024 Form 10-Qs”) to restate the segment information disclosure included in those filings. These restatements do not impact ADM’s Consolidated Statements of Earnings, Consolidated Statements of Comprehensive Income (Loss), Consolidated Balance Sheets, Consolidated Statements of Cash Flows or Consolidated Statements of Shareholders’ Equity as of and for the periods presented in the Amended Reports.As previously disclosed in Note 13. Segment Information, to the Company’s unaudited Consolidated Financial Statements included in the Form 10-Q, the Company identified and corrected certain intersegment sales amounts that either (i) were not in accordance with prior disclosures about presenting such sales at amounts approximating market or (ii) included intrasegment sales (resulting from sales within the segment) and should have included exclusively intersegment sales (resulting from sales from one segment to another). In connection with the error corrections, the Company identified a material weakness in its internal control over financial reporting related to its accounting practices and procedures for intersegment sales. The Company put in place a plan to remediate this material weakness, as disclosed in the 2023 Form 10-K and Q1 and Q2 2024 Form 10-Qs.In the course of testing new controls implemented as part of the Company’s material weakness remediation plan in the third quarter of 2024, the Company identified additional misclassified intersegment transactions. These newly identified errors concern additional intersegment sales for each of its Ag Services and Oilseeds, Carbohydrate Solutions and Nutrition segments that included certain intrasegment sales and should have included exclusively intersegment sales. The Company also identified some intersegment transactions between Ag Services and Oilseeds and Carbohydrate Solutions that were not accounted for consistently in accordance with revenue recognition and segment reporting standards and should not have been reported as intersegment sales. The Company also is correcting certain segment disclosure presentation errors in the Amended Reports.This Amendment reflects corrections for the newly identified errors related to intersegment sales (described below), the previously-corrected errors related to intersegment sales and segment operating profit, and other segment disclosure corrections (See Note 1 to the Consolidated Financial Statements in this Amendment for further information).Restatement of Consolidated Financial StatementsThis Amendment includes unaudited restated Consolidated Financial Statements for the Affected Periods. See Note 13 to the Consolidated Financial Statements in this Amendment for the restated unaudited segment information as of March 31, 2024 and 2023 for the quarters ended March 31, 2024 and 2023.Items Amended in This FilingThis Amendment amends and restates the following items of the Form 10-Q:•Part I - Item 1. Financial Statements•Part I - Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations•Part I - Item 4. Controls and Procedures•Part II - Item 1A. Risk Factors•Part II - Item 6. Exhibits The exhibit list included in Item 6, “Exhibits” herein has been amended to contain currently dated certifications from the Company’s Chief Executive Officer (as Principal Executive Officer) and Chief Financial Officer (as Principal Financial Officer), as required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002 and filed as Exhibits 31.1/31.2 and 32.1/32.2, respectively.In accordance with applicable SEC rules, this Form 10-Q/A also includes an updated signature page. Please note that the only changes to the Form 10-Q are those related to the matters described herein and only in the Items listed above. Otherwise, this Amendment speaks as of the original filing date of the Form 10-Q, and does not modify, amend or update any other item or disclosures in the Form 10-Q. As such, this Amendment does not reflect events occurring after the filing of the Form 10-Q or modify or update those disclosures affected by subsequent events. Such subsequent information or events include, among others, the information and events described in our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2024, which we are restating currently with this Amendment, and the information and events described in our Current Reports on Form 8-K filed subsequent to the date of the Form 10-Q. For a description of such subsequent information and events, please read our reports filed pursuant to the Exchange Act subsequent to the date of the Form 10-Q, which update and supersede certain information contained in the Form 10-Q and this Amendment.
Debt Securities [Member]
Class of Stock [Line Items]
Title of 12(b) Security	1.000% Notes due 2025
Security Exchange Name	NYSE
No Trading Symbol Flag	true
Common Stock [Member]
Class of Stock [Line Items]
Title of 12(b) Security	Common Stock, no par value
Trading Symbol	ADM
Security Exchange Name	NYSE

Consolidated Statements Of Earnings - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenues	$ 21,847	$ 24,072
Cost of Products Sold	20,188	21,992
Gross Profit	1,659	2,080
Selling, general, and administrative expenses	951	881
Asset impairment, exit, and restructuring costs	18	7
Interest Expense	166	147
Equity in (earnings) losses of unconsolidated affiliates	(212)	(174)
Interest and investment income	(123)	(134)
Other (Income) Expense - Net	(26)	(44)
Earnings Before Income Taxes	885	1,397
Income taxes	166	225
Net earnings including noncontrolling interests	719	1,172
Net Income (Loss) Attributable to Noncontrolling Interest	(10)	2
Net Earnings Attributable to Controlling Interests	$ 729	$ 1,170
Average number of shares outstanding - basic	513	550
Average number of shares outstanding - diluted	514	551
Earnings Per Share, Basic	$ 1.42	$ 2.13
Earnings Per Share, Diluted	1.42	2.12
Dividends per common share	$ 0.50	$ 0.45

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net earnings including noncontrolling interests	$ 719	$ 1,172
Other Comprehensive Income (Loss), before Tax
Foreign currency translation adjustment, before tax	4	153
Pension and other postretirement benefit liabilities adjustment, before tax	(4)	(26)
Unrealized gain (loss) on investments, before tax	(7)	4
Other Comprehensive Income (Loss), Tax
Foreign currency translation adjustment, tax effect	(20)	14
Pension and other postretirement benefit liabilities adjustment, tax effect	1	(13)
Unrealized gain (loss) on investments, tax effect	(1)	(1)
Other Comprehensive Income (Loss), Net of Tax
Foreign currency translation adjustment, net of tax	(16)	167
Pension and other postretirement benefit liabilities adjustment, net of tax	(3)	(39)
Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), Before Reclassification, Before Tax	(69)	(104)
Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), After Reclassification Adjustment, Tax	10	16
Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), After Reclassification Adjustment, After Tax	(59)	(88)
Unrealized gain (loss) on investments, net of tax	(8)	3
Other comprehensive income (loss)	(86)	43
Comprehensive income (loss) including noncontrolling interests	633	1,215
Less: Comprehensive income (loss) attributable to noncontrolling interests	(13)	(1)
Comprehensive income (loss) attributable to controlling interests	$ 646	$ 1,216

Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Current Assets
Cash and cash equivalents	$ 830	$ 1,368
Segregated cash and investments	7,381	7,228
Trade receivables	4,178	4,232
Inventories	11,634	11,957
Other current assets	4,983	4,982
Total Current Assets	29,006	29,767
Investments and Other Assets
Investments in and advances to affiliates	5,566	5,500
Goodwill and other intangible assets	7,051	6,341
Operating Lease, Right-of-Use Asset	1,285	1,211
Other assets	1,327	1,304
Total Investments and Other Assets	15,229	14,356
Property, Plant, and Equipment
Land and Land Improvements	573	573
Buildings	5,940	5,876
Machinery and equipment	20,298	20,223
Construction in progress	1,421	1,360
Gross Property, Plant, and Equipment	28,232	28,032
Accumulated depreciation	(17,636)	(17,524)
Net Property, Plant, and Equipment	10,596	10,508
Total Assets	54,831	54,631
Current Liabilities
Short-term debt	1,734	105
Trade payables	5,599	6,313
Payables to Brokerage Customers	8,176	7,867
Accrued expenses and other payables	3,922	4,076
Operating Lease, Liability, Current	298	300
Current maturities of long-term debt	1	1
Total Current Liabilities	19,730	18,662
Long-Term Liabilities
Long-term debt	8,245	8,259
Deferred income taxes	1,291	1,309
Operating Lease, Liability, Noncurrent	1,010	931
Other	1,016	1,005
Total Long-Term Liabilities	11,562	11,504
Redeemable Noncontrolling Interest, Equity, Carrying Amount	307	320
Shareholders' Equity
Common stock	2,720	3,154
Reinvested earnings	23,069	23,465
Accumulated other comprehensive income (loss)	(2,570)	(2,487)
Noncontrolling interests	13	13
Total Shareholders' Equity	23,232	24,145
Total Liabilities and Shareholders' Equity	$ 54,831	$ 54,631

Consolidated Statements Of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating Activities
Net earnings including noncontrolling interests	$ 719	$ 1,172
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities
Depreciation and amortization	280	259
Asset impairment charges	3	3
Deferred income taxes	(64)	47
Equity in earnings of affiliates, net of dividends	(136)	(113)
Stock compensation expense	66	65
Deferred cash flow hedges	(69)	(104)
(Gain) Loss on Disposition of Assets	14	(11)
Other - net	69	(8)
Increase (Decrease) of Restricted Investments	(159)	(935)
Changes in operating assets and liabilities, net of businesses acquired
Trade receivables	61	488
Inventories	295	52
Other current assets	163	328
Trade payables	(713)	(1,556)
Increase (Decrease) in Payables to Brokerage Customers	319	(460)
Accrued expenses and other payables	(148)	(837)
Total Operating Activities	700	(1,610)
Investing Activities
Purchases of property, plant, and equipment	(328)	(327)
Proceeds from sale of business and assets	6	13
Net assets of businesses acquired	(915)	0
Payments to Acquire Interest in Subsidiaries and Affiliates	(4)	(4)
Other - net	11	(10)
Total Investing Activities	(1,230)	(328)
Financing Activities
Long-term debt payments	0	(2)
Net borrowings (payments) under lines of credit agreements	1,619	1,306
Purchases of treasury stock	(1,327)	(351)
Cash dividends	(257)	(248)
Other - net	(37)	(107)
Total Financing Activities	(2)	598
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	(13)	(6)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(545)	(1,346)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Beginning	5,390	7,033
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Ending	4,845	5,687
Reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents [Abstract]
Cash and cash equivalents	830	899
Restricted Cash and Cash Equivalents	$ 4,015	$ 4,788

Consolidated Statements Of Shareholders' Equity - USD ($) shares in Millions, $ in Millions	Total	Common Stock [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Noncontrolling Interests [Member]
Balance (shares) at Dec. 31, 2022		547
Balance at Dec. 31, 2022	$ 24,317	$ 3,147	$ 23,646	$ (2,509)	$ 33
Comprehensive income
Net earnings including noncontrolling interests	1,172		1,170		2
Other comprehensive income (loss)	43			46	(3)
Total comprehensive income	$ 1,215
Common Stock, Dividends, Per Share, Cash Paid	$ 0.45
Cash dividends paid	$ (248)		(248)
Stock Repurchased During Period, Value	(351)		(351)
Stock Repurchased During Period, Shares		(4)
Stock compensation expense, shares		3
Stock compensation expense	65	$ 65
Stock option exercises net of taxes, value	(108)	$ (108)
Stock option exercises net of taxes, shares		(1)
Other, shares		0
Other	6	$ 2	0	0	4
Balance (shares) at Mar. 31, 2023		546
Balance at Mar. 31, 2023	24,896	$ 3,106	24,217	(2,463)	36
Balance (shares) at Dec. 31, 2023		513
Balance at Dec. 31, 2023	24,145	$ 3,154	23,465	(2,487)	13
Comprehensive income
Net earnings including noncontrolling interests	719		729		(10)
Other comprehensive income (loss)	(86)			(83)	(3)
Total comprehensive income	$ 633
Common Stock, Dividends, Per Share, Cash Paid	$ 0.50
Cash dividends paid	$ (257)		(257)
Stock Repurchased During Period, Value	(868)		(868)
Stock Repurchased During Period, Shares		(13)
Adjustments to Additional Paid in Capital, Other	(462)	$ (462)
Stock compensation expense, shares		3
Stock compensation expense	66	$ 66
Stock option exercises net of taxes, value	(41)	$ (41)
Stock option exercises net of taxes, shares		(1)
Other, shares		0
Other	16	$ 3	0	0	13
Balance (shares) at Mar. 31, 2024		502
Balance at Mar. 31, 2024	$ 23,232	$ 2,720	$ 23,069	$ (2,570)	$ 13

Consolidated Statements Of Shareholders' Equity (Parenthetical) - $ / shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Stockholders' Equity [Abstract]
Cash dividends paid, per share	$ 0.50	$ 0.45

Basis of Presentation and Restatement of Previously Filed Consolidated Financial Statements

3 Months Ended

Mar. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation and Restatement of Previously Filed Consolidated Financial Statements

Principles of Consolidation

Restatement of Previously Filed Financial Statements

The Company has restated its Consolidated Financial Statements for the quarters ended March 31, 2024 and 2023 in Note 13, Segment Information (Unaudited).

Segregated Cash and Investments

Receivables

Changes to the allowance for estimated uncollectible accounts are as follows:


	March 31, 2024		March 31, 2023
	(In millions)
Beginning, January 1	$	215	$	199
Current year provisions	5		4
Recoveries	8		1
Write-offs against allowance	(13)		(24)
Foreign exchange translation adjustment	1		1
Other	—		1
Ending, March 31	$	216	$	182

Inventories

The following table sets forth the Company’s inventories as of March 31, 2024 and December 31, 2023.


	March 31, 2024		December 31, 2023
	(In millions)
Raw materials and supplies	$	1,880	$	1,944
Finished goods	3,047		3,026
Market inventories	6,707		6,987
Total inventories	$	11,634	$	11,957

Included in raw materials and supplies are work in process inventories which were not material as of March 31, 2024 and December 31, 2023.

Cost Method Investments

New Accounting Standards	3 Months Ended
New Accounting Standards	Mar. 31, 2024
Accounting Changes and Error Corrections [Abstract]
Accounting Standards Update and Change in Accounting Principle [Text Block]	New Accounting Standards Through December 31, 2024, the Company has the option to adopt the amended guidance of Accounting Standards Codification (ASC) 848, Reference Rate Reform, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The expedients and exceptions provided by the amended guidance do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2024, except for hedging relationships existing as of December 31, 2024, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. Through March 31, 2024, ADM has completed the transition of its financing, funding, and hedging portfolios from LIBOR to alternative reference rates. The transition did not have an impact on the Company’s consolidated financial statements. Effective December 31, 2024, the Company will be required to adopt the amended guidance of ASC 280, Segment Reporting, which improves disclosures about a public entity’s reportable segments and addresses requests from investors and other allocators of capital for more detailed information about a reportable segment’s expenses. The amended guidance improves reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses and permits entities to disclose more than one measure of a reportable segment’s profitability used by the Chief Operating Decision Maker. The adoption of the amended guidance will result in expanded disclosures in the Company’s segment and geographic information footnote but will not have an impact on the consolidated financial statements. Effective December 31, 2025, the Company will be required to adopt the amended guidance of ASC 740, Income Taxes, which enhances the transparency and decision usefulness of income tax disclosures. The amendments address investor requests for more transparency about income tax information. The adoption of the amended guidance will result in expanded disclosures in the Company’s income taxes footnote but will not have an impact on the consolidated financial statements.

Revenues Revenues

3 Months Ended

Mar. 31, 2023

Revenues [Abstract]

Revenues [Text Block]

Revenues

Revenue Recognition

Shipping and Handling Costs

Taxes Collected from Customers and Remitted to Governmental Authorities

Contract Liabilities

Disaggregation of Revenues

The following tables present revenue disaggregated by timing of recognition and major product lines for the three months ended March 31, 2024 and 2023.


	Three Months Ended March 31, 2024
	Topic 606 Revenue						Topic 815(1)		Total
(In millions)	Point in Time		Over Time		Total		Revenue		Revenues









Ag Services and Oilseeds
Ag Services	$	1,022	$	193	$	1,215	$	9,982	$	11,197
Crushing	117		—		117		3,210		3,327
Refined Products and Other	548		—		548		2,147		2,695
Total Ag Services and Oilseeds	1,687		193		1,880		15,339		17,219
Carbohydrate Solutions
Starches and Sweeteners	1,593		—		1,593		563		2,156
Vantage Corn Processors	527		—		527		—		527
Total Carbohydrate Solutions	2,120		—		2,120		563		2,683
Nutrition
Human Nutrition	964		—		964		—		964
Animal Nutrition	872		—		872		—		872
Total Nutrition	1,836		—		1,836		—		1,836

Total Segment Revenues	5,643		193		5,836		15,902		21,738
Other Business	109		—		109		—		109
Total Revenues	$	5,752	$	193	$	5,945	$	15,902	$	21,847


	Three Months Ended March 31, 2023
	Topic 606 Revenue						Topic 815(1)		Total
(In millions)	Point in Time		Over Time		Total		Revenue		Revenues









Ag Services and Oilseeds
Ag Services	$	1,017	$	178	$	1,195	$	10,500	$	11,695
Crushing	191		—		191		3,492		3,683
Refined Products and Other	626		—		626		2,575		3,201
Total Ag Services and Oilseeds	1,834		178		2,012		16,567		18,579
Carbohydrate Solutions
Starches and Sweeteners	2,084		—		2,084		653		2,737
Vantage Corn Processors	800		—		800		—		800
Total Carbohydrate Solutions	2,884		—		2,884		653		3,537
Nutrition
Human Nutrition	936		—		936		—		936
Animal Nutrition	917		—		917		—		917
Total Nutrition	1,853		—		1,853		—		1,853

Total Segment Revenues	6,571		178		6,749		17,220		23,969
Other Business	103		—		103		—		103
Total Revenues	$	6,674	$	178	$	6,852	$	17,220	$	24,072

(1) Topic 815 revenue relates to the physical delivery or the settlement of the Company’s sales contracts that are accounted for as derivatives and are outside the scope of Topic 606.

Ag Services and Oilseeds

Carbohydrate Solutions

Nutrition

Other Business

Acquisitions

3 Months Ended

Mar. 31, 2024

Business Combinations [Abstract]

Acquisitions

The aggregate cash consideration of these acquisitions, net of $9 million in cash acquired, was allocated as follows, subject to final measurement period adjustments:


(In millions)	Revela		FDL		PT		Total
Working capital	$	50	$	—	$	5	$	55
Property, plant, and equipment	38		33		5		76
Goodwill	403		145		5		553
Other intangible assets	166		97		—		263
Other long-term assets	28		1		—		29
Long-term liabilities	(35)		(26)		—		(61)
Aggregate cash consideration	$	650	$	250	$	15	$	915

The following table sets forth the fair values and the useful lives of the other intangible assets acquired.


	Useful Lives			Revela		FDL		Total
	(In years)			(In millions)



Intangible assets with finite lives:
Trademarks/brands	3			$	—	$	4	$	4
Customer lists	10	to	18	124		73		197
Recipes and others	10	to	21	42		20		62
Total other intangible assets acquired				$	166	$	97	$	263

Fair Value Measurements

3 Months Ended

Mar. 31, 2024

Fair Value Disclosures [Abstract]

Fair Value Measurements

The following tables set forth, by level, the Company’s assets and liabilities that were accounted for at fair value on a recurring basis as of March 31, 2024 and December 31, 2023.


	Fair Value Measurements at March 31, 2024
	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
	(In millions)

Assets:
Inventories carried at market	$	—	$	3,759	$	2,948	$	6,707
Unrealized derivative gains:
Commodity contracts	—		598		764		1,362
Foreign currency contracts	—		187		—		187


Cash equivalents	206		—		—		206

Segregated investments	1,663		—		—		1,663

Total Assets	$	1,869	$	4,544	$	3,712	$	10,125

Liabilities:
Unrealized derivative losses:
Commodity contracts	$	—	$	448	$	435	$	883
Foreign currency contracts	—		94		—		94


Inventory-related payables	—		1,928		62		1,990

Total Liabilities	$	—	$	2,470	$	497	$	2,967


	Fair Value Measurements at December 31, 2023
	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
	(In millions)

Assets:
Inventories carried at market	$	—	$	4,274	$	2,713	$	6,987
Unrealized derivative gains:
Commodity contracts	—		628		731		1,359
Foreign currency contracts	—		187		—		187

Cash equivalents	209		—		—		209

Segregated investments	1,362		—		—		1,362

Total Assets	$	1,571	$	5,089	$	3,444	$	10,104

Liabilities:
Unrealized derivative losses:
Commodity contracts	$	—	$	500	$	457	$	957
Foreign currency contracts	—		144		—		144


Inventory-related payables	—		1,219		101		1,320
Total Liabilities	$	—	$	1,863	$	558	$	2,421

The Company’s cash equivalents are comprised of money market funds valued using quoted market prices and are classified as Level 1.

The Company’s segregated investments are comprised of U.S. Treasury securities. U.S. Treasury securities are valued using quoted market prices and are classified in Level 1.

The following table presents a rollforward of assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2024.


	Level 3 Fair Value Asset Measurements at
	March 31, 2024
	Inventories Carried at Market		Commodity Derivative Contracts Gains		Total Assets
	(In millions)
Balance, December 31, 2023	$	2,713	$	731	$	3,444
Total increase (decrease) in net realized/unrealized gains included in cost of products sold*	(97)		375		278
Purchases	3,789		—		3,789
Sales	(3,883)		—		(3,883)
Settlements	—		(352)		(352)
Transfers into Level 3	516		28		544
Transfers out of Level 3	(90)		(18)		(108)
Ending balance, March 31, 2024	$	2,948	$	764	$	3,712

* Includes increase in unrealized gains of $564 million relating to Level 3 assets still held at March 31, 2024.

The following table presents a rollforward of liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2024.


	Level 3 Fair Value Liability Measurements at
	March 31, 2024
	Inventory- related Payables		Commodity Derivative Contracts Losses		Total Liabilities
	(In millions)

Balance, December 31, 2023	$	101	$	457	$	558
Total increase (decrease) in net realized/unrealized losses included in cost of products sold*	(3)		329		326
Purchases	1		—		1
Sales	(38)		—		(38)
Settlements	—		(290)		(290)
Transfers into Level 3	1		13		14
Transfers out of Level 3	—		(74)		(74)
Ending balance, March 31, 2024	$	62	$	435	$	497

* Includes increase in unrealized losses of $338 million relating to Level 3 liabilities still held at March 31, 2024.

The following table presents a rollforward of assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2023.


	Level 3 Fair Value Asset Measurements at
	March 31, 2023
	Inventories Carried at Market		Commodity Derivative Contracts Gains		Total Assets
	(In millions)

Balance, December 31, 2022	$	2,760	$	541	$	3,301
Total increase (decrease) in net realized/unrealized gains included in cost of products sold*	2		477		479
Purchases	8,665		—		8,665
Sales	(8,254)		—		(8,254)
Settlements	—		(382)		(382)
Transfers into Level 3	605		50		655
Transfers out of Level 3	(275)		(37)		(312)
Ending balance, March 31, 2023	$	3,503	$	649	$	4,152

* Includes increase in unrealized gains of $632 million relating to Level 3 assets still held at March 31, 2023.

The following table presents a rollforward of liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2023.


	Level 3 Fair Value Liability Measurements at
	March 31, 2023
	Inventory- related Payables		Commodity Derivative Contracts Losses		Debt Conversion Option		Total Liabilities
	(In millions)

Balance, December 31, 2022	$	89	$	603	$	6	$	698
Total increase (decrease) in net realized/unrealized losses included in cost of products sold and interest expense*	(2)		243		(5)		236
Purchases	2		—		—		2

Settlements	(31)		(424)		—		(455)
Transfers into Level 3	—		39		—		39
Transfers out of Level 3	(1)		(6)		—		(7)
Ending balance, March 31, 2023	$	57	$	455	$	1	$	513

* Includes increase in unrealized losses of $248 million relating to Level 3 liabilities still held at March 31, 2023.

In some cases, the price components that result in differences between exchange-traded prices and local prices for inventories


	Weighted Average % of Total Price
	March 31, 2024				December 31, 2023
Component Type	Assets		Liabilities		Assets		Liabilities
Inventories and Related Payables
Basis	28.2	%	25.9	%	25.0	%	33.2	%
Transportation cost	18.6	%	—	%	11.5	%	—	%

Commodity Derivative Contracts
Basis	40.1	%	28.2	%	24.2	%	24.9	%
Transportation cost	8.3	%	1.5	%	9.3	%	3.2	%

Derivative Instruments and Hedging Activities

3 Months Ended

Mar. 31, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments and Hedging Activities

Derivatives Not Designated as Hedging Instruments

The following table sets forth the fair value of derivatives not designated as hedging instruments as of March 31, 2024 and December 31, 2023.


	March 31, 2024				December 31, 2023
	Assets		Liabilities		Assets		Liabilities
	(In millions)

Foreign Currency Contracts	$	145	$	94	$	187	$	122

Commodity Contracts	1,351		883		1,343		957

Total	$	1,496	$	977	$	1,530	$	1,079


					Other (income) expense - net
			Cost of				Interest
(In millions)	Revenues		products sold				expense
Three Months Ended March 31, 2024
Consolidated Statement of Earnings	$	21,847	$	20,188	$	(26)	$	166

Pre-tax gains (losses) on:





Foreign Currency Contracts	$	1	$	(63)	$	54	$	—
Commodity Contracts	—		197		—		—

Total gain (loss) recognized in earnings	$	1	$	134	$	54	$	—	$	189

Three Months Ended March 31, 2023
Consolidated Statement of Earnings	$	24,072	$	21,992	$	(44)	$	147

Pre-tax gains (losses) on:
Foreign Currency Contracts	$	(11)	$	95	$	(16)	$	—
Commodity Contracts	—		440		—		—
Debt Conversion Option	—		—		—		5
Total gain (loss) recognized in earnings	$	(11)	$	535	$	(16)	$	5	$	513

Derivatives Designated as Cash Flow and Net Investment Hedging Strategies

The Company had certain derivatives designated as cash flow and net investment hedges as of March 31, 2024 and December 31, 2023.

Commodity Contracts

Foreign Currency Contracts

The following table sets forth the fair value of derivatives designated as hedging instruments as of March 31, 2024 and December 31, 2023.


	March 31, 2024				December 31, 2023
	Assets		Liabilities		Assets		Liabilities
	(In millions)
Commodity Contracts	$	11	$	—	$	16	$	—
Foreign Currency Contracts	42		—		—		22

Total	$	53	$	—	$	16	$	22


	Cost of products sold
(In millions)
Three Months Ended March 31, 2024
Consolidated Statement of Earnings	$	20,188

Effective amounts recognized in earnings
Pre-tax gains (losses) on:

Commodity Contracts	$	19

Total gain (loss) recognized in earnings	$	19	$	19

Three Months Ended March 31, 2023
Consolidated Statement of Earnings	$	21,992

Effective amounts recognized in earnings
Pre-tax gains (losses) on:

Commodity Contracts	$	(104)




Total gain (loss) recognized in earnings	$	(104)	$	(104)

Other Net Investment Hedging Strategies

Other Current Assets

3 Months Ended

Mar. 31, 2024

Other Assets [Abstract]

Other Current Assets

The following table sets forth the items in other current assets:


	March 31,		December 31,
	2024		2023
	(In millions)

Unrealized gains on derivative contracts	$	1,549	$	1,546

Margin deposits and grain accounts	585		560
Customer omnibus receivable	1,131		1,052
Financing receivables - net (1)	178		237
Insurance premiums receivable	48		61
Prepaid expenses	412		445
Biodiesel tax credit	77		119
Tax receivables	479		491
Non-trade receivables	376		304
Other current assets	148		167
	$	4,983	$	4,982

Accrued Expenses And Other Payables

3 Months Ended

Mar. 31, 2024

Accrued Liabilities and Other Liabilities [Abstract]

Accrued Expenses And Other Payables

Accrued Expenses and Other Payables

The following table sets forth the items in accrued expenses and other payables:


	March 31,		December 31,
	2024		2023
	(In millions)

Unrealized losses on derivative contracts	$	977	$	1,101
Accrued compensation	327		439
Income tax payable	312		284
Other taxes payable	196		172


Insurance claims payable	84		73
Contract liability	508		626


Other accruals and payables	1,518		1,381
	$	3,922	$	4,076

Debt And Financing Arrangements	3 Months Ended
Debt And Financing Arrangements	Mar. 31, 2024
Debt Disclosure [Abstract]
Debt And Financing Arrangements	Debt and Financing Arrangements At March 31, 2024, the fair value of the Company’s long-term debt was below the carrying value by $0.3 billion, as estimated using quoted market prices (a Level 2 measurement under applicable accounting standards). At March 31, 2024, the Company had lines of credit, including the accounts receivable securitization programs described below, totaling $12.8 billion, of which $8.8 billion was unused. Of the Company’s total lines of credit, $5.0 billion supported the combined U.S. and European commercial paper borrowing programs, against which there was $0.9 billion of commercial paper outstanding at March 31, 2024. The Company has accounts receivable securitization programs (the “Programs”). The Programs provide the Company with up to $3.0 billion in funding resulting from the sale of accounts receivable with $0.7 billion unused capacity as of March 31, 2024.

Income Taxes	3 Months Ended
Income Taxes	Mar. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company’s effective tax rate was 18.8% for the three months ended March 31, 2024 compared to 16.1% for the three months ended March 31, 2023. The increase in the rate was primarily due to the change in the geographic mix of forecasted pretax earnings and the impact of discrete tax items. The Organization for Economic Cooperation and Development’s Pillar Two initiative introduced a 15% global minimum tax applied on a country-by-country basis that has been enacted in certain jurisdictions in which the Company operates, with effective dates starting in fiscal year 2024. The Company is in scope of the enacted legislation and has performed an assessment of the potential exposure based on its most recent tax filings, country-by-country reporting, and the financial results of the constituent entities. Based on the assessment, the effective tax rates in most of the jurisdictions in which the Company operates are above the 15% global minimum tax threshold. However, there are a limited number of jurisdictions where the effective tax rate is close to 15%. ADM does not expect a material liability to global minimum tax in those jurisdictions. The Company is subject to income taxation and routine examinations in many jurisdictions around the world and frequently faces challenges regarding the amount of taxes due. These challenges include positions taken by the Company related to the timing, nature, and amount of deductions and the allocation of income among various tax jurisdictions. In its routine evaluations of the exposure associated with various tax filing positions, the Company recognizes a liability, when necessary, for estimated potential tax owed by the Company in accordance with applicable accounting standards. Resolution of the related tax positions, through negotiations with relevant tax authorities or through litigation, may take years to complete. Therefore, it is difficult to predict the timing for resolution of tax positions and the Company cannot predict or provide assurance as to the ultimate outcome of these ongoing or future examinations. However, the Company does not anticipate the total amount of unrecognized tax benefits will increase or decrease significantly in the next twelve months. Given the long periods of time involved in resolving tax positions, the Company does not expect the recognition of unrecognized tax benefits will have a material impact on the Company’s effective income tax rate in any given period. In 2014, the Company’s wholly-owned subsidiary in the Netherlands, ADM Europe B.V., received a tax assessment from the Netherlands tax authority challenging the transfer pricing aspects of a 2009 business reorganization, which involved two of its subsidiary companies in the Netherlands. As of March 31, 2024, this assessment was $88 million in tax and $34 million in interest (adjusted for variation in currency exchange rates). On April 23, 2020, the court issued an unfavorable ruling and in October 2020, assigned a third party expert to establish a valuation. During the second quarter of 2021, the third party expert issued a final valuation. On September 30, 2022, the court issued a ruling consistent with the valuation report, and the Dutch tax authorities have filed an appeal. During the quarter ended March 31, 2023, ADM filed a cross-appeal and is currently awaiting the court’s ruling. As of March 31, 2024, the Company has accrued its best estimate of what it believes will be the likely outcome of the litigation.

Shareholders' Equity

3 Months Ended

Mar. 31, 2024

Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]

Equity

Shareholders’ Equity

Accelerated Share Repurchase

of each month commencing in March 2024, and upon final settlement of the ASR transaction, which is expected to occur no later than the end of the second quarter of 2024.

As of March 31, 2024, the Company had 38.5 million remaining shares under its share repurchase program.

Accumulated Other Comprehensive Income

The following tables set forth the changes in AOCI by component for the three months ended March 31, 2024 and the reclassifications out of AOCI for the three months ended March 31, 2024 and 2023:


	Three months ended March 31, 2024
	Foreign Currency Translation Adjustment		Deferred Gain (Loss) on Hedging Activities		Pension Liability Adjustment		Unrealized Gain (Loss) on Investments		Total
	(In millions)
Balance at December 31, 2023	$	(2,539)	$	158	$	(108)	$	2	$	(2,487)
Other comprehensive income (loss) before reclassifications	(77)		(50)		(2)		(7)		(136)
Gain (loss) on net investment hedges	84		—		—		—		84
Amounts reclassified from AOCI	—		(19)		(2)		—		(21)
Tax effect	(20)		10		1		(1)		(10)
Net of tax amount	(13)		(59)		(3)		(8)		(83)
Balance at March 31, 2024	$	(2,552)	$	99	$	(111)	$	(6)	$	(2,570)


	Amount reclassified from AOCI
	Three months ended March 31,				Affected line item in the consolidated statements of earnings
Details about AOCI components	2024		2023
	(In millions)





Deferred loss (gain) on hedging activities

	(19)		104			Cost of products sold


	(19)		104			Total before tax
	4		(18)			Tax
	$	(15)	$	86		Net of tax

Pension liability adjustment
Amortization of defined benefit pension items:
Prior service loss (credit)	$	(5)	$	(11)		Other (income) expense-net
Actuarial losses	3		(20)			Other (income) expense-net
	(2)		(31)			Total before tax
	1		(12)			Tax
	$	(1)	$	(43)		Net of tax

The Company’s accounting policy is to release the income tax effects from AOCI when the individual units of account are sold, terminated, or extinguished.

Other (Income) Expense - Net

3 Months Ended

Mar. 31, 2024

Other Income and Expenses [Abstract]

Other (Income) Expense - Net

Other (Income) Expense – Net

The following table sets forth the items in other (income) expense:


	Three Months Ended
	March 31,
	2024		2023
	(In millions)
Gains on sale of assets	$	(2)	$	(11)



Other – net	(24)		(33)
Other (Income) Expense – Net	$	(26)	$	(44)

Segment Information

3 Months Ended

Mar. 31, 2024

Segment Reporting [Abstract]

Segment Information

Segment Information - Restated

Restatement of Certain Segment-Specific Historical Financial Information

In the course of testing new controls implemented as part of the Company’s material weakness remediation plan in the third quarter of 2024, ADM identified additional intrasegment sales previously misclassified and reported as intersegment sales. The Company also identified some intersegment sales that were not accounted for consistently in accordance with revenue recognition and segment reporting standards and should not have been reported as intersegment sales. These amounts are presented in the table below as Additional intersegment classification adjustments. The Company also is correcting certain segment disclosure presentation errors in this Form 10-Q/A. See Note 1 for further information.

Impact of the Restatement on the Ag Services and Oilseeds Segment


	Three Months Ended
	March 31,
(In millions)	2024 (Restated)		2023 (Restated)




Intersegment revenues, as originally reported	$	609	$	1,335
Intersegment pricing adjustments	—		1
Intersegment classification adjustments	—		(595)
Intersegment revenues, as previously reported	609		741
Additional intersegment classification adjustments	(183)		(211)
Intersegment revenues, as restated	$	426	$	530

Segment operating profit, as originally reported	$	864	$	1,210
Intersegment pricing adjustments	—		1
Segment operating profit, as restated	$	864	$	1,211

Impact of the Restatement on the Carbohydrate Solutions Segment


	Three Months Ended
	March 31,
(In millions)	2024 (Restated)		2023 (Restated)




Intersegment revenues, as originally reported	$	279	$	729
Intersegment pricing adjustments	—		6
Intersegment classification adjustments	—		(230)
Intersegment revenues, as previously reported	279		505
Additional intersegment classification adjustments	(71)		(235)
Intersegment revenues, as restated	$	208	$	270

Segment operating profit, as originally reported	$	248	$	273
Intersegment pricing adjustments	—		6
Segment operating profit, as restated	$	248	$	279

Impact of the Restatement on the Nutrition Segment


	Three Months Ended
	March 31,
(In millions)	2024 (Restated)		2023 (Restated)
Intersegment revenues, as originally reported	$	6	$	91
Intersegment pricing adjustments	—		—
Intersegment classification adjustments	—		(55)
Intersegment revenues, as previously reported	6		36
Additional intersegment classification adjustments	7		(24)
Intersegment revenues, as restated	$	13	$	12

Segment operating profit, as originally reported	$	84	$	145
Intersegment pricing adjustments	—		(7)
Segment operating profit, as restated	$	84	$	138


Segment Information for the Three Months ended March 31, 2024 and 2023
	Three Months Ended
	March 31,
(In millions)	2024		2023
























Revenues from external customers










Ag Services and Oilseeds
Ag Services	$	11,197	$	11,695
Crushing	3,327		3,683
Refined Products and Other	2,695		3,201
Total Ag Services and Oilseeds	17,219		18,579
Carbohydrate Solutions
Starches and Sweeteners	2,156		2,737
Vantage Corn Processors	527		800
Total Carbohydrate Solutions	2,683		3,537
Nutrition
Human Nutrition	964		936
Animal Nutrition	872		917
Total Nutrition	1,836		1,853
Total segment revenues from external customers	21,738		23,969

Other Business	109		103


Total revenues from external customers	$	21,847	$	24,072

Intersegment revenues, as restated


Ag Services and Oilseeds	$	426	$	530
Carbohydrate Solutions	208		270
Nutrition	13		12

Total intersegment revenues, as restated	$	647	$	812






Segment operating profit, as restated


Ag Services and Oilseeds	$	864	$	1,211
Carbohydrate Solutions	248		279
Nutrition	84		138




Total segment operating profit, as restated	1,196		1,628
Other Business earnings (loss)	121		97
Corporate	(426)		(322)

Specified items:
Gains on sale of assets(1)	—		1
Impairment and restructuring charges(2)	(6)		(7)
Earnings before income taxes	$	885	$	1,397

(1) Prior quarter gains were related to the sale of certain assets.

(2) Current and prior quarter charges were related to the impairment of certain long-lived assets and restructuring.

Asset Impairment, Exit, and Restructuring Costs	3 Months Ended
Asset Impairment, Exit, and Restructuring Costs	Mar. 31, 2024
Restructuring, Settlement and Impairment Provisions [Abstract]
Asset Impairment, Exit, and Restructuring Costs	Asset Impairment, Exit, and Restructuring Costs Asset impairment, exit, and restructuring costs in the three months ended March 31, 2024 consisted of impairments related to certain long-lived assets of $3 million and restructuring charges of $3 million, presented as specified items, and restructuring charges in Corporate of $12 million. Asset impairment, exit, and restructuring costs in the three months ended March 31, 2023 consisted of $3 million of impairments related to certain long-lived assets and $4 million of restructuring charges, presented as specified items.

Sale of Accounts Receivable	3 Months Ended
Sale of Accounts Receivable	Mar. 31, 2024
Transfers and Servicing [Abstract]
Sale of Accounts Receivable	The Company has an accounts receivable securitization program (the “First Program”) with certain commercial paper conduit purchasers and committed purchasers (collectively, the “First Purchasers”). Under the First Program, certain U.S.-originated trade accounts receivable are sold to a wholly-owned bankruptcy-remote entity, ADM Receivables, LLC (“ADM Receivables”). ADM Receivables transfers certain of the purchased accounts receivable to each of the First Purchasers together with a security interest in all of its right, title, and interest in the remaining purchased accounts receivable. In exchange, ADM Receivables receives a cash payment of up to $1.9 billion for the accounts receivable transferred. The First Program terminates on May 17, 2024, unless extended. The Company also has an accounts receivable securitization program (the “Second Program”) with certain commercial paper conduit purchasers and committed purchasers (collectively, the “Second Purchasers”). Under the Second Program, certain non-U.S.-originated trade accounts receivable are sold to a wholly-owned bankruptcy-remote entity, ADM Ireland Receivables Company (ADM Ireland Receivables). ADM Ireland Receivables transfers certain of the purchased accounts receivable to each of the Second Purchasers together with a security interest in all of its right, title, and interest in the remaining purchased accounts receivable. In exchange, ADM Ireland Receivables receives a cash payment of up to $1.1 billion (€1.0 billion) for the accounts receivables transferred. The Second Program terminates on April 18, 2025, unless extended. Under the First and Second Programs (collectively, the “Programs”), ADM Receivables and ADM Ireland Receivables use the cash proceeds from the transfer of receivables to the First Purchasers and Second Purchasers (collectively, the “Purchasers”) and other consideration, as applicable, to finance the purchase of receivables from the Company and the ADM subsidiaries originating the receivables. The Company accounts for these transfers as sales. The Company acts as a servicer for the transferred receivables. At March 31, 2024 and December 31, 2023, the Company did not record a servicing asset or liability related to its retained responsibility, based on its assessment of the servicing fee, market values for similar transactions, and its cost of servicing the receivables sold. As of March 31, 2024 and December 31, 2023, the fair value of trade receivables transferred to the Purchasers under the Programs and derecognized from the Company’s consolidated balance sheets was $2.3 billion and $1.6 billion, respectively. Total receivables sold were $12.3 billion and $15.1 billion for the three months ended March 31, 2024 and 2023, respectively. Cash collections from customers on receivables sold were $11.8 billion and $14.8 billion for the three months ended March 31, 2024 and 2023, respectively. As of March 31, 2024 and December 31, 2023, receivables pledged as collateral to the Purchasers was $0.7 billion and $1.1 billion, respectively. Transfers of receivables under the Programs resulted in an expense for the loss on sale of $27 million and $23 million for the three months ended March 31, 2024 and 2023, respectively, which is classified as selling, general, and administrative expenses in the consolidated statements of earnings. All cash flows under the Programs are classified as operating activities because the cash received from the Purchasers upon both the sale and collection of the receivables is not subject to significant interest rate risk given the short-term nature of the Company’s trade receivables.

Supplier Finance Programs

3 Months Ended

Mar. 31, 2024

Payables and Accruals [Abstract]

Supplier Finance Program

Supplier Finance Programs

Changes to the outstanding payment obligations are as follows:


	March 31, 2024
	(In millions)
Beginning, January 1, 2024	$	274
Obligations confirmed	257
Obligations paid	(256)
Ending, March 31, 2024	$	275

Legal Proceedings	3 Months Ended
Legal Proceedings	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Legal Matters and Contingencies	Legal Proceedings The Company is routinely involved in a number of actual or threatened legal actions, including those involving alleged personal injuries, employment law, product liability, intellectual property, environmental issues, alleged tax liability (see Note 10 for information on income tax matters), and class actions. The Company also routinely receives inquiries from regulators and other government authorities relating to various aspects of its business, and at any given time, the Company has matters at various stages of resolution. The outcomes of these matters are not within Company’s complete control and may not be known for prolonged periods of time. In some actions, claimants seek damages, as well as other relief including injunctive relief, that could require significant expenditures or result in lost revenues. In accordance with applicable accounting standards, the Company records a liability in its consolidated financial statements for material loss contingencies when a loss is known or considered probable and the amount can be reasonably estimated. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a material loss contingency is reasonably possible but not known or probable, and can be reasonably estimated, the estimated loss or range of loss is disclosed in the notes to the consolidated financial statements. When determining the estimated loss or range of loss, significant judgment is required to estimate the amount and timing of a loss to be recorded. Estimates of probable losses resulting from litigation and governmental proceedings involving the Company are inherently difficult to predict, particularly when the matters are in early procedural stages, with incomplete facts or legal discovery; involve unsubstantiated or indeterminate claims for damages; potentially involve penalties, fines, disgorgement, or punitive damages; or could result in a change in business practice. Commodities Class Actions On September 4, 2019, AOT Holding AG (“AOT”) filed a putative class action under the U.S. Commodities Exchange Act in federal district court in Urbana, Illinois, alleging that the Company sought to manipulate the benchmark price used to price and settle ethanol derivatives traded on futures exchanges. On March 16, 2021, AOT filed an amended complaint adding a second named plaintiff Maize Capital Group, LLC (“Maize”). AOT and Maize allege that members of the putative class collectively suffered damages calculated to be between approximately $500 million to over $2.0 billion as a result of the Company’s alleged actions. On July 14, 2020, Green Plains Inc. and its related entities (“GP”) filed a putative class action lawsuit, alleging substantially the same operative facts, in federal court in Nebraska, seeking to represent sellers of ethanol. On July 23, 2020, Midwest Renewable Energy, LLC (“MRE”) filed a putative class action in federal court in Illinois alleging substantially the same operative facts and asserting claims under the Sherman Act. On November 11, 2020, United Wisconsin Grain Producers LLC (“UWGP”) and five other ethanol producers filed a lawsuit in federal court in Illinois alleging substantially the same facts and asserting claims under the Sherman Act and Illinois, Iowa, and Wisconsin law. The court granted ADM’s motion to dismiss the MRE and UWGP complaints without prejudice on August 9, 2021 and September 28, 2021, respectively. On August 16, 2021, the court granted ADM’s motion to dismiss the GP complaint, dismissing one claim with prejudice and declining jurisdiction over the remaining state law claim. MRE filed an amended complaint on August 30, 2021, which ADM moved to dismiss on September 27, 2021. The court denied ADM’s motion to dismiss on September 26, 2023. UWGP filed an amended complaint on October 19, 2021, which the court dismissed on July 12, 2022. UWGP has appealed the dismissal to the United States Court of Appeals for the Seventh Circuit. On October 26, 2021, GP filed a new complaint in Nebraska federal district court, alleging substantially the same facts and asserting a claim for tortious interference with contractual relations. On March 18, 2022, the Nebraska federal district court granted ADM’s motion to transfer the GP case back to the Central District of Illinois for further proceedings. ADM moved to dismiss the complaint on May 20, 2022 and on December 30, 2022, the court dismissed GP’s complaint with prejudice. GP appealed the dismissal. On January 12, 2024, the appellate court vacated the dismissal and remanded the case to the district court for further proceedings. On March 8, 2024, GP filed an amended complaint. The Company denies liability, and is vigorously defending itself in these actions. As these actions are in pretrial proceedings, the Company is unable at this time to predict the final outcome with any reasonable degree of certainty, but believes the outcome will not have a material adverse effect on its financial condition, results of operations, or cash flows. Intersegment Sales Investigations On June 30, 2023, the Company received a voluntary document request from the SEC relating to intersegment sales between the Company’s Nutrition reporting segment and the Company’s Ag Services and Oilseeds and Carbohydrate Solutions reporting segments, and subsequently received an additional document request from the SEC. The Company is cooperating with the SEC. Following the Company’s January 21, 2024 announcement of the Investigation, the Company received document requests from the Department of Justice (“DOJ”) focused primarily on the same subject matter, and the DOJ directed grand jury subpoenas to certain current and former Company employees. The Company is cooperating with the DOJ. The Company is unable to predict the final outcome of these investigations with any reasonable degree of certainty. Securities Litigation On January 24, 2024, following the Company’s January 21, 2024 announcement of the investigation relating to intersegment sales, a purported stockholder of the Company filed a putative class action in the U.S. District Court for the Northern District of Illinois against the Company and its Chief Executive Officer, as well as Vikram Luthar and Ray Young. The plaintiff alleges false and misleading statements in the Company’s disclosures and seeks unspecified compensatory and punitive damages. On March 29, 2024 and April 12, 2024, purported stockholders of the Company filed derivative lawsuits in the U.S. District Court for the Northern District of Illinois against the Chief Executive Officer, Vikram Luthar, Ray Young, and certain individual ADM Directors, alleging false and misleading statements in the Company’s proxy statements, breach of fiduciary duty, and corporate waste, among other claims, and seeking unspecified damages. On April 23, 2024, a purported stockholder of the Company filed a derivative lawsuit in the U.S. District Court for the District of Delaware against the Chief Executive Officer, Vikram Luthar, Ray Young, and certain individual ADM Directors, asserting claims for breach of fiduciary duty and contribution and indemnification under the Securities Exchange Act and seeking unspecified damages. The Company is unable to predict the final outcome of these proceedings with any reasonable degree of certainty.

Subsequent Events	3 Months Ended
Subsequent Events	Mar. 31, 2024
Subsequent Events [Abstract]
Subsequent Events [Text Block]	Subsequent Event On April 15, 2024, the Company received a final delivery of 7,325,733 shares at an average share price of $63.065 or $462 million as final settlement of the ASR transaction (see Note 11 for more information).

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Millions	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss) Attributable to Parent	$ 729	$ 1,170

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Mar. 31, 2024
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	None of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted, modified or terminated any contract, instruction, or written plan for the purchase or sale of ADM’s securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the quarter ended March 31, 2024.
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Revenues Revenues (Policies)	3 Months Ended
Revenues Revenues (Policies)	Mar. 31, 2023
Revenues [Abstract]
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition The Company principally generates revenue from merchandising and transporting agricultural commodities, and manufacturing products for use in food, beverages, feed, energy, and industrial applications, and ingredients and solutions for human and animal nutrition. Revenue is measured based on the consideration specified in the contract with a customer. The Company follows a policy of recognizing revenue at a single point in time when it satisfies its performance obligation by transferring control over a product or service to a customer. The majority of the Company’s contracts with customers have one performance obligation and a contract duration of one year or less. The Company applies the practical expedient in paragraph 10-50-14 of ASC 606, Revenue from Contracts with Customers, (Topic 606) and does not disclose information about remaining performance obligations that have original expected durations of one year or less. For transportation service contracts, the Company recognizes revenue over time as the mode of transportation moves towards its destination in accordance with the transfer of control guidance of Topic 606. The Company recognized revenue from transportation service contracts of $193 million and $178 million for the three months ended March 31, 2024 and 2023, respectively. For physically settled derivative sales contracts that are outside the scope of Topic 606, the Company recognizes revenue when control of the inventory is transferred within the meaning of Topic 606 as required by ASC 610-20, Gains and Losses from the Derecognition of Nonfinancial Assets (Topic 610-20). Shipping and Handling Costs Shipping and handling costs related to contracts with customers for the sale of goods are accounted for as a fulfillment activity and are included in cost of products sold. Accordingly, amounts billed to customers for such costs are included as a component of revenues. Taxes Collected from Customers and Remitted to Governmental Authorities The Company does not include taxes assessed by governmental authorities that are (i) imposed on and concurrent with a specific revenue-producing transaction and (ii) collected from customers, in the measurement of transaction prices or as a component of revenues and cost of products sold.

Basis of Presentation and Restatement of Previously Filed Consolidated Financial Statements (Tables)

3 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Inventory, Current

The following table sets forth the Company’s inventories as of March 31, 2024 and December 31, 2023.


	March 31, 2024		December 31, 2023
	(In millions)
Raw materials and supplies	$	1,880	$	1,944
Finished goods	3,047		3,026
Market inventories	6,707		6,987
Total inventories	$	11,634	$	11,957

Accounts Receivable, Allowance for Credit Loss

Changes to the allowance for estimated uncollectible accounts are as follows:


	March 31, 2024		March 31, 2023
	(In millions)
Beginning, January 1	$	215	$	199
Current year provisions	5		4
Recoveries	8		1
Write-offs against allowance	(13)		(24)
Foreign exchange translation adjustment	1		1
Other	—		1
Ending, March 31	$	216	$	182

Revenues Revenues (Tables)

3 Months Ended

Mar. 31, 2024

Revenues [Abstract]

Disaggregation of Revenue [Table Text Block]

Disaggregation of Revenues

The following tables present revenue disaggregated by timing of recognition and major product lines for the three months ended March 31, 2024 and 2023.


	Three Months Ended March 31, 2024
	Topic 606 Revenue						Topic 815(1)		Total
(In millions)	Point in Time		Over Time		Total		Revenue		Revenues









Ag Services and Oilseeds
Ag Services	$	1,022	$	193	$	1,215	$	9,982	$	11,197
Crushing	117		—		117		3,210		3,327
Refined Products and Other	548		—		548		2,147		2,695
Total Ag Services and Oilseeds	1,687		193		1,880		15,339		17,219
Carbohydrate Solutions
Starches and Sweeteners	1,593		—		1,593		563		2,156
Vantage Corn Processors	527		—		527		—		527
Total Carbohydrate Solutions	2,120		—		2,120		563		2,683
Nutrition
Human Nutrition	964		—		964		—		964
Animal Nutrition	872		—		872		—		872
Total Nutrition	1,836		—		1,836		—		1,836

Total Segment Revenues	5,643		193		5,836		15,902		21,738
Other Business	109		—		109		—		109
Total Revenues	$	5,752	$	193	$	5,945	$	15,902	$	21,847


	Three Months Ended March 31, 2023
	Topic 606 Revenue						Topic 815(1)		Total
(In millions)	Point in Time		Over Time		Total		Revenue		Revenues









Ag Services and Oilseeds
Ag Services	$	1,017	$	178	$	1,195	$	10,500	$	11,695
Crushing	191		—		191		3,492		3,683
Refined Products and Other	626		—		626		2,575		3,201
Total Ag Services and Oilseeds	1,834		178		2,012		16,567		18,579
Carbohydrate Solutions
Starches and Sweeteners	2,084		—		2,084		653		2,737
Vantage Corn Processors	800		—		800		—		800
Total Carbohydrate Solutions	2,884		—		2,884		653		3,537
Nutrition
Human Nutrition	936		—		936		—		936
Animal Nutrition	917		—		917		—		917
Total Nutrition	1,853		—		1,853		—		1,853

Total Segment Revenues	6,571		178		6,749		17,220		23,969
Other Business	103		—		103		—		103
Total Revenues	$	6,674	$	178	$	6,852	$	17,220	$	24,072

(1) Topic 815 revenue relates to the physical delivery or the settlement of the Company’s sales contracts that are accounted for as derivatives and are outside the scope of Topic 606.

Acquisitions Business Acquisition (Tables)

3 Months Ended

Mar. 31, 2024

Business Combinations [Abstract]

Schedule of Business Acquisitions, by Acquisition [Table Text Block]

The aggregate cash consideration of these acquisitions, net of $9 million in cash acquired, was allocated as follows, subject to final measurement period adjustments:


(In millions)	Revela		FDL		PT		Total
Working capital	$	50	$	—	$	5	$	55
Property, plant, and equipment	38		33		5		76
Goodwill	403		145		5		553
Other intangible assets	166		97		—		263
Other long-term assets	28		1		—		29
Long-term liabilities	(35)		(26)		—		(61)
Aggregate cash consideration	$	650	$	250	$	15	$	915

Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]

The following table sets forth the fair values and the useful lives of the other intangible assets acquired.


	Useful Lives			Revela		FDL		Total
	(In years)			(In millions)



Intangible assets with finite lives:
Trademarks/brands	3			$	—	$	4	$	4
Customer lists	10	to	18	124		73		197
Recipes and others	10	to	21	42		20		62
Total other intangible assets acquired				$	166	$	97	$	263

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2024

Fair Value Disclosures [Abstract]

Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

The following tables set forth, by level, the Company’s assets and liabilities that were accounted for at fair value on a recurring basis as of March 31, 2024 and December 31, 2023.


	Fair Value Measurements at March 31, 2024
	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
	(In millions)

Assets:
Inventories carried at market	$	—	$	3,759	$	2,948	$	6,707
Unrealized derivative gains:
Commodity contracts	—		598		764		1,362
Foreign currency contracts	—		187		—		187


Cash equivalents	206		—		—		206

Segregated investments	1,663		—		—		1,663

Total Assets	$	1,869	$	4,544	$	3,712	$	10,125

Liabilities:
Unrealized derivative losses:
Commodity contracts	$	—	$	448	$	435	$	883
Foreign currency contracts	—		94		—		94


Inventory-related payables	—		1,928		62		1,990

Total Liabilities	$	—	$	2,470	$	497	$	2,967


	Fair Value Measurements at December 31, 2023
	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
	(In millions)

Assets:
Inventories carried at market	$	—	$	4,274	$	2,713	$	6,987
Unrealized derivative gains:
Commodity contracts	—		628		731		1,359
Foreign currency contracts	—		187		—		187

Cash equivalents	209		—		—		209

Segregated investments	1,362		—		—		1,362

Total Assets	$	1,571	$	5,089	$	3,444	$	10,104

Liabilities:
Unrealized derivative losses:
Commodity contracts	$	—	$	500	$	457	$	957
Foreign currency contracts	—		144		—		144


Inventory-related payables	—		1,219		101		1,320
Total Liabilities	$	—	$	1,863	$	558	$	2,421

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

The following table presents a rollforward of assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2024.


	Level 3 Fair Value Asset Measurements at
	March 31, 2024
	Inventories Carried at Market		Commodity Derivative Contracts Gains		Total Assets
	(In millions)
Balance, December 31, 2023	$	2,713	$	731	$	3,444
Total increase (decrease) in net realized/unrealized gains included in cost of products sold*	(97)		375		278
Purchases	3,789		—		3,789
Sales	(3,883)		—		(3,883)
Settlements	—		(352)		(352)
Transfers into Level 3	516		28		544
Transfers out of Level 3	(90)		(18)		(108)
Ending balance, March 31, 2024	$	2,948	$	764	$	3,712

* Includes increase in unrealized gains of $564 million relating to Level 3 assets still held at March 31, 2024.

The following table presents a rollforward of assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2023.


	Level 3 Fair Value Asset Measurements at
	March 31, 2023
	Inventories Carried at Market		Commodity Derivative Contracts Gains		Total Assets
	(In millions)

Balance, December 31, 2022	$	2,760	$	541	$	3,301
Total increase (decrease) in net realized/unrealized gains included in cost of products sold*	2		477		479
Purchases	8,665		—		8,665
Sales	(8,254)		—		(8,254)
Settlements	—		(382)		(382)
Transfers into Level 3	605		50		655
Transfers out of Level 3	(275)		(37)		(312)
Ending balance, March 31, 2023	$	3,503	$	649	$	4,152

* Includes increase in unrealized gains of $632 million relating to Level 3 assets still held at March 31, 2023.

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

The following table presents a rollforward of liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2024.


	Level 3 Fair Value Liability Measurements at
	March 31, 2024
	Inventory- related Payables		Commodity Derivative Contracts Losses		Total Liabilities
	(In millions)

Balance, December 31, 2023	$	101	$	457	$	558
Total increase (decrease) in net realized/unrealized losses included in cost of products sold*	(3)		329		326
Purchases	1		—		1
Sales	(38)		—		(38)
Settlements	—		(290)		(290)
Transfers into Level 3	1		13		14
Transfers out of Level 3	—		(74)		(74)
Ending balance, March 31, 2024	$	62	$	435	$	497

* Includes increase in unrealized losses of $338 million relating to Level 3 liabilities still held at March 31, 2024.

The following table presents a rollforward of liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2023.


	Level 3 Fair Value Liability Measurements at
	March 31, 2023
	Inventory- related Payables		Commodity Derivative Contracts Losses		Debt Conversion Option		Total Liabilities
	(In millions)

Balance, December 31, 2022	$	89	$	603	$	6	$	698
Total increase (decrease) in net realized/unrealized losses included in cost of products sold and interest expense*	(2)		243		(5)		236
Purchases	2		—		—		2

Settlements	(31)		(424)		—		(455)
Transfers into Level 3	—		39		—		39
Transfers out of Level 3	(1)		(6)		—		(7)
Ending balance, March 31, 2023	$	57	$	455	$	1	$	513

* Includes increase in unrealized losses of $248 million relating to Level 3 liabilities still held at March 31, 2023.

In some cases, the price components that result in differences between exchange-traded prices and local prices for inventories

Unobservable Price Components Present in the Level 3 Valuations of Assets and Liabilities Measured at Fair Value on a Recurring Basis


	Weighted Average % of Total Price
	March 31, 2024				December 31, 2023
Component Type	Assets		Liabilities		Assets		Liabilities
Inventories and Related Payables
Basis	28.2	%	25.9	%	25.0	%	33.2	%
Transportation cost	18.6	%	—	%	11.5	%	—	%

Commodity Derivative Contracts
Basis	40.1	%	28.2	%	24.2	%	24.9	%
Transportation cost	8.3	%	1.5	%	9.3	%	3.2	%

Derivative Instruments and Hedging Activities (Tables)

3 Months Ended

Mar. 31, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]

The following table sets forth the fair value of derivatives not designated as hedging instruments as of March 31, 2024 and December 31, 2023.


	March 31, 2024				December 31, 2023
	Assets		Liabilities		Assets		Liabilities
	(In millions)

Foreign Currency Contracts	$	145	$	94	$	187	$	122

Commodity Contracts	1,351		883		1,343		957

Total	$	1,496	$	977	$	1,530	$	1,079


					Other (income) expense - net
			Cost of				Interest
(In millions)	Revenues		products sold				expense
Three Months Ended March 31, 2024
Consolidated Statement of Earnings	$	21,847	$	20,188	$	(26)	$	166

Pre-tax gains (losses) on:





Foreign Currency Contracts	$	1	$	(63)	$	54	$	—
Commodity Contracts	—		197		—		—

Total gain (loss) recognized in earnings	$	1	$	134	$	54	$	—	$	189

Three Months Ended March 31, 2023
Consolidated Statement of Earnings	$	24,072	$	21,992	$	(44)	$	147

Pre-tax gains (losses) on:
Foreign Currency Contracts	$	(11)	$	95	$	(16)	$	—
Commodity Contracts	—		440		—		—
Debt Conversion Option	—		—		—		5
Total gain (loss) recognized in earnings	$	(11)	$	535	$	(16)	$	5	$	513

The following table sets forth the fair value of derivatives designated as hedging instruments as of March 31, 2024 and December 31, 2023.


	March 31, 2024				December 31, 2023
	Assets		Liabilities		Assets		Liabilities
	(In millions)
Commodity Contracts	$	11	$	—	$	16	$	—
Foreign Currency Contracts	42		—		—		22

Total	$	53	$	—	$	16	$	22


	Cost of products sold
(In millions)
Three Months Ended March 31, 2024
Consolidated Statement of Earnings	$	20,188

Effective amounts recognized in earnings
Pre-tax gains (losses) on:

Commodity Contracts	$	19

Total gain (loss) recognized in earnings	$	19	$	19

Three Months Ended March 31, 2023
Consolidated Statement of Earnings	$	21,992

Effective amounts recognized in earnings
Pre-tax gains (losses) on:

Commodity Contracts	$	(104)




Total gain (loss) recognized in earnings	$	(104)	$	(104)

Other Current Assets (Tables)

3 Months Ended

Mar. 31, 2024

Other Assets [Abstract]

Other Current Assets

The following table sets forth the items in other current assets:


	March 31,		December 31,
	2024		2023
	(In millions)

Unrealized gains on derivative contracts	$	1,549	$	1,546

Margin deposits and grain accounts	585		560
Customer omnibus receivable	1,131		1,052
Financing receivables - net (1)	178		237
Insurance premiums receivable	48		61
Prepaid expenses	412		445
Biodiesel tax credit	77		119
Tax receivables	479		491
Non-trade receivables	376		304
Other current assets	148		167
	$	4,983	$	4,982

Accrued Expenses And Other Payables (Tables)

3 Months Ended

Mar. 31, 2024

Accrued Liabilities and Other Liabilities [Abstract]

Accrued Expenses And Other Payables

The following table sets forth the items in accrued expenses and other payables:


	March 31,		December 31,
	2024		2023
	(In millions)

Unrealized losses on derivative contracts	$	977	$	1,101
Accrued compensation	327		439
Income tax payable	312		284
Other taxes payable	196		172


Insurance claims payable	84		73
Contract liability	508		626


Other accruals and payables	1,518		1,381
	$	3,922	$	4,076

Shareholders' Equity (Tables)

3 Months Ended

Mar. 31, 2024

Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]

The following tables set forth the changes in AOCI by component for the three months ended March 31, 2024 and the reclassifications out of AOCI for the three months ended March 31, 2024 and 2023:


	Three months ended March 31, 2024
	Foreign Currency Translation Adjustment		Deferred Gain (Loss) on Hedging Activities		Pension Liability Adjustment		Unrealized Gain (Loss) on Investments		Total
	(In millions)
Balance at December 31, 2023	$	(2,539)	$	158	$	(108)	$	2	$	(2,487)
Other comprehensive income (loss) before reclassifications	(77)		(50)		(2)		(7)		(136)
Gain (loss) on net investment hedges	84		—		—		—		84
Amounts reclassified from AOCI	—		(19)		(2)		—		(21)
Tax effect	(20)		10		1		(1)		(10)
Net of tax amount	(13)		(59)		(3)		(8)		(83)
Balance at March 31, 2024	$	(2,552)	$	99	$	(111)	$	(6)	$	(2,570)

Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]


	Amount reclassified from AOCI
	Three months ended March 31,				Affected line item in the consolidated statements of earnings
Details about AOCI components	2024		2023
	(In millions)





Deferred loss (gain) on hedging activities

	(19)		104			Cost of products sold


	(19)		104			Total before tax
	4		(18)			Tax
	$	(15)	$	86		Net of tax

Pension liability adjustment
Amortization of defined benefit pension items:
Prior service loss (credit)	$	(5)	$	(11)		Other (income) expense-net
Actuarial losses	3		(20)			Other (income) expense-net
	(2)		(31)			Total before tax
	1		(12)			Tax
	$	(1)	$	(43)		Net of tax

Other (Income) Expense - Net (Tables)

3 Months Ended

Mar. 31, 2024

Other Income and Expenses [Abstract]

Other (Income) Expense - Net

The following table sets forth the items in other (income) expense:


	Three Months Ended
	March 31,
	2024		2023
	(In millions)
Gains on sale of assets	$	(2)	$	(11)



Other – net	(24)		(33)
Other (Income) Expense – Net	$	(26)	$	(44)

Segment Information (Tables)

3 Months Ended

Mar. 31, 2024

Segment Reporting [Abstract]

Segment Information

Impact of the Restatement on the Ag Services and Oilseeds Segment


	Three Months Ended
	March 31,
(In millions)	2024 (Restated)		2023 (Restated)




Intersegment revenues, as originally reported	$	609	$	1,335
Intersegment pricing adjustments	—		1
Intersegment classification adjustments	—		(595)
Intersegment revenues, as previously reported	609		741
Additional intersegment classification adjustments	(183)		(211)
Intersegment revenues, as restated	$	426	$	530

Segment operating profit, as originally reported	$	864	$	1,210
Intersegment pricing adjustments	—		1
Segment operating profit, as restated	$	864	$	1,211

Impact of the Restatement on the Carbohydrate Solutions Segment


	Three Months Ended
	March 31,
(In millions)	2024 (Restated)		2023 (Restated)




Intersegment revenues, as originally reported	$	279	$	729
Intersegment pricing adjustments	—		6
Intersegment classification adjustments	—		(230)
Intersegment revenues, as previously reported	279		505
Additional intersegment classification adjustments	(71)		(235)
Intersegment revenues, as restated	$	208	$	270

Segment operating profit, as originally reported	$	248	$	273
Intersegment pricing adjustments	—		6
Segment operating profit, as restated	$	248	$	279

Impact of the Restatement on the Nutrition Segment


	Three Months Ended
	March 31,
(In millions)	2024 (Restated)		2023 (Restated)
Intersegment revenues, as originally reported	$	6	$	91
Intersegment pricing adjustments	—		—
Intersegment classification adjustments	—		(55)
Intersegment revenues, as previously reported	6		36
Additional intersegment classification adjustments	7		(24)
Intersegment revenues, as restated	$	13	$	12

Segment operating profit, as originally reported	$	84	$	145
Intersegment pricing adjustments	—		(7)
Segment operating profit, as restated	$	84	$	138


Segment Information for the Three Months ended March 31, 2024 and 2023
	Three Months Ended
	March 31,
(In millions)	2024		2023
























Revenues from external customers










Ag Services and Oilseeds
Ag Services	$	11,197	$	11,695
Crushing	3,327		3,683
Refined Products and Other	2,695		3,201
Total Ag Services and Oilseeds	17,219		18,579
Carbohydrate Solutions
Starches and Sweeteners	2,156		2,737
Vantage Corn Processors	527		800
Total Carbohydrate Solutions	2,683		3,537
Nutrition
Human Nutrition	964		936
Animal Nutrition	872		917
Total Nutrition	1,836		1,853
Total segment revenues from external customers	21,738		23,969

Other Business	109		103


Total revenues from external customers	$	21,847	$	24,072

Intersegment revenues, as restated


Ag Services and Oilseeds	$	426	$	530
Carbohydrate Solutions	208		270
Nutrition	13		12

Total intersegment revenues, as restated	$	647	$	812






Segment operating profit, as restated


Ag Services and Oilseeds	$	864	$	1,211
Carbohydrate Solutions	248		279
Nutrition	84		138




Total segment operating profit, as restated	1,196		1,628
Other Business earnings (loss)	121		97
Corporate	(426)		(322)

Specified items:
Gains on sale of assets(1)	—		1
Impairment and restructuring charges(2)	(6)		(7)
Earnings before income taxes	$	885	$	1,397

(1) Prior quarter gains were related to the sale of certain assets.

(2) Current and prior quarter charges were related to the impairment of certain long-lived assets and restructuring.

Supplier Finance Programs (Tables)

3 Months Ended

Mar. 31, 2024

Payables and Accruals [Abstract]

Supplier Finance Program

Changes to the outstanding payment obligations are as follows:


	March 31, 2024
	(In millions)
Beginning, January 1, 2024	$	274
Obligations confirmed	257
Obligations paid	(256)
Ending, March 31, 2024	$	275

Basis of Presentation and Restatement of Previously Filed Consolidated Financial Statements (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity Securities, FV-NI and without Readily Determinable Fair Value	$ 421		$ 438
Inventory, Raw Materials and Supplies, Net of Reserves	1,880		1,944
Inventory, Finished Goods, Net of Reserves	3,047		3,026
Inventories at market	6,707		6,987
Inventories	11,634		11,957
Accounts Receivable, Allowance for Credit Loss	216	$ 182	$ 215	$ 199
Accounts Receivable, Credit Loss Expense (Reversal)	5	4
Accounts Receivable, Allowance for Credit Loss, Recovery	8	1
Accounts Receivable, Allowance for Credit Loss, Writeoff	(13)	(24)
Accounts Receivable, Allowance for Credit Loss, Foreign Currency	1	1
Accounts Receivable, Allowance for Credit Loss, Other Adjustments	0	1
Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount	115
Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount	94
Equity Securities, FV-NI, Unrealized Gain (Loss)		$ 0
Equity Securities, FV-NI, Unrealized Loss	18
Equity Securities, FV-NI, Unrealized Gain	$ 2

Revenues (Details) - USD ($) $ in Millions	3 Months Ended
Revenues (Details) - USD ($) $ in Millions	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 21,847	$ 24,072
Revenues	21,847	24,072
Contract with Customer, Liability [Abstract]
Contract with Customer, Liability	508		$ 626
Change in Contract with Customer, Liability [Abstract]
Contract with Customer, Liability, Revenue Recognized	235
Operating Segments [Member]
Revenue from Contract with Customer [Abstract]
Revenues	21,738	23,969
Ag Services and Oilseeds [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	17,219	18,579
Revenues	17,219	18,579
Ag Services [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	11,197	11,695
Revenues	11,197	11,695
Crushing [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	3,327	3,683
Revenues	3,327	3,683
Refined Products and Other [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	2,695	3,201
Revenues	2,695	3,201
Carbohydrate Solutions [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	2,683	3,537
Revenues	2,683	3,537
Starches and sweeteners [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	2,156	2,737
Revenues	2,156	2,737
VCP [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	527	800
Revenues	527	800
Nutrition [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	1,836	1,853
Revenues	1,836	1,853
Human Nutrition [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	964	936
Revenues	964	936
Animal Nutrition [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	872	917
Revenues	872	917
Other [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	109	103
Other [Member] \| Operating Segments [Member]
Revenue from Contract with Customer [Abstract]
Revenues	109	103
Non MTM Products and Services [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	5,945	6,852
Non MTM Products and Services [Member] \| Operating Segments [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	5,836	6,749
Non MTM Products and Services [Member] \| Transferred at Point in Time [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	5,752	6,674
Non MTM Products and Services [Member] \| Transferred at Point in Time [Member] \| Operating Segments [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	5,643	6,571
Non MTM Products and Services [Member] \| Transferred over Time [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	193	178
Non MTM Products and Services [Member] \| Transferred over Time [Member] \| Operating Segments [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	193	178
Non MTM Products and Services [Member] \| Ag Services and Oilseeds [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	1,880	2,012
Non MTM Products and Services [Member] \| Ag Services and Oilseeds [Member] \| Transferred at Point in Time [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	1,687	1,834
Non MTM Products and Services [Member] \| Ag Services and Oilseeds [Member] \| Transferred over Time [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	193	178
Non MTM Products and Services [Member] \| Ag Services [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	1,215	1,195
Non MTM Products and Services [Member] \| Ag Services [Member] \| Transferred at Point in Time [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	1,022	1,017
Non MTM Products and Services [Member] \| Ag Services [Member] \| Transferred over Time [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	193	178
Non MTM Products and Services [Member] \| Crushing [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	117	191
Non MTM Products and Services [Member] \| Crushing [Member] \| Transferred at Point in Time [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	117	191
Non MTM Products and Services [Member] \| Refined Products and Other [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	548	626
Non MTM Products and Services [Member] \| Refined Products and Other [Member] \| Transferred at Point in Time [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	548	626
Non MTM Products and Services [Member] \| Carbohydrate Solutions [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	2,120	2,884
Non MTM Products and Services [Member] \| Carbohydrate Solutions [Member] \| Transferred at Point in Time [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	2,120	2,884
Non MTM Products and Services [Member] \| Starches and sweeteners [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	1,593	2,084
Non MTM Products and Services [Member] \| Starches and sweeteners [Member] \| Transferred at Point in Time [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	1,593	2,084
Non MTM Products and Services [Member] \| VCP [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	527	800
Non MTM Products and Services [Member] \| VCP [Member] \| Transferred at Point in Time [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	527	800
Non MTM Products and Services [Member] \| Nutrition [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	1,836	1,853
Non MTM Products and Services [Member] \| Nutrition [Member] \| Transferred at Point in Time [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	1,836	1,853
Non MTM Products and Services [Member] \| Human Nutrition [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	964	936
Non MTM Products and Services [Member] \| Human Nutrition [Member] \| Transferred at Point in Time [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	964	936
Non MTM Products and Services [Member] \| Animal Nutrition [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	872	917
Non MTM Products and Services [Member] \| Animal Nutrition [Member] \| Transferred at Point in Time [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	872	917
Non MTM Products and Services [Member] \| Other [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	109	103
Non MTM Products and Services [Member] \| Other [Member] \| Transferred at Point in Time [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	109	103
Mark-to-Market Products [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	15,902	17,220
Mark-to-Market Products [Member] \| Operating Segments [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	15,902	17,220
Mark-to-Market Products [Member] \| Ag Services and Oilseeds [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	15,339	16,567
Mark-to-Market Products [Member] \| Ag Services [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	9,982	10,500
Mark-to-Market Products [Member] \| Crushing [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	3,210	3,492
Mark-to-Market Products [Member] \| Refined Products and Other [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	2,147	2,575
Mark-to-Market Products [Member] \| Carbohydrate Solutions [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	563	653
Mark-to-Market Products [Member] \| Starches and sweeteners [Member]
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 563	$ 653

Acquisitions (Narrative) (Details)	3 Months Ended
Acquisitions (Narrative) (Details)	Mar. 31, 2024 USD ($)
Business Acquisition [Line Items]
Payments to Acquire Businesses, Gross	$ 924,000,000
Cash Acquired from Acquisition	9,000,000
Business Acquisition, Goodwill, Expected Tax Deductible Amount	0
Goodwill, Acquired During Period	$ 553,000,000

Acquisitions Other Intangible Assets (Details) $ in Millions	3 Months Ended
	Mar. 31, 2024 USD ($)
Schedule of Other Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	$ 263
Revela
Schedule of Other Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	166
FDL
Schedule of Other Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	97
PT
Schedule of Other Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	0
Trademarks and Trade Names [Member]
Schedule of Other Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	$ 4
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	3 years
Trademarks and Trade Names [Member] \| Revela
Schedule of Other Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	$ 0
Trademarks and Trade Names [Member] \| FDL
Schedule of Other Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	4
Customer Lists [Member]
Schedule of Other Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	197
Customer Lists [Member] \| Revela
Schedule of Other Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	124
Customer Lists [Member] \| FDL
Schedule of Other Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	73
Recipes
Schedule of Other Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	62
Recipes \| Revela
Schedule of Other Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	42
Recipes \| FDL
Schedule of Other Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	$ 20
Minimum [Member] \| Customer Lists [Member]
Schedule of Other Intangible Assets [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	10 years
Minimum [Member] \| Recipes
Schedule of Other Intangible Assets [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	10 years
Maximum [Member] \| Customer Lists [Member]
Schedule of Other Intangible Assets [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	18 years
Maximum [Member] \| Recipes
Schedule of Other Intangible Assets [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	21 years

Acquisitions (Details) - USD ($) $ in Millions	3 Months Ended
Acquisitions (Details) - USD ($) $ in Millions	Mar. 31, 2024	Mar. 31, 2023
Business Acquisition [Line Items]
Business Acquisition, Purchase Price Allocation, Working Capital	$ 55
Business Acquisition, Purchase Price Allocation, Property, Plant and Equipment	76
Goodwill, Acquired During Period	553
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	263
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets	29
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities	(61)
Payments to Acquire Businesses, Net of Cash Acquired	915	$ 0
Revela
Business Acquisition [Line Items]
Business Acquisition, Purchase Price Allocation, Working Capital	50
Business Acquisition, Purchase Price Allocation, Property, Plant and Equipment	38
Goodwill, Acquired During Period	403
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	166
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets	28
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities	(35)
Payments to Acquire Businesses, Net of Cash Acquired	650
FDL
Business Acquisition [Line Items]
Business Acquisition, Purchase Price Allocation, Working Capital	0
Business Acquisition, Purchase Price Allocation, Property, Plant and Equipment	33
Goodwill, Acquired During Period	145
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	97
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets	1
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities	(26)
Payments to Acquire Businesses, Net of Cash Acquired	250
PT
Business Acquisition [Line Items]
Business Acquisition, Purchase Price Allocation, Working Capital	5
Business Acquisition, Purchase Price Allocation, Property, Plant and Equipment	5
Goodwill, Acquired During Period	5
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	0
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets	0
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities	0
Payments to Acquire Businesses, Net of Cash Acquired	$ 15

Fair Value Measurements (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Fair Value Measurements [Line Items]
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)	$ (338)	$ (248)
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss)	$ 564	$ 632
Weighted Average [Member] \| Fair Value, Recurring [Member] \| Significant Unobservable Inputs (Level 3) [Member] \| Inventory Related Payables [Member]
Fair Value Measurements [Line Items]
Basis	25.90%		33.20%
Weighted Average [Member] \| Fair Value, Recurring [Member] \| Significant Unobservable Inputs (Level 3) [Member] \| Inventories Carried At Market [Member]
Fair Value Measurements [Line Items]
Basis	28.20%		25.00%

Fair Value Measurements (Fair Value Measurements At Reporting Date) (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Assets:
Derivative Asset	$ 1,549	$ 1,546
Liabilities:
Derivative Liability	977	1,101
Fair Value, Recurring [Member]
Assets:
Inventories carried at market	6,707	6,987
Cash Equivalents, at Carrying Value	206	209
Restricted Investments, at Fair Value	1,663	1,362
Total Assets	10,125	10,104
Liabilities:
Inventory-related payables	1,990	1,320
Total Liabilities	2,967	2,421
Fair Value, Recurring [Member] \| Commodity Contracts [Member]
Assets:
Derivative Asset	1,362	1,359
Liabilities:
Derivative Liability	883	957
Fair Value, Recurring [Member] \| Foreign Exchange Contracts [Member]
Assets:
Derivative Asset	187	187
Liabilities:
Derivative Liability	94	144
Fair Value, Recurring [Member] \| Quoted Prices In Active Markets For Identical Assets (Level 1) [Member]
Assets:
Inventories carried at market	0	0
Cash Equivalents, at Carrying Value	206	209
Restricted Investments, at Fair Value	1,663	1,362
Total Assets	1,869	1,571
Liabilities:
Inventory-related payables	0	0
Total Liabilities	0	0
Fair Value, Recurring [Member] \| Quoted Prices In Active Markets For Identical Assets (Level 1) [Member] \| Commodity Contracts [Member]
Assets:
Derivative Asset	0	0
Liabilities:
Derivative Liability	0	0
Fair Value, Recurring [Member] \| Quoted Prices In Active Markets For Identical Assets (Level 1) [Member] \| Foreign Exchange Contracts [Member]
Assets:
Derivative Asset	0	0
Liabilities:
Derivative Liability	0	0
Fair Value, Recurring [Member] \| Significant Other Observable Inputs (Level 2) [Member]
Assets:
Inventories carried at market	3,759	4,274
Cash Equivalents, at Carrying Value	0	0
Restricted Investments, at Fair Value	0	0
Total Assets	4,544	5,089
Liabilities:
Inventory-related payables	1,928	1,219
Total Liabilities	2,470	1,863
Fair Value, Recurring [Member] \| Significant Other Observable Inputs (Level 2) [Member] \| Commodity Contracts [Member]
Assets:
Derivative Asset	598	628
Liabilities:
Derivative Liability	448	500
Fair Value, Recurring [Member] \| Significant Other Observable Inputs (Level 2) [Member] \| Foreign Exchange Contracts [Member]
Assets:
Derivative Asset	187	187
Liabilities:
Derivative Liability	94	144
Fair Value, Recurring [Member] \| Significant Unobservable Inputs (Level 3) [Member]
Assets:
Inventories carried at market	2,948	2,713
Cash Equivalents, at Carrying Value	0	0
Restricted Investments, at Fair Value	0	0
Total Assets	3,712	3,444
Liabilities:
Inventory-related payables	62	101
Total Liabilities	497	558
Fair Value, Recurring [Member] \| Significant Unobservable Inputs (Level 3) [Member] \| Commodity Contracts [Member]
Assets:
Derivative Asset	764	731
Liabilities:
Derivative Liability	435	457
Fair Value, Recurring [Member] \| Significant Unobservable Inputs (Level 3) [Member] \| Foreign Exchange Contracts [Member]
Assets:
Derivative Asset	0	0
Liabilities:
Derivative Liability	$ 0	$ 0

Fair Value Measurements (Reconciliation Of Assets Measured At Fair Value On A Recurring Basis) (Details) - Significant Unobservable Inputs (Level 3) [Member] - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	$ 3,444	$ 3,301
Total increase (decrease) in unrealized gains included in cost of products sold	278	479
Purchases	3,789	8,665
Sales	(3,883)	(8,254)
Settlements	(352)	(382)
Transfers into Level 3	544	655
Transfers out of Level 3	(108)	(312)
Balance at end of period	3,712	4,152
Inventories Carried At Market [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	2,713	2,760
Total increase (decrease) in unrealized gains included in cost of products sold	(97)	2
Purchases	3,789	8,665
Sales	(3,883)	(8,254)
Settlements	0	0
Transfers into Level 3	516	605
Transfers out of Level 3	(90)	(275)
Balance at end of period	2,948	3,503
Commodity Derivative Contracts Gains [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	731	541
Total increase (decrease) in unrealized gains included in cost of products sold	375	477
Purchases	0	0
Sales	0	0
Settlements	(352)	(382)
Transfers into Level 3	28	50
Transfers out of Level 3	(18)	(37)
Balance at end of period	$ 764	$ 649

Fair Value Measurements (Reconciliation Of Liabilities Measured At Fair Value On A Recurring Basis) (Details) - Significant Unobservable Inputs (Level 3) [Member] - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	$ 558	$ 698
Total increase (decrease) in unrealized losses included in cost of products sold	326	236
Purchases	1	2
Sales	(38)
Settlements	(290)	(455)
Transfers into Level 3	14	39
Transfers out of Level 3	(74)	(7)
Balance at end of period	497	513
Long-term Debt [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period		6
Total increase (decrease) in unrealized losses included in cost of products sold		(5)
Purchases		0
Balance at end of period		1
Inventory Related Payables [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	101	89
Total increase (decrease) in unrealized losses included in cost of products sold	(3)	(2)
Purchases	1	2
Sales	(38)
Settlements	0	(31)
Transfers into Level 3	1	0
Transfers out of Level 3	0	(1)
Balance at end of period	62	57
Commodity Derivative Contracts Losses [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	457	603
Total increase (decrease) in unrealized losses included in cost of products sold	329	243
Purchases	0	0
Sales	0
Settlements	(290)	(424)
Transfers into Level 3	13	39
Transfers out of Level 3	(74)	(6)
Balance at end of period	$ 435	$ 455

Fair Value Measurements (Unobservable Inputs In Level 3 Valuations Of Assets And Liabilities Measured At Fair Value On A Recurring Basis) (Details) - Weighted Average [Member] - Significant Unobservable Inputs (Level 3) [Member] - Fair Value, Recurring [Member]	Mar. 31, 2024	Dec. 31, 2023
Inventory Related Payables [Member]
Unobservable inputs in Level 3 Valuations of Assets and Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Basis	25.90%	33.20%
Transportation cost	0.00%	0.00%
Commodity Derivative Contracts Losses [Member]
Unobservable inputs in Level 3 Valuations of Assets and Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Basis	28.20%	24.90%
Transportation cost	1.50%	3.20%
Inventories Carried At Market [Member]
Unobservable inputs in Level 3 Valuations of Assets and Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Basis	28.20%	25.00%
Transportation cost	18.60%	11.50%
Commodity Derivative Contracts Gains [Member]
Unobservable inputs in Level 3 Valuations of Assets and Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Basis	40.10%	24.20%
Transportation cost	8.30%	9.30%

Derivative Instruments and Hedging Activities (Narrative) (Details) bu in Millions, $ in Millions, € in Billions	3 Months Ended	12 Months Ended
	Mar. 31, 2024 EUR (€)	Dec. 31, 2023 EUR (€)	Mar. 31, 2024 USD ($) bu	Dec. 31, 2023 USD ($)
Derivative [Line Items]
Corn processed per month (in bushels) \| bu			59
Notional Amount of Nonderivative Instruments \| €	€ 0.7	€ 0.7
Foreign Debt used in Net Investment Hedge, Net of Tax			$ 224	$ 212
Financing Receivable, Allowance for Credit Loss			6	6
Designated As Hedging Instrument [Member]
Derivative [Line Items]
Unrealized Gain (Loss) on Price Risk Cash Flow Hedges, after Tax, Accumulated Other Comprehensive Income			9	(42)
Price Risk Cash Flow Hedge Unrealized Gain (Loss) to be Reclassified During Next 12 Months			$ 9
Corn [Member] \| Designated As Hedging Instrument [Member]
Derivative [Line Items]
Derivative Hedged Item Time Period	12 months
Corn [Member] \| Minimum [Member] \| Designated As Hedging Instrument [Member]
Derivative [Line Items]
Percentage of anticipated commodity purchases or production hedged during historical hedging period (as a percent)			12.00%
Percentage of anticipated commodity purchases or production hedged over future hedging period (as a percent)			0.00%
Corn [Member] \| Maximum [Member] \| Designated As Hedging Instrument [Member]
Derivative [Line Items]
Percentage of anticipated commodity purchases or production hedged during historical hedging period (as a percent)			34.00%
Percentage of anticipated commodity purchases or production hedged over future hedging period (as a percent)			29.00%
Soybean [Member] \| Designated As Hedging Instrument [Member]
Derivative [Line Items]
Derivative Hedged Item Time Period	12 months
Soybean [Member] \| Minimum [Member] \| Designated As Hedging Instrument [Member]
Derivative [Line Items]
Percentage of anticipated commodity purchases or production hedged during historical hedging period (as a percent)			77.00%
Percentage of anticipated commodity purchases or production hedged over future hedging period (as a percent)			3.00%
Soybean [Member] \| Maximum [Member] \| Designated As Hedging Instrument [Member]
Derivative [Line Items]
Percentage of anticipated commodity purchases or production hedged during historical hedging period (as a percent)			100.00%
Percentage of anticipated commodity purchases or production hedged over future hedging period (as a percent)			100.00%
Natural Gas \| Designated As Hedging Instrument [Member]
Derivative [Line Items]
Derivative Hedged Item Time Period	12 months
Natural Gas \| Minimum [Member] \| Designated As Hedging Instrument [Member]
Derivative [Line Items]
Percentage of anticipated commodity purchases or production hedged during historical hedging period (as a percent)			39.00%
Percentage of anticipated commodity purchases or production hedged over future hedging period (as a percent)			34.00%
Natural Gas \| Maximum [Member] \| Designated As Hedging Instrument [Member]
Derivative [Line Items]
Percentage of anticipated commodity purchases or production hedged during historical hedging period (as a percent)			80.00%
Percentage of anticipated commodity purchases or production hedged over future hedging period (as a percent)			70.00%
Net Investment Hedging [Member]
Derivative [Line Items]
Derivatives used in Net Investment Hedge, Net of Tax			$ (46)	5
Net Investment Hedging [Member] \| Currency Swap [Member]
Derivative [Line Items]
Derivative Liability, Notional Amount			800	800
Net Investment Hedging [Member] \| Foreign Exchange Forward [Member]
Derivative [Line Items]
Derivative Liability, Notional Amount			$ 2,100	$ 2,100

Derivative Instruments and Hedging Activities (Fair Value Of Derivatives Not Designated As Hedging Instruments) (Details) - Not Designated As Hedging Instrument [Member] - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Derivative [Line Items]
FX Contracts Assets	$ 145	$ 187
Commodity Contracts Assets	1,351	1,343
Total fair value of derivative assets not designated as hedging instruments	1,496	1,530
FX Contracts Liabilities	94	122
Commodity Contracts Liabilities	883	957
Total fair value of derivative liabilities not designated as hedging instruments.	$ 977	$ 1,079

Derivative Instruments and Hedging Activities (Pre-Tax Gains (Losses) On Derivatives Not Designated As Hedging Instruments) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Derivative [Line Items]
Revenues	$ 21,847	$ 24,072
Cost of Products Sold	20,188	21,992
Other (Income) Expense - Net	(26)	(44)
Interest Expense	166	147
Total gain (loss) recognized in earnings	189	513
Revenues [Member]
Derivative [Line Items]
FX Contracts	1	(11)
Total gain (loss) recognized in earnings	1	(11)
Cost of Products Sold [Member]
Derivative [Line Items]
FX Contracts	(63)	95
Commodity Contracts	197	440
Total gain (loss) recognized in earnings	134	535
Interest Expense [Member]
Derivative [Line Items]
Embedded Derivative, Gain (Loss) on Embedded Derivative, Net		5
Total gain (loss) recognized in earnings	0	5
Other (Income) Expense - Net [Member]
Derivative [Line Items]
FX Contracts	54	(16)
Commodity Contracts	0	0
Total gain (loss) recognized in earnings	$ 54	$ (16)

Derivative Instruments and Hedging Activities (Fair Value Of Derivatives Designated As Hedging Instruments) (Details) - Designated As Hedging Instrument [Member] - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Derivative [Line Items]
Price Risk Cash Flow Hedge Asset, at Fair Value	$ 11	$ 16
Derivative Instruments in Hedges, Net Investment in Foreign Operations, Assets, Fair Value	42	0
Derivative Instruments in Hedges, Assets, at Fair Value	53	16
Price Risk Fair Value Hedge Liability, at Fair Value	0	0
Derivative Instruments in Hedges, Net Investment in Foreign Operations, Liabilities, Fair Value	0	22
Derivative Instruments in Hedges, Liabilities, at Fair Value	$ 0	$ 22

Derivative Instruments and Hedging Activities (Pre-Tax Gains (Losses) On Derivatives Designated As Hedging Instruments) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Derivative Instruments, Gains (Loss) [Line Items]
Revenues	$ 21,847	$ 24,072
Cost of Products Sold	20,188	21,992
Interest Expense	166	147
Other (Income) Expense - Net	(26)	(44)
Designated As Hedging Instrument [Member]
Derivative Instruments, Gains (Loss) [Line Items]
Gain (Loss) on Hedging Activity	19	(104)
Designated As Hedging Instrument [Member] \| Cost of Products Sold [Member]
Derivative Instruments, Gains (Loss) [Line Items]
Gain (Loss) on Hedging Activity	19	(104)
Commodity Contracts effective amount recognized in earnings	$ 19	$ (104)

Other Current Assets (Details) - USD ($) $ in Millions	3 Months Ended
Other Current Assets (Details) - USD ($) $ in Millions	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Other Assets [Abstract]
Derivative Asset	$ 1,549		$ 1,546
Margin Deposit Assets	585		560
Receivables from Customers	1,131		1,052
Financing Receivable, after Allowance for Credit Loss	178		237
Premiums Receivable, Net	48		61
Prepaid Expense, Current	412		445
Biodiesel tax credit	77		119
Tax receivables	479		491
Other Receivables	376		304
Other current assets	148		167
Total other current assets	4,983		4,982
Financing Receivable, Allowance for Credit Loss	6		$ 6
Interest on financing receivables	$ 5	$ 6

Accrued Expenses And Other Payables (Details) - USD ($)
$ in Millions

3 Months Ended

Mar. 31, 2024

Dec. 31, 2023

Accrued Liabilities and Other Liabilities [Abstract]

Derivative Liability

$ 977

$ 1,101

Employee-related Liabilities

327

439

Accrued Income Taxes, Current

312

284

Accrual for Taxes Other than Income Taxes, Current

196

172

Liability for Claims and Claims Adjustment Expense

Contract with Customer, Liability

508

626

Accrued expenses and other payables

1,518

1,381

Total accrued expenses and other payables

$ 3,922

$ 4,076

Accrued Expenses And Other Payables

Accrued Expenses and Other Payables

The following table sets forth the items in accrued expenses and other payables:


	March 31,		December 31,
	2024		2023
	(In millions)

Unrealized losses on derivative contracts	$	977	$	1,101
Accrued compensation	327		439
Income tax payable	312		284
Other taxes payable	196		172


Insurance claims payable	84		73
Contract liability	508		626


Other accruals and payables	1,518		1,381
	$	3,922	$	4,076

Debt And Financing Arrangements (Narrative) (Details) $ in Millions, € in Billions	3 Months Ended	12 Months Ended
	Mar. 31, 2024 EUR (€)	Dec. 31, 2023 EUR (€)	Mar. 31, 2024 USD ($)
Debt Instrument [Line Items]
Notional Amount of Nonderivative Instruments \| €	€ 0.7	€ 0.7
Fair Value of Debt Below Carrying Value			$ 300
Line of Credit [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity			12,800
Unused lines of credit			8,800
Commercial Paper [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity			5,000
Commercial Paper			900
Accounts Receivable Securitization Facility [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity			3,000
Unused lines of credit			$ 700

Income Taxes (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
Income Taxes (Narrative) (Details) - USD ($) $ in Millions	Mar. 31, 2024	Mar. 31, 2023
Income Tax Contingency [Line Items]
Effective income tax rate	18.80%	16.10%
Tax and Customs Administration, Netherlands [Member]
Income Tax Contingency [Line Items]
Income tax assessment	$ 88
Additional income tax assessment - Interest and Penalties	$ 34

Shareholders' Equity Share Repurchase Program (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Accelerated Share Repurchases [Line Items]
Stock Repurchased During Period, Value	$ 868	$ 351
Total Share Repurchase Program
Accelerated Share Repurchases [Line Items]
Stock Repurchase Program, Number of Shares Authorized to be Repurchased	200,000,000
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased	38,500,000
Stock Repurchase Program Expiration Date	Dec. 31, 2024
ASR $1.0 billion
Accelerated Share Repurchases [Line Items]
Stock Repurchase Program, Authorized Amount	$ 1,000
Shares Acquired, Average Cost Per Share	$ 60.596
Stock Repurchased During Period, Value	$ 538
Stock Repurchased During Period, Shares	8,880,986

Shareholders' Equity AOCI (Details) $ in Millions	3 Months Ended
Shareholders' Equity AOCI (Details) $ in Millions	Mar. 31, 2024 USD ($)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance of Accumulated Other Comprehensive Income (Loss) at Beginning of Period	$ (2,487)
Other comprehensive income (loss) before reclassifications	(136)
Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax	84
Amounts reclassified from AOCI	(21)
Other comprehensive income (loss), tax, portion attributable to parent	(10)
Other Comprehensive Income (Loss), Net of Tax	(83)
Balance of Accumulated Other Comprehensive Income (Loss) at End of period	(2,570)
Foreign Currency Translation Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance of Accumulated Other Comprehensive Income (Loss) at Beginning of Period	(2,539)
Other comprehensive income (loss) before reclassifications	(77)
Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax	84
Amounts reclassified from AOCI	0
Other comprehensive income (loss), tax, portion attributable to parent	(20)
Other Comprehensive Income (Loss), Net of Tax	(13)
Balance of Accumulated Other Comprehensive Income (Loss) at End of period	(2,552)
Deferred Gain (Loss) On Hedging Activities [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance of Accumulated Other Comprehensive Income (Loss) at Beginning of Period	158
Other comprehensive income (loss) before reclassifications	(50)
Amounts reclassified from AOCI	(19)
Other comprehensive income (loss), tax, portion attributable to parent	10
Other Comprehensive Income (Loss), Net of Tax	(59)
Balance of Accumulated Other Comprehensive Income (Loss) at End of period	99
Pension Liability Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance of Accumulated Other Comprehensive Income (Loss) at Beginning of Period	(108)
Other comprehensive income (loss) before reclassifications	(2)
Amounts reclassified from AOCI	(2)
Other comprehensive income (loss), tax, portion attributable to parent	1
Other Comprehensive Income (Loss), Net of Tax	(3)
Balance of Accumulated Other Comprehensive Income (Loss) at End of period	(111)
Unrealized Gain (Loss) On Investments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance of Accumulated Other Comprehensive Income (Loss) at Beginning of Period	2
Other comprehensive income (loss) before reclassifications	(7)
Amounts reclassified from AOCI	0
Other comprehensive income (loss), tax, portion attributable to parent	(1)
Other Comprehensive Income (Loss), Net of Tax	(8)
Balance of Accumulated Other Comprehensive Income (Loss) at End of period	$ (6)

Shareholders' Equity Reclassification (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Earnings Before Income Taxes	$ (885)	$ (1,397)
Income taxes	(166)	(225)
Net Earnings Including Noncontrolling Interests	(719)	(1,172)
Reclassification out of Accumulated Other Comprehensive Income [Member] \| Deferred (Gain) Loss On Hedging Activities [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Earnings Before Income Taxes	(19)	104
Income taxes	(4)	18
Net Earnings Including Noncontrolling Interests	(15)	86
Reclassification out of Accumulated Other Comprehensive Income [Member] \| Pension Liability Adjustment [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Earnings Before Income Taxes	(2)	(31)
Income taxes	(1)	12
Net Earnings Including Noncontrolling Interests	(1)	(43)
Cost of Products Sold [Member] \| Reclassification out of Accumulated Other Comprehensive Income [Member] \| Deferred (Gain) Loss On Hedging Activities [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	(19)	104
Other (Income) Expense - Net [Member] \| Reclassification out of Accumulated Other Comprehensive Income [Member] \| Pension Liability Adjustment [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Prior Service Cost (Credit)	(5)	(11)
Actuarial Losses	$ 3	$ (20)

Other (Income) Expense (Details) - USD ($) $ in Millions	3 Months Ended
Other (Income) Expense (Details) - USD ($) $ in Millions	Mar. 31, 2024	Mar. 31, 2023
Segment Reporting Information [Line Items]
Gain (Loss) on Sale and Revaluation of Assets	$ 2	$ 11
Other - net	24	33
Other (Income) Expense - Net	(26)	(44)
Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component	$ (5)	$ (4)

Segment Information (Narrative) (Details)	3 Months Ended
Segment Information (Narrative) (Details)	Mar. 31, 2024 segment
Segment Reporting [Abstract]
Number of reportable segments	3

Segment Information (Segment Information) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Segment Information
Revenues	$ 21,847	$ 24,072
Earnings Before Income Taxes	885	1,397
Restructuring, Settlement and Impairment Provisions	(18)	(7)
Ag Services and Oilseeds [Member]
Segment Information
Revenues	17,219	18,579
Ag Services [Member]
Segment Information
Revenues	11,197	11,695
Crushing [Member]
Segment Information
Revenues	3,327	3,683
Refined Products and Other [Member]
Segment Information
Revenues	2,695	3,201
Carbohydrate Solutions [Member]
Segment Information
Revenues	2,683	3,537
Starches and sweeteners [Member]
Segment Information
Revenues	2,156	2,737
VCP [Member]
Segment Information
Revenues	527	800
Nutrition [Member]
Segment Information
Revenues	1,836	1,853
Human Nutrition [Member]
Segment Information
Revenues	964	936
Animal Nutrition [Member]
Segment Information
Revenues	872	917
Operating Segments [Member]
Segment Information
Revenues	21,738	23,969
Earnings Before Income Taxes	1,196	1,628
Operating Segments [Member] \| Ag Services and Oilseeds [Member]
Segment Information
Earnings Before Income Taxes	864	1,211
Operating Segments [Member] \| Ag Services and Oilseeds [Member] \| Previously Reported
Segment Information
Earnings Before Income Taxes	864	1,210
Operating Segments [Member] \| Ag Services and Oilseeds [Member] \| Intersegment pricing adjustments
Segment Information
Earnings Before Income Taxes	0	1
Operating Segments [Member] \| Carbohydrate Solutions [Member]
Segment Information
Earnings Before Income Taxes	248	279
Operating Segments [Member] \| Carbohydrate Solutions [Member] \| Previously Reported
Segment Information
Earnings Before Income Taxes	248	273
Operating Segments [Member] \| Carbohydrate Solutions [Member] \| Intersegment pricing adjustments
Segment Information
Earnings Before Income Taxes	0	6
Operating Segments [Member] \| Nutrition [Member]
Segment Information
Earnings Before Income Taxes	84	138
Operating Segments [Member] \| Nutrition [Member] \| Previously Reported
Segment Information
Earnings Before Income Taxes	84	145
Operating Segments [Member] \| Nutrition [Member] \| Intersegment pricing adjustments
Segment Information
Earnings Before Income Taxes	0	(7)
Operating Segments [Member] \| Other [Member]
Segment Information
Revenues	109	103
Earnings Before Income Taxes	121	97
Intersegment Elimination [Member]
Segment Information
Revenues	647	812
Intersegment Elimination [Member] \| Ag Services and Oilseeds [Member]
Segment Information
Revenues	426	530
Intersegment Elimination [Member] \| Ag Services and Oilseeds [Member] \| Previously Reported
Segment Information
Revenues	609	1,335
Intersegment Elimination [Member] \| Ag Services and Oilseeds [Member] \| Intersegment pricing adjustments
Segment Information
Revenues	0	1
Intersegment Elimination [Member] \| Ag Services and Oilseeds [Member] \| Intersegment classification adjustments
Segment Information
Revenues	0	(595)
Intersegment Elimination [Member] \| Ag Services and Oilseeds [Member] \| Intersegment revenues, as previously reported
Segment Information
Revenues	609	741
Intersegment Elimination [Member] \| Ag Services and Oilseeds [Member] \| Additional intersegment classification adjustments
Segment Information
Revenues	(183)	(211)
Intersegment Elimination [Member] \| Carbohydrate Solutions [Member]
Segment Information
Revenues	208	270
Intersegment Elimination [Member] \| Carbohydrate Solutions [Member] \| Previously Reported
Segment Information
Revenues	279	729
Intersegment Elimination [Member] \| Carbohydrate Solutions [Member] \| Intersegment pricing adjustments
Segment Information
Revenues	0	6
Intersegment Elimination [Member] \| Carbohydrate Solutions [Member] \| Intersegment classification adjustments
Segment Information
Revenues	0	(230)
Intersegment Elimination [Member] \| Carbohydrate Solutions [Member] \| Intersegment revenues, as previously reported
Segment Information
Revenues	279	505
Intersegment Elimination [Member] \| Carbohydrate Solutions [Member] \| Additional intersegment classification adjustments
Segment Information
Revenues	(71)	(235)
Intersegment Elimination [Member] \| Nutrition [Member]
Segment Information
Revenues	13	12
Intersegment Elimination [Member] \| Nutrition [Member] \| Previously Reported
Segment Information
Revenues	6	91
Intersegment Elimination [Member] \| Nutrition [Member] \| Intersegment pricing adjustments
Segment Information
Revenues	0	0
Intersegment Elimination [Member] \| Nutrition [Member] \| Intersegment classification adjustments
Segment Information
Revenues	0	(55)
Intersegment Elimination [Member] \| Nutrition [Member] \| Intersegment revenues, as previously reported
Segment Information
Revenues	6	36
Intersegment Elimination [Member] \| Nutrition [Member] \| Additional intersegment classification adjustments
Segment Information
Revenues	7	(24)
Segment Reconciling Items [Member]
Segment Information
Gain (Loss) on Disposition of Other Assets	0	1
Restructuring, Settlement and Impairment Provisions	(6)	(7)
Corporate, Non-Segment [Member]
Segment Information
Earnings Before Income Taxes	$ (426)	$ (322)

Asset Impairment, Exit, and Restructuring Costs (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Asset Impairment Charges And Exit Costs [Line Items]
Asset Impairment Charges	$ 3	$ 3
Restructuring Charges	3	$ 4
Corporate, Non-Segment [Member]
Asset Impairment Charges And Exit Costs [Line Items]
Restructuring Charges	$ 12

Sale of Accounts Receivable (Narrative) (Details) $ in Millions, € in Billions	3 Months Ended
	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Mar. 31, 2024 EUR (€)	Dec. 31, 2023 USD ($)
Securitization or Asset-backed Financing Arrangement, Financial Asset for which Transfer is Accounted as Sale [Line Items]
Transfer of Financial Assets Accounted for as Sales, Fair Value of Derecognized Assets	$ 2,300			$ 1,600
Proceeds from Sale of Other Receivables	11,800	$ 14,800
Loss on transfer of accounts receivables to purchasers	27	23
Amount of receivables sold	12,300	$ 15,100
Accounts Receivable, after Allowance for Credit Loss, Current	4,178			4,232
Asset Pledged as Collateral without Right
Securitization or Asset-backed Financing Arrangement, Financial Asset for which Transfer is Accounted as Sale [Line Items]
Accounts Receivable, after Allowance for Credit Loss, Current	700			$ 1,100
Accounts Receivable Securitization Facility [Member]
Securitization or Asset-backed Financing Arrangement, Financial Asset for which Transfer is Accounted as Sale [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	3,000
First Purchasers [Member] \| Accounts Receivable Securitization Facility [Member]
Securitization or Asset-backed Financing Arrangement, Financial Asset for which Transfer is Accounted as Sale [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	1,900
Second Purchasers [Member] \| Accounts Receivable Securitization Facility [Member]
Securitization or Asset-backed Financing Arrangement, Financial Asset for which Transfer is Accounted as Sale [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 1,100		€ 1.0

Supplier Finance Programs (Details) - USD ($) $ in Millions	3 Months Ended
Supplier Finance Programs (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Payables and Accruals [Abstract]
Supplier Finance Program, Obligation	$ 275	$ 274
Supplier Finance Program, Obligation, Addition	257
Supplier Finance Program, Obligation, Settlement	$ (256)

Legal Proceedings (Details) - AOT and Maize $ in Millions	3 Months Ended
Legal Proceedings (Details) - AOT and Maize $ in Millions	Mar. 31, 2024 USD ($)
Minimum [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	$ 500
Maximum [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	$ 2,000

Subsequent Events Subsequent Events (Details) - USD ($) $ / shares in Units, $ in Millions		3 Months Ended
	Apr. 15, 2024	Mar. 31, 2024	Mar. 31, 2023
Subsequent Event [Line Items]
Stock Repurchased During Period, Value		$ 868	$ 351
ASR $1.0 billion
Subsequent Event [Line Items]
Stock Repurchased During Period, Shares		8,880,986
Stock Repurchased During Period, Value		$ 538
Shares Acquired, Average Cost Per Share		$ 60.596
Subsequent Event [Member] \| ASR $1.0 billion
Subsequent Event [Line Items]
Stock Repurchased During Period, Shares	7,325,733
Stock Repurchased During Period, Value	$ 462
Shares Acquired, Average Cost Per Share	$ 63.065

	Real-time Prices	Level 2
London Stock Exchange
Chi-X Europe
BATS Europe
Aquis Exchange
New York Stock Exchange
NASDAQ
American Stock Exchange
Dow Jones Indices
Precious Metal

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

ADM Archer Daniels Midland Company